,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,1,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line,Confirmatory,,
1,3,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H226 Non-Small Cell Lung cell line,Confirmatory,,
2,5,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line,Confirmatory,,
3,7,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line,Confirmatory,,
4,9,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line,Confirmatory,,
5,13,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line,Confirmatory,,
6,15,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line,Confirmatory,,
7,19,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line,Confirmatory,,
8,21,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line,Confirmatory,,
9,23,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the LOX IMVI Melanoma cell line,Confirmatory,,
10,25,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line,Confirmatory,,
11,29,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line,Confirmatory,,
12,33,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line,Confirmatory,,
13,35,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line,Confirmatory,,
14,37,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line,Confirmatory,,
15,39,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-28 Melanoma cell line,Confirmatory,,
16,41,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line,Confirmatory,,
17,43,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line,Confirmatory,,
18,45,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line,Confirmatory,,
19,47,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line,Confirmatory,,
20,49,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line,Confirmatory,,
21,53,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line,Confirmatory,,
22,55,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line,Confirmatory,,
23,59,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line,Confirmatory,,
24,65,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HT29 Colon cell line,Confirmatory,,
25,67,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line,Confirmatory,,
26,71,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line,Confirmatory,,
27,73,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line,Confirmatory,,
28,77,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line,Confirmatory,,
29,79,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line,Confirmatory,,
30,81,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line,Confirmatory,,
31,83,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line,Confirmatory,,
32,85,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line,Confirmatory,,
33,87,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line,Confirmatory,,
34,91,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line,Confirmatory,,
35,93,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line,Confirmatory,,
36,95,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-231/ATCC Breast cell line,Confirmatory,,
37,97,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line,Confirmatory,,
38,99,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-3 Ovarian cell line,Confirmatory,,
39,101,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line,Confirmatory,,
40,105,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line,Confirmatory,,
41,107,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line,Confirmatory,,
42,109,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line,Confirmatory,,
43,113,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line,Confirmatory,,
44,115,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line,Confirmatory,,
45,119,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line,Confirmatory,,
46,121,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line,Confirmatory,,
47,123,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line,Confirmatory,,
48,125,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line,Confirmatory,,
49,131,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line,Confirmatory,,
50,137,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line,Confirmatory,,
51,139,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line,Confirmatory,,
52,141,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the TK-10 Renal cell line,Confirmatory,,
53,143,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line,Confirmatory,,
54,145,1,1,,120913,4421,Inactive,,,,,NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line,Confirmatory,,
55,179,1,1,,120913,4421,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
56,248,1,1,,120913,4421,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
57,357,2,1,,855620,4421,Inactive,,,,,AP1 Signaling Pathway,Confirmatory,,
58,361,1,2,,855620,4421,Inactive,285623.0,,,,Pyruvate Kinase,Confirmatory,,
59,364,1,3,,855620,4421,Inactive,,,,,Cell Proliferation & Viability (Cytotoxicity) Assay,Confirmatory,,
60,368,2,3,,855620,4421,Inactive,4757950.0,994.0,,,Cdc25B Catalytic Domain protein tyrosine phosphatase  HTS,Screening,,
61,371,1,1,,855620,4421,Inactive,,,,,Human A549 Lung Tumor Cell Growth Inhibition Assay,Screening,,
62,373,1,4,,855620,4421,Inactive,38788193.0,1903.0,,,S1P3 Agonist Primary HTS and Confirmation Assays,Screening,,
63,374,2,3,,855620,4421,Inactive,4758204.0,1843.0,,,In vitro Primary HTS Assay for MKP-1,Screening,,
64,375,2,3,,855620,4421,Inactive,90108679.0,,,,Mycobacterium tuberculosis Pantothenate Synthetase Assay,Confirmatory,,
65,411,2,1,,855620,4421,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
66,421,1,3,,17389812,4421,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
67,422,1,5,,855620,4421,Inactive,21464101.0,7532.0,,,HTS for 14-3-3 protein interaction modulators,Screening,,
68,425,3,2,,855620,4421,Inactive,16758752.0,116663.0,,IC50,MKP-3 in vitro HTS assay,Confirmatory,,
69,426,1,2,,17389812,4421,Inactive,,,,,Cell Viability - Jurkat,Confirmatory,,
70,427,1,1,,17389812,4421,Inactive,,,,,Cell Viability - Hek293,Confirmatory,,
71,429,1,5,,855620,4421,Inactive,4261762.0,3326.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
72,429,1,5,,855620,4421,Inactive,154146191.0,3320.0,,,HTS for Tumor Hsp90 Inhibitors,Screening,,
73,430,2,4,,855620,4421,Inactive,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7 cells),Confirmatory,,
74,431,2,4,,855620,4421,Inactive,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HPDE-C7K cells),Confirmatory,,
75,432,2,4,,855620,4421,Inactive,11024684.0,12044.0,,IC50,HTS discovery of chemical inhibitors of anti-apoptotic protein Bfl-1,Confirmatory,,
76,433,1,1,,17389812,4421,Inactive,,,,,Cell Viability - HepG2,Confirmatory,,
77,434,1,2,,17389812,4421,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
78,435,1,2,,17389812,4421,Inactive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
79,436,2,1,,855620,4421,Inactive,68565074.0,8314.0,,,HTS for BAP1 Enzyme inhibitors,Screening,,
80,438,1,4,,855620,4421,Inactive,223468676.0,5970.0,,,Cellular assay for TNF alpha induced NFkappaB translocation,Screening,,
81,440,3,3,,855620,4421,Inactive,4503779.0,2357.0,,,Primary HTS Assay for Formylpeptide Receptor (FPR) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide-Like-1 (FPRL1) Ligands,Screening,,
82,441,3,3,,855620,4421,Inactive,54112388.0,2358.0,,,Primary HTS Assay for Formylpeptide Receptor-Like-1 (FPRL1) Ligands and Primary HTS Counter-Screen Assay for Formylpeptide Receptor (FPR) Ligands,Screening,,
83,444,1,1,,855620,4421,Inactive,,,,,NFAT Signaling Pathway,Confirmatory,,
84,445,3,1,,17389812,4421,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
85,446,1,1,,855620,4421,Inactive,,,,,Stat Signaling Pathway,Confirmatory,,
86,449,1,5,,855620,4421,Inactive,13027636.0,1901.0,,,Primary HTS and Confirmation Assays for S1P1 Agonists and Agonism Potentiators,Screening,,
87,450,1,2,,855620,4421,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
88,454,1,7,,855620,4421,Inactive,,,,,VCAM-1 Plate Reader Assay in Pooled HUVECs: Inhibition of TNFa induced VCAM-1 cell surface expression,Screening,,
89,455,1,7,,855620,4421,Inactive,,,,,VCAM-1 Plate Reader Assay in Pooled HUVECs: Augmentation of TNFa induced VCAM-1 cell surface expression,Screening,,
90,456,1,7,,855620,4421,Inactive,,,,,VCAM-1 Imaging Assay in Pooled HUVECs: Inhibition of TNFa induced VCAM-1 cell surface expression,Screening,,
91,457,1,7,,855620,4421,Inactive,,,,,VCAM-1 Imaging Assay in Pooled HUVECs: Augmentation of TNFa induced VCAM-1 cell surface expression.,Screening,,
92,460,2,2,,855620,4421,Inactive,4503155.0,1514.0,,,Cathepsin L,Screening,,
93,483,1,6,,855620,4421,Inactive,296434520.0,3064.0,,,Aggregation and Clearance of Mutant Huntingtin Protein,Screening,,
94,485,1,8,,855620,4421,Inactive,38788193.0,1903.0,,,Primary HTS Assay for S1P3 Antagonists,Screening,,
95,487,1,2,,855620,4421,Inactive,,,,,TNFalpha Induced E-Selectin Expression -  Primary screen,Screening,,
96,488,2,1,,855620,4421,Inactive,63102437.0,1508.0,,,Cathepsin B compound mixture screening,Screening,,
97,501,2,2,,855620,4421,Inactive,23110962.0,1520.0,,,Cathepsin S,Screening,,
98,518,2,6,,855620,4421,Inactive,116734717.0,249.0,,IC50,TNAP luminescent HTS assay,Confirmatory,,
99,521,2,5,,855620,4421,Inactive,18375660.0,5778.0,,IC50,"HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target",Confirmatory,,
100,522,1,2,,855620,4421,Inactive,20070193.0,2516.0,,,Primary Cell-based High Throughput Screening assay for activators of the nuclear receptor Steroidogenic Factor 1 (SF-1),Screening,,
101,524,1,3,,855620,4421,Inactive,4506055.0,5566.0,,,Primary biochemical high-throughput screening assay for inhibitors of protein kinase A (PKA) activity,Screening,,
102,525,1,3,,855620,4421,Inactive,20070193.0,2516.0,,,Primary Cell-based High Throughput Screening assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1),Screening,,
103,527,3,1,,855620,4421,Inactive,,,,,Primary HTS Assay for Inhibitors of Bacterial Quorum Sensing,Screening,,
104,528,1,4,,855620,4421,Inactive,67191027.0,3676.0,,,Allosteric Agonists for the VLA-4 Integrin,Screening,,
105,529,1,4,,855620,4421,Inactive,67191027.0,3676.0,,,Allosteric Antagonists for the VLA-4 Integrin,Screening,,
106,530,1,1,,17389812,4421,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
107,538,2,2,,855620,4421,Inactive,4502495.0,716.0,,,Complement factor C1s,Screening,,
108,539,1,2,,855620,4421,Inactive,116077694.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - PMK,Screening,,
109,540,1,1,,17389812,4421,Inactive,,,,,Cell Viability - N2a,Confirmatory,,
110,541,1,1,,17389812,4421,Inactive,,,,,Cell Viability - NIH 3T3,Confirmatory,,
111,542,1,1,,17389812,4421,Inactive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
112,543,1,1,,17389812,4421,Inactive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
113,544,2,1,,17389812,4421,Inactive,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
114,545,1,1,,17389812,4421,Inactive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
115,546,1,1,,17389812,4421,Inactive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
116,552,1,3,,855620,4421,Inactive,,,,,Antimicrobial HTS Assay for E. coli BW25113 (wild type),Screening,,
117,555,1,2,,855620,4421,Inactive,116516899.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - MK,Screening,,
118,556,1,3,,855620,4421,Inactive,116076351.0,,,,Screening for Inhibitors of the Mevalonate Pathway in Streptococcus Pneumoniae - DPM-DC,Screening,,
119,559,2,2,,855620,4421,Inactive,147728.0,,,,RNA polymerase,Screening,,
120,560,1,2,,855620,4421,Inactive,548814.0,6095.0,,,Primary Cell-based High Throughput Screening assay for activators of the Retinoic Acid Receptor-related orphan receptor A (RORA),Screening,,
121,561,1,3,,855620,4421,Inactive,548814.0,6095.0,,,Primary Cell-based High Throughput Screening assay for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA),Screening,,
122,565,1,4,,855620,4421,Inactive,1431733.0,,,,HIV-1 RT-RNase H  MLSCN HTS MH077605,Screening,,
123,567,1,4,,855620,4421,Inactive,55956923.0,3350.0,,,Primary HTS assay for 5-Hydroxytryptamine (Serotonin) Receptor Subtype 1a (5HT1a) agonists,Screening,,
124,568,1,7,,855620,4421,Inactive,5729877.0,3312.0,,IC50,High Throughput Screening Assay for Hsc70 Inhibitors,Confirmatory,,
125,568,1,7,,855620,4421,Inactive,24234686.0,3312.0,,IC50,High Throughput Screening Assay for Hsc70 Inhibitors,Confirmatory,,
126,570,1,4,,855620,4421,Inactive,4505209.0,4322.0,,,Primary biochemical high-throughput screening assay for inhibitors of Matrix Metalloproteinase 13 (MMP13) activity,Screening,,
127,571,1,4,,855620,4421,Inactive,112822.0,3354.0,,,Primary Cell Based High Throughput Screening Assay for Antagonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E),Screening,,
128,572,1,5,,855620,4421,Inactive,,,,,Human SK-BR-3 Breast Tumor Cell Growth Inhibition In a 24- Hour Assay (Pilot Screen),Screening,,
129,573,1,4,,855620,4421,Inactive,,,,,Primary Antimicrobial Assay for E. coli BW25113 &#8710;tolC::kan Protocol for 384-well HTS,Screening,,
130,574,1,3,,855620,4421,Inactive,112822.0,3354.0,,,Primary Cell Based High Throughput Screening Assay for Agonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5HT1E),Screening,,
131,575,1,4,,855620,4421,Inactive,,,,,Human Endothelial Cell Proliferation Assay,Screening,,
132,576,1,2,,855620,4421,Inactive,67191027.0,3676.0,,,Auto-fluorescence of compounds effecting screening of VLA-4 Integrin,Other,,
133,577,1,1,,855620,4421,Inactive,11528014.0,912267.0,,,HTS to identify Inhibitors of West Nile Virus NS2bNS3 Proteinase,Screening,,
134,580,1,5,,855620,4421,Inactive,,,,,Human H69AR Lung Tumor Cell Growth Inhibition Assay,Screening,,
135,581,2,2,,855620,4421,Inactive,15680217.0,1511.0,,,Cathepsin G,Screening,,
136,583,2,6,,855620,4421,Inactive,123271505.0,,,IC50,High Throughput Screening Assay for Hsp70 Inhibitors,Confirmatory,,
137,584,1,3,,17389812,4421,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
138,585,1,4,,17389812,4421,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
139,587,1,5,,855620,4421,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
140,588,1,4,,855620,4421,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
141,589,1,3,,855620,4421,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
142,590,1,3,,855620,4421,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
143,591,1,4,,855620,4421,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
144,592,1,6,,855620,4421,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
145,593,1,4,,855620,4421,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
146,594,1,4,,855620,4421,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
147,595,1,3,,17389812,4421,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
148,596,1,2,,17389812,4421,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
149,597,1,3,,855620,4421,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
150,598,1,4,,855620,4421,Inactive,,,,,Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen,Screening,,
151,601,1,4,,855620,4421,Inactive,,,,,Identification of Molecular Probes that Reverse MRP-Mediated Drug Resistance Pilot Screen,Screening,,
152,602,1,4,,855620,4421,Inactive,,,,,Identification of Molecular Probes that Reverse MRP-Mediated Drug Resistance,Screening,,
153,603,1,2,,17389812,4421,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
154,604,1,3,,855620,4421,Inactive,41872583.0,9475.0,,,Primary biochemical high-throughput screening assay for inhibitors of Rho kinase 2 (Rhok2),Screening,,
155,605,1,2,,17389812,4421,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
156,606,1,3,,855620,4421,Inactive,224586929.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
157,606,1,3,,855620,4421,Inactive,301171662.0,26191.0,,,HTS for LYP Inhibitors-an Autoimmunity Target - Primary screen,Confirmatory,,
158,609,1,2,,855620,4421,Inactive,,,,,Chemical Complementation Assay for MKP-3,Screening,,
159,614,1,6,,855620,4421,Inactive,116734717.0,249.0,,,HTS colorimetric detection of phosphate released in TNAP reaction,Screening,,
160,615,1,6,,855620,4421,Inactive,116734717.0,249.0,,,HTS colorimetric detection of p-nitrophenol released in TNAP reaction,Screening,,
161,618,2,6,,855620,4421,Inactive,6690534.0,4323.0,,EC50,Luminescent HTS for small molecule inhibitors of MT1-MMP transcription,Confirmatory,,
162,620,2,5,,855620,4421,Inactive,,,,EC50,Fluorescent HTS Cytotoxicity/Cell viability assay (HT1080 cells),Confirmatory,,
163,622,1,2,,855620,4421,Inactive,499328.0,29738.0,,,Voltage-Dependent Potassium Channel Beta Subunit (KvBeta) Negative Modulator Primary Screen,Screening,,
164,623,1,3,,855620,4421,Inactive,499328.0,29738.0,,,Voltage-Dependent Potassium Channel Beta Subunit (KvBeta) Positive Modulator: Primary Screen,Screening,,
165,624,1,2,,855620,4421,Inactive,,,,,Measurement of GPCR-mediated thallium flux through GIRK channels: Primary Screen,Screening,,
166,625,1,2,,855620,4421,Inactive,,,,,Discovery of Novel Allosteric Agonists of the M4 Muscarinic Receptor: Primary Screen,Screening,,
167,626,1,3,,855620,4421,Inactive,,,,,Discovery of Novel Allosteric Modulators of the M1 Muscarinic Receptor: Agonist  Primary Screen,Screening,,
168,628,2,4,,855620,4421,Inactive,113121.0,25229.0,,,Discovery of novel allosteric modulators of the M1 muscarinic receptor: Antagonist Primary Screen,Screening,,
169,629,1,3,,855620,4421,Inactive,118764400.0,2099.0,,,HTS of Estrogen Receptor- alpha Coactivator Binding inhibitors,Screening,,
170,630,1,1,,855620,4421,Inactive,5174513.0,4088.0,,,HTS of Smad transcription factor inhibitors,Screening,,
171,631,1,4,,855620,4421,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
172,631,1,4,,855620,4421,Inactive,22538455.0,8648.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
173,633,1,3,,855620,4421,Inactive,10835013.0,2100.0,,,HTS for Estrogen Receptor-beta Coactivator Binding inhibitors,Screening,,
174,636,1,4,,855620,4421,Inactive,,,,,Modulators of Post-Golgi Transport - 384-well pilot screen,Screening,,
175,637,1,4,,855620,4421,Inactive,,,,,Modulators of Post-Golgi Transport - 1536-well pilot screen,Screening,,
176,639,1,2,,855620,4421,Inactive,118764400.0,2099.0,,,HTS of Estrogen Receptor- alpha Coactivator Binding Potentiators,Screening,,
177,641,1,4,,855620,4421,Inactive,,,,,Allosteric Modulators of D1 Receptors: Primary Screen,Screening,,
178,645,1,4,,855620,4421,Inactive,,,,,Isolation of Inhibitors of Her-Kinase Expression - 66K library screen,Screening,,
179,648,1,3,,855620,4421,Inactive,,,,,Human Endothelial Cell Proliferation Assay in 384-well format,Screening,,
180,654,1,1,,17389812,4421,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
181,655,1,1,,17389812,4421,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
182,656,1,1,,17389812,4421,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
183,657,1,1,,17389812,4421,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
184,658,1,1,,17389812,4421,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
185,659,1,1,,17389812,4421,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
186,660,1,1,,17389812,4421,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
187,661,1,1,,17389812,4421,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
188,662,1,1,,17389812,4421,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
189,663,1,1,,17389812,4421,Inactive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
190,664,1,1,,17389812,4421,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
191,665,1,1,,17389812,4421,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
192,666,1,1,,17389812,4421,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
193,667,1,1,,17389812,4421,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
194,680,1,10,,855620,4421,Inactive,180352.0,,,,Factor XIa Mixture HTS,Screening,,
195,684,1,12,,855620,4421,Inactive,317373446.0,2161.0,,,Factor XIIa Mixture HTS,Screening,,
196,686,1,1,,855620,4421,Inactive,,,,,Zebrafish Lipid Metabolism Assay---Primary Screen,Screening,,
197,687,1,17,,855620,4421,Inactive,180352.0,,,,Factor XIa Single Well HTS,Screening,,
198,701,1,17,,855620,4421,Inactive,317373446.0,2161.0,,,Factor XIIa Single Well HTS,Screening,,
199,708,1,4,,855620,4421,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Absorbance at 340 nm,Screening,,
200,709,1,2,,855620,4421,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Autofluorescence at 339/460 nm,Screening,,
201,719,1,3,,855620,4421,Inactive,,,,,Human Lung Fibroblast Proliferation Assay,Screening,,
202,731,1,5,,855620,4421,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
203,731,1,5,,855620,4421,Inactive,32307126.0,8202.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
204,746,1,1,,855620,4421,Inactive,2507196.0,5602.0,,,Primary biochemical high-throughput screening assay for inhibitors of the c-Jun N-Terminal Kinase 3 (JNK3),Screening,,
205,750,1,3,,855620,4421,Inactive,,,,,Luminescent HTS for small molecule activators of MT1-MMP transcription,Screening,,
206,751,1,3,,855620,4421,Inactive,,,,,Disassembly of the 26S Proteasome (ATP Hydrolysis-dependent),Screening,,
207,757,1,4,,855620,4421,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac wildtype,Screening,,
208,758,1,4,,855620,4421,Inactive,164058.0,404007.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab7 wildtype,Screening,,
209,759,1,4,,855620,4421,Inactive,190938.0,3265.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Ras wildtype,Screening,,
210,760,1,4,,855620,4421,Inactive,46577642.0,404009.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rab2 wildtype,Screening,,
211,761,1,4,,855620,4421,Inactive,56202836.0,,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Cdc42 wildtype,Screening,,
212,764,1,4,,855620,4421,Inactive,8574038.0,5879.0,,,HTS to identify specific small molecule inhibitors of Ras and Ras-related GTPases specifically Rac activated mutant,Screening,,
213,770,1,1,,855620,4421,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (24 Hour Treatment Protocol),Screening,,
214,771,1,2,,855620,4421,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (48 Hour Treatment Protocol),Screening,,
215,772,1,2,,855620,4421,Inactive,,,,,Cell Growth High Content Screening Assay of Human HT29 Colon Tumor Cells (72 Hour Treatment Protocol),Screening,,
216,774,1,2,,855620,4421,Inactive,,,,,Profiling the NIH Molecular Libraries Small Molecule Repository: Inhibition of Enzymes Frequently Used to reach a NAD/NADH Endpoint,Other,,
217,775,1,3,,855620,4421,Active,,,,,Screen for Chemicals that Extend Yeast Lifespan,Screening,,
218,781,1,1,,855620,4421,Inactive,27807367.0,287022.0,,,uHTS for 14-3-3/Bad interaction inhibitors,Screening,,
219,782,1,2,,855620,4421,Inactive,83627717.0,13684.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
220,782,1,2,,855620,4421,Inactive,302699239.0,1981.0,,,uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation,Screening,,
221,784,1,4,,855620,4421,Inactive,55584151.0,2629.0,,,Primary Cell Based High Throughput Screening Assay for Enhancers of Beta-Glucosidase Activity,Screening,,
222,793,1,2,,855620,4421,Inactive,4505447.0,4887.0,,,Primary cell based high-throughput screening assay for antagonists of neuropeptide Y receptor Y2 (NPY-Y2),Screening,,
223,795,1,1,,855620,4421,Inactive,,,,,MLSCN Assay for Activators of Prostate Cell Differentiation,Screening,,
224,797,1,1,,855620,4421,Inactive,115529463.0,5587.0,,,Fluorescence polarization assay for PKD inhibitors,Screening,,
225,798,2,12,,855620,4421,Inactive,180352.0,,,,Factor XIa 1536 HTS,Screening,,
226,799,1,5,,855620,4421,Inactive,134142337.0,4363.0,,,Identification of Molecular Probes that Activate MRP-1,Screening,,
227,800,2,11,,855620,4421,Inactive,317373446.0,2161.0,,,Factor XIIa 1536 HTS,Screening,,
228,803,1,4,,855620,4421,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify agonists of Galanin Receptor 2 (GALR2),Screening,,
229,804,1,3,,855620,4421,Inactive,,,,,Screen for Chemicals that Shorten Yeast Lifespan,Screening,,
230,809,1,3,,855620,4421,Active,,,,,"Screen for Chemicals that Extend Yeast Lifespan, Dose Response",Confirmatory,,
231,811,1,2,,26534558,4421,Inactive,55662034.0,,,,Primary Cell Based High Throughput Screening Assay for Inhibitors of TLR4-MyD88 binding,Screening,,
232,812,1,3,,855620,4421,Inactive,,,,,Screen for Chemicals that Extend Yeast Lifespan; Lifespan Extension in the Absence of Nicotinamide Secondary Screen,Confirmatory,,
233,813,1,4,,855620,4421,Inactive,116734717.0,249.0,,,HTS identification of compounds activating TNAP at intermediate concentration of phosphate acceptor detected in luminescent assay,Screening,,
234,816,1,3,,855620,4421,Inactive,,,,,Screen for Chemicals that Extend Yeast Lifespan; Counterscreen for Compounds that Activate the Gal1p promoter,Confirmatory,,
235,817,1,1,,855620,4421,Inactive,1360328.0,,,,Identification and characterization of compounds for addressing human bone marrow failure,Other,,
236,818,1,2,,855620,4421,Inactive,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression,Screening,,
237,827,1,2,,855620,4421,Inactive,,,,,High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor,Screening,,
238,828,1,5,,855620,4421,Inactive,6016094.0,8811.0,,,Primary cell-based high-throughput screening assay to identify antagonists of Galanin Receptor 2 (GALR2),Screening,,
239,833,1,2,,26534558,4421,Inactive,2578455.0,29234.0,,,Primary Cell Based High Throughput Screening Assay for Agonists of GALR2,Screening,,
240,834,1,3,,855620,4421,Inactive,,,,,C. albicans biofilm killing,Screening,,
241,841,1,1,,855620,4421,Inactive,,,,,Non-Nucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity HTS Single Point (MLSMR Library),Screening,,
242,847,1,2,,855620,4421,Inactive,,,,,Human SK-BR-3 Breast Tumor Cell Growth Inhibition In a 24- Hour Assay,Screening,,
243,861,1,1,,855620,4421,Inactive,55662034.0,,,,Primary cell-based high-throughput screening assay for inhibitors of TLR4-MyD88 binding,Screening,,
244,862,1,2,,855620,4421,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 inhibition,Screening,,
245,868,1,3,,855620,4421,Inactive,,,,,Screen for Chemicals that Inhibit the RAM Network,Screening,,
246,871,1,2,,855620,4421,Inactive,13272532.0,6774.0,,,Primary cell-based high throughput screening assay to measure STAT3 activation,Screening,,
247,873,1,13,,855620,4421,Inactive,6912644.0,25818.0,,,Kallikrein 5 1536 HTS,Screening,,
248,875,1,2,,855620,4421,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
249,875,1,2,,17389812,4421,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
250,878,1,2,,855620,4421,Inactive,,,,,NIH Compound Library Profiling: Compound and DTT Dependent Redox Cycling H2O2 Generation.,Screening,,
251,880,2,1,,855620,4421,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
252,880,2,1,,855620,4421,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
253,880,2,1,,17389812,4421,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
254,880,2,1,,17389812,4421,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
255,880,2,1,,26746931,4421,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
256,880,2,1,,26746931,4421,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
257,880,2,1,,26751459,4421,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
258,880,2,1,,26751459,4421,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
259,881,2,2,,855620,4421,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
260,881,2,2,,17389812,4421,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
261,881,2,2,,26751459,4421,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
262,884,1,2,,855620,4421,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
263,884,1,2,,17389812,4421,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
264,885,1,2,,855620,4421,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
265,885,1,2,,17389812,4421,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
266,886,1,2,,17389812,4421,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
267,886,1,2,,17389812,4421,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
268,887,1,2,,855620,4421,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
269,887,1,2,,17389812,4421,Inactive,1832253.0,246.0,,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
270,889,1,3,,855620,4421,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
271,889,1,3,,17389812,4421,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
272,892,1,2,,855620,4421,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
273,892,1,2,,17389812,4421,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
274,893,1,2,,855620,4421,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
275,893,1,2,,855620,4421,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
276,893,1,2,,17389812,4421,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
277,893,1,2,,17389812,4421,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
278,894,2,1,,855620,4421,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
279,894,2,1,,17389812,4421,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
280,894,2,1,,26746931,4421,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
281,894,2,1,,26751459,4421,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
282,898,1,1,,855620,4421,Inactive,28373018.0,1239205.0,,,YopH  HTS,Screening,,
283,900,1,3,,855620,4421,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
284,900,1,3,,17389812,4421,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
285,902,1,2,,855620,4421,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
286,902,1,2,,17389812,4421,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
287,910,1,2,,855620,4421,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
288,912,1,2,,17389812,4421,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
289,914,1,3,,855620,4421,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
290,915,1,3,,855620,4421,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
291,920,1,2,,855620,4421,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 inhibition,Screening,,
292,921,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-001,Confirmatory,,
293,923,1,2,,855620,4421,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
294,923,1,2,,17389812,4421,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
295,924,1,2,,855620,4421,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
296,924,1,2,,17389812,4421,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
297,925,1,2,,17389812,4421,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
298,926,1,2,,17389812,4421,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
299,927,1,3,,855620,4421,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
300,930,1,2,,855620,4421,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
301,932,1,4,,855620,4421,Inactive,6274552.0,6772.0,,,Primary cell-based high throughput screening assay to measure STAT1 activation,Screening,,
302,938,1,2,,17389812,4421,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
303,940,1,2,,855620,4421,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
304,940,1,2,,26612057,4421,Inactive,31881630.0,5732.0,,,Modulators of the EP2 prostaglandin E2 receptor - Primary Screening,Screening,,
305,946,1,2,,17389812,4421,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
306,947,1,2,,17389812,4421,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
307,948,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
308,950,1,1,,855620,4421,Inactive,231632.0,596.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-2.",Screening,,
309,951,1,1,,855620,4421,Inactive,23396469.0,10017.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-B.",Screening,,
310,952,1,1,,855620,4421,Inactive,1572493.0,599.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-W.",Screening,,
311,955,1,2,,17389812,4421,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
312,960,1,2,,17389812,4421,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
313,961,1,2,,17389812,4421,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
314,962,1,2,,17389812,4421,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
315,963,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
316,964,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
317,965,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-003,Confirmatory,,
318,966,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-004,Confirmatory,,
319,967,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-005,Confirmatory,,
320,968,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-009,Confirmatory,,
321,969,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-011,Confirmatory,,
322,970,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-013,Confirmatory,,
323,971,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-015,Confirmatory,,
324,972,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-017,Confirmatory,,
325,973,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-019,Confirmatory,,
326,974,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-021,Confirmatory,,
327,975,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-023,Confirmatory,,
328,976,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-025,Confirmatory,,
329,977,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-002,Confirmatory,,
330,978,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-006,Confirmatory,,
331,979,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-007,Confirmatory,,
332,980,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-008,Confirmatory,,
333,981,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-010,Confirmatory,,
334,982,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-012,Confirmatory,,
335,983,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-014,Confirmatory,,
336,984,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-016,Confirmatory,,
337,985,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-018,Confirmatory,,
338,986,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-020,Confirmatory,,
339,987,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-022,Confirmatory,,
340,988,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-024,Confirmatory,,
341,989,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP2-026,Confirmatory,,
342,993,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
343,994,1,2,,17389812,4421,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
344,995,1,2,,855620,4421,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
345,995,1,2,,17389812,4421,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
346,999,1,1,,46487920,4421,Inactive,,,,,A Validation Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor Using a Diverse Compound Set,Screening,,
347,1001,2,2,,855620,4421,Inactive,116734717.0,249.0,,EC50,uHTS identification of compounds activating TNAP in the absence of phosphate acceptor performed in luminescent assay,Confirmatory,,
348,1004,1,1,,46487920,4421,Inactive,,,,,A Validation Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression Using a Diverse Compound Set,Screening,,
349,1006,1,6,,855620,4421,Inactive,,,,,Counter Screen for Luciferase-based Primary Inhibition Assays,Screening,,
350,1007,1,1,,855620,4421,Inactive,510901.0,598.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bcl-XL.",Screening,,
351,1008,1,2,,855620,4421,Inactive,4757840.0,597.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Bfl-1",Screening,,
352,1009,1,2,,855620,4421,Inactive,7582271.0,4170.0,,,"Multiplexed high-throughput screen for small molecule regulators of Bcl-2 family protein interactions, specifically Bim-Mcl-1",Screening,,
353,1012,1,4,,855620,4421,Inactive,116734717.0,249.0,,,uHTS identification of TNAP inhibitors in the absence of phosphate acceptor performed in luminescent assay,Screening,,
354,1016,1,4,,855620,4421,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of activators of bovine intestinal alkaline phosphatase,Screening,,
355,1018,2,5,,855620,4421,Inactive,8744934.0,,,IC50,Chemical Antagonists IAP-family anti-apoptotic proteins,Confirmatory,,
356,1019,1,4,,855620,4421,Inactive,68299797.0,280993.0,,,Luminescent assay for identification of inhibitors of bovine intestinal alkaline phosphatase,Screening,,
357,1020,1,5,,855620,4421,Inactive,149631.0,,,,Counter Screen for Glucose-6-Phosphate Dehydrogenase-based Primary Assay,Screening,,
358,1021,1,1,,855620,4421,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Bid interaction inhibitors,Screening,,
359,1022,1,1,,855620,4421,Inactive,7582271.0,4170.0,,,uHTS of Mcl-1/Noxa interaction inhibitors,Screening,,
360,1027,1,3,,855620,4421,Inactive,,,,,Counter Screen for Luciferase-based Primary Stimulation Assays,Screening,,
361,1030,2,1,,855620,4421,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
362,1030,2,1,,17389812,4421,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
363,1030,2,1,,26746931,4421,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
364,1030,2,1,,26751459,4421,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
365,1032,1,2,,855620,4421,Inactive,20336229.0,5468.0,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
366,1032,1,2,,855620,4421,Inactive,62201602.0,,,,Primary biochemical High Throughput Screening assay for agonists of the steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Screening,,
367,1040,1,2,,855620,4421,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for antagonists of NPY-Y1,Screening,,
368,1044,1,1,,26534558,4421,Inactive,13027636.0,1901.0,,,Primary cell-based high-throughput screening assay to identify agonists of Sphingosine 1-Phosphate receptor 1 (S1P1),Screening,,
369,1046,1,6,,855620,4421,Inactive,339641.0,2147.0,,,Thrombin 1536 HTS,Screening,,
370,1048,1,1,,855620,4421,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
371,1048,1,1,,855620,4421,Inactive,32307126.0,8202.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 3 (SRC-3) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
372,1049,1,1,,855620,4421,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
373,1049,1,1,,855620,4421,Inactive,62201602.0,,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 2 (SRC-2) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
374,1051,1,1,,855620,4421,Inactive,20336229.0,5468.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
375,1051,1,1,,855620,4421,Inactive,22538455.0,8648.0,,,Measurement of TR-FRET detection format artefact in the screen for agonists of steroid receptor coactivator 1 (SRC-1) recruitment by the peroxisome proliferator-activated receptor gamma (PPARgamma),Other,,
376,1063,1,1,,855620,4421,Inactive,,,,,Leishmania major promastigote HTS,Screening,,
377,1066,1,2,,855620,4421,Inactive,9937384.0,,,,High Throughput Screen to Identify Compounds that Inhibit Class II HMG-CoA Reductases  - Primary Screen,Screening,,
378,1085,1,1,,855620,4421,Inactive,139424501.0,5176170.0,,,uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors,Screening,,
379,1135,1,3,,855620,4421,Inactive,116734717.0,249.0,,,uHTS identification of compounds inhibiting TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
380,1136,1,3,,855620,4421,Inactive,116734717.0,249.0,,,uHTS identification of compounds activating TNAP at a high concentration of phosphate acceptor detected in a luminescent assay,Screening,,
381,1189,1,5,,48414083,4421,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
382,1194,1,3,,48414083,4421,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
383,1195,1,2,,48416305,4421,Active,,,,,DSSTox (FDAMDD) FDA Maximum (Recommended) Daily Dose Database,Other,,
384,1199,1,3,,48414083,4421,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Mouse Bioassay Results,Other,,
385,1203,1,3,,855620,4421,Inactive,12803275.0,3303.0,,,Primary cell-based high-throughput screening assay to identify transcriptional activators of heat shock protein 70 (Hsp70),Screening,,
386,1205,1,4,,48414083,4421,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
387,1208,1,3,,48414083,4421,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
388,1209,2,2,,855620,4421,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Confirmatory,,
389,1214,1,4,,855620,4421,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay.,Screening,,
390,1216,1,5,,855620,4421,Inactive,16878311.0,4351.0,,,HTS identification of compounds activating phosphomannose isomerase (PMI) via a fluorescence intensity assay using a near- saturating concentration of mannose 6-phosphat,Screening,,
391,1217,1,4,,855620,4421,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
392,1220,2,2,,855620,4421,Inactive,16878311.0,4351.0,,IC50,HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate,Confirmatory,,
393,1222,1,6,,855620,4421,Inactive,,,,EC50,High Throughput Screen for Inhibitors of ER Stress-induced Cell Death in a 384 well format.,Confirmatory,,
394,1229,1,3,,855620,4421,Inactive,17391426.0,1738.0,,,uHTS Identification of Diaphorase Activators and Chemical Reducers: Counter Screen for Diaphorase-based Primary Assays,Screening,,
395,1235,1,2,,855620,4421,Inactive,,,,,Alternative Pathway ELISA_orthogonal screening,Screening,,
396,1236,1,1,,855620,4421,Inactive,1628587.0,397393.0,,,uHTS for Calpain Inhibitors,Screening,,
397,1239,1,3,,855620,4421,Inactive,34577122.0,4790.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
398,1239,1,3,,855620,4421,Inactive,223468676.0,5970.0,,,High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Primary Screen,Screening,,
399,1242,1,1,,855620,4421,Inactive,11094021.0,,,,C. albicans biofilm killing---Mixture HTS,Screening,,
400,1251,1,1,,855620,4421,Inactive,,,,,"Anti-Viral Drugs Against Arbovirus Infections, a Primary Screen",Screening,,
401,1273,1,1,,855620,4421,Inactive,59036749.0,3630.0,,,Primary screen for compounds that inhibit Insulin promoter activity in TRM-6 cells,Screening,,
402,1274,1,2,,855620,4421,Inactive,115298672.0,653361.0,,,"uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs)",Screening,,
403,1276,1,1,,855620,4421,Inactive,257380.0,351.0,,,Primary screen for compounds that activate Alzheimer's amyloid precursor,Screening,,
404,1285,1,1,,855620,4421,Inactive,257380.0,351.0,,,Primary screen for compounds that inhibit Alzheimer's amyloid precursor protein (APP) translation,Screening,,
405,1296,1,1,,855620,4421,Inactive,59036749.0,3630.0,,,Primary screen for compounds that activate Insulin promoter activity in TRM-6 cells,Screening,,
406,1304,1,2,,855620,4421,Inactive,4505445.0,4886.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1,Screening,,
407,1321,1,2,,855620,4421,Inactive,47123300.0,7465.0,,,Primary Cell-based High Throughput Screening Assay for Inhibitors of Wee1 Degradation,Screening,,
408,1325,1,2,,855620,4421,Inactive,62526033.0,9429.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCG2 screen, ABCB1 counter-screen",Screening,,
409,1326,1,4,,855620,4421,Inactive,42741659.0,5243.0,,,"High-throughput multiplex screening for ABC transporter inhibitors: specifically ABCB1 screen, ABCG2 counter-screen",Screening,,
410,1359,1,4,,855620,4421,Inactive,4505447.0,4887.0,,,Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2,Screening,,
411,1362,1,2,,855620,4421,Inactive,,,,,Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen,Screening,,
412,1376,1,2,,855620,4421,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
413,1377,1,1,,855620,4421,Inactive,,,,,HTS to identify inhibitors of zVAD Induced Cell Death in L929 Cells.,Screening,,
414,1379,1,2,,855620,4421,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
415,1379,1,2,,26746931,4421,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
416,1379,1,2,,26751459,4421,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
417,1381,1,1,,855620,4421,Inactive,,,,,HCS to Identify Inhibitors of Dynein Mediated Cargo Transport on Microtubules.,Screening,,
418,1385,2,2,,855620,4421,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
419,1415,1,2,,855620,4421,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
420,1415,1,2,,855620,4421,Inactive,86301151.0,5999.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS4-Galphao.",Screening,,
421,1416,1,2,,855620,4421,Inactive,134304838.0,9451.0,,,Primary cell-based high-throughput screening assay to measure PERK inhibition,Screening,,
422,1422,1,1,,855620,4421,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
423,1422,1,1,,26612057,4421,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
424,1423,1,2,,855620,4421,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
425,1423,1,2,,855620,4421,Inactive,74355113.0,85397.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS8-Galphao.",Screening,,
426,1424,1,1,,855620,4421,Inactive,34330186.0,368273.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1),Screening,,
427,1430,1,1,,855620,4421,Inactive,70832125.0,3663016.0,,,HTS assay for inhibitors of Trypanosoma brucei hexokinase 1,Screening,,
428,1434,2,3,,855620,4421,Inactive,13124881.0,865.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
429,1434,2,3,,855620,4421,Inactive,19923198.0,861.0,,IC50,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay.,Confirmatory,,
430,1439,1,1,,855620,4421,Inactive,1166512.0,6000.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
431,1439,1,1,,855620,4421,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS7-Galphao.",Screening,,
432,1440,1,1,,855620,4421,Inconclusive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
433,1440,1,1,,855620,4421,Inconclusive,86990435.0,10287.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS19-Galphao.",Screening,,
434,1441,1,1,,855620,4421,Inactive,10567816.0,2775.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
435,1441,1,1,,855620,4421,Inactive,156416009.0,6004.0,,,"Multiplexed high-throughput screen for small molecule regulators of RGS family protein interactions, specifically RGS16-Galphao.",Screening,,
436,1443,1,3,,855620,4421,Inactive,4507593.0,8743.0,,,uHTS for the identification of compounds that potentiate TRAIL-induced apoptosis of cancer cells,Screening,,
437,1445,1,1,,855620,4421,Inactive,124512980.0,813945.0,,IC50,Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP),Confirmatory,,
438,1446,1,3,,855620,4421,Inactive,119579178.0,3717.0,,,Primary cell-based high throughput assay for inhibitors of the Janus kinase 2 mutant JAK2V617F,Screening,,
439,1448,1,3,,855620,4421,Inactive,38174238.0,55283.0,,,Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3),Screening,,
440,1452,1,1,,855620,4421,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
441,1452,1,1,,17389812,4421,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
442,1452,1,1,,26751459,4421,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
443,1454,1,1,,855620,4421,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
444,1454,1,1,,26746931,4421,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
445,1456,1,1,,855620,4421,Inactive,12003227.0,57468.0,,,Identification of Novel Modulators of Cl- dependent Transport Process via HTS: Primary Screen,Other,,
446,1457,1,1,,855620,4421,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
447,1457,1,1,,17389812,4421,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
448,1457,1,1,,26746931,4421,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
449,1457,1,1,,26751459,4421,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
450,1458,1,1,,855620,4421,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
451,1458,1,1,,17389812,4421,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
452,1458,1,1,,26746931,4421,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
453,1460,1,3,,855620,4421,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
454,1460,1,3,,26746931,4421,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
455,1460,1,3,,26751459,4421,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
456,1461,1,2,,855620,4421,Inactive,46395496.0,387129.0,,Potency,qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction,Confirmatory,,
457,1463,1,1,,855620,4421,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
458,1463,1,1,,26746931,4421,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
459,1463,1,1,,26751459,4421,Inactive,,,,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
460,1465,1,1,,855620,4421,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
461,1466,1,2,,855620,4421,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
462,1467,1,3,,26746931,4421,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
463,1467,1,3,,26751459,4421,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
464,1468,1,1,,855620,4421,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
465,1468,1,1,,26746931,4421,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
466,1468,1,1,,26751459,4421,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
467,1469,1,1,,855620,4421,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
468,1469,1,1,,17389812,4421,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
469,1469,1,1,,26746931,4421,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
470,1469,1,1,,26751459,4421,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
471,1469,1,1,,26751460,4421,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
472,1471,2,1,,17389812,4421,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
473,1471,2,1,,26746931,4421,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
474,1471,2,1,,26751459,4421,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
475,1471,2,1,,26751460,4421,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
476,1476,2,1,,855620,4421,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
477,1476,2,1,,17389812,4421,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
478,1476,2,1,,26746931,4421,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
479,1476,2,1,,26751459,4421,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
480,1477,1,1,,855620,4421,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
481,1477,1,1,,17389812,4421,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
482,1477,1,1,,26746931,4421,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
483,1477,1,1,,26751459,4421,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
484,1478,2,1,,855620,4421,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
485,1478,2,1,,17389812,4421,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
486,1478,2,1,,26746931,4421,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
487,1478,2,1,,26751459,4421,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
488,1479,1,2,,855620,4421,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
489,1479,1,2,,17389812,4421,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
490,1479,1,2,,26746931,4421,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
491,1479,1,2,,26751459,4421,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
492,1479,1,2,,26751460,4421,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
493,1481,1,2,,855620,4421,Inactive,111305821.0,7415.0,,,Primary biochemical high-throughput screening assay to measure P97 ATPase inhibition,Screening,,
494,1486,1,3,,855620,4421,Inactive,,,,,Counterscreen for inhibitors of Janus kinase 2 mutant JAK2V617F: Cell-based high throughput assay to identify inhibitors of parental Ba/F3 cell viability.,Screening,,
495,1487,1,1,,855620,4421,Inconclusive,27436948.0,4000.0,0.1259,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
496,1490,2,1,,855620,4421,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
497,1490,2,1,,26746931,4421,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
498,1490,2,1,,26751459,4421,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
499,1490,2,1,,26751460,4421,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
500,1496,1,4,,855620,4421,Inactive,13124881.0,865.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
501,1496,1,4,,855620,4421,Inactive,19923198.0,861.0,,,uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb via a fluorescence resonance energy transfer (FRET) assay.,Screening,,
502,1509,1,2,,855620,4421,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
503,1510,1,3,,855620,4421,Inactive,15929025.0,8698.0,,,Primary Cell-Based Assay to Identify Antagonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4),Screening,,
504,1511,1,3,,855620,4421,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
505,1515,1,2,,855620,4421,Inactive,24119166.0,10741.0,,,Primary biochemical high throughput screening assay to identify inhibitors of Retinoblastoma binding protein 9 (RBBP9),Screening,,
506,1519,1,3,,26746931,4421,Inconclusive,,,31.6228,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
507,1527,1,3,,855620,4421,Inactive,7381449.0,14678525.0,,,Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase,Screening,,
508,1529,1,1,,855620,4421,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
509,1530,1,1,,855620,4421,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
510,1531,1,1,,855620,4421,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
511,1532,1,1,,855620,4421,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
512,1554,1,1,,855620,4421,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
513,1556,1,4,,855620,4421,Inactive,27368096.0,,,,Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase,Screening,,
514,1565,2,2,,855620,4421,Inactive,219689097.0,162466.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1,Confirmatory,,
515,1566,2,3,,855620,4421,Inactive,11545912.0,64127.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD2,Confirmatory,,
516,1578,3,2,,855620,4421,Inactive,5174617.0,10392.0,,EC50,uHTS luminescence assay for the identification of compounds that inhibit NOD1,Confirmatory,,
517,1580,1,1,,8149659,4421,Inconclusive,,,,,Screen for compounds that inhibit mitochondrial permeability transition (MitoPT),Other,,
518,1581,1,1,,8149659,4421,Inconclusive,,,,,Screen of Compounds to Block PAR4 - aPKC Interaction for Treatment of Neurodegeneration (Par4_PKC),Other,,
519,1582,1,1,,8149659,4421,Inconclusive,,,,,Yeast cell-based screen for Novel HDAC inhibitors using a PHO84-LacZ reporter gene (PHO84),Other,,
520,1583,1,1,,8149659,4421,Unspecified,,,,,Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3),Other,,
521,1584,1,1,,8149659,4421,Inconclusive,,,,,Screen for compounds that inhibit in vitro mutant huntingtin aggregation (QA1),Other,,
522,1585,1,1,,8149659,4421,Inconclusive,,,,,"Screen for compounds that inhibit the ability of solid phase synthetic polyglutamine aggregates to elongate by incorporating solution-phase biotin-tagged, monomeric polyglutamine (QA3)",Other,,
523,1586,1,1,,8149659,4421,Inconclusive,,,,,A 2-Hybrid Test for Interactions Between Polyglutamine-Containing Proteins in the Yeast Nucleus  (Qn2Hy),Other,,
524,1587,1,1,,8149659,4421,Inconclusive,,,,,Screen for compounds that increase the expression of EAAT-2 in rat spinal cord organotypic slice cultures (X4_EAAT2),Other,,
525,1588,1,1,,8149659,4421,Inconclusive,,,,,Screen for compounds that reduce polyglutamine aggregation as measured by turbidity (QTHIO),Other,,
526,1589,1,1,,8149659,4421,Inconclusive,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (SDS),Other,,
527,1590,1,1,,8149659,4421,Inconclusive,,,,,Cellular toxicity caused by inducible expressing of N-terminal huntingtin with expanded ployglutamine repeat (Htt-N63-148Q) in PC12 cells (ROSShtt),Other,,
528,1593,1,1,,8149659,4421,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU),Other,,
529,1594,1,1,,8149659,4421,Inconclusive,,,,,Screen for compounds that decrease glutamate induced motor neuron death measured by TUNEL staining for DNA degradation (MNGlu),Other,,
530,1595,1,1,,8149659,4421,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYe),Other,,
531,1596,1,1,,8149659,4421,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH100),Other,,
532,1597,1,1,,8149659,4421,Inconclusive,,,,,Suppression of Polyglutamine Toxicity in Whole Organism Drosophila Model of SCA1 (SCA1FLYp),Other,,
533,1598,1,1,,8149659,4421,Inconclusive,,,,,Screen for compounds that selectively increase SMN2 splicing relative to SMN1 splicing (SMNLUC),Other,,
534,1599,1,1,,8149659,4421,Unspecified,,,,,"Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU)",Other,,
535,1600,1,1,,8149659,4421,Inconclusive,,,,,Yeast Assay for Parkinson&apos;s Disease (YAPD),Other,,
536,1601,1,1,,8149659,4421,Inconclusive,,,,,Screen for compounds that suppress mutant SOD1-mediated cell death (mSODtox),Other,,
537,1602,1,1,,8149659,4421,Inconclusive,,,,,Screen for compounds that attenuate mutant SOD1 toxicity (mSOD1),Other,,
538,1603,1,1,,8149659,4421,Unspecified,,,,,Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel),Other,,
539,1604,1,1,,8149659,4421,Unspecified,,,,,Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG),Other,,
540,1605,1,1,,8149659,4421,Unspecified,,,,,Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1),Other,,
541,1606,1,1,,8149659,4421,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH20),Other,,
542,1607,1,1,,8149659,4421,Inconclusive,,,,,Screen for compounds that promote the turnover of an expanded polyglutamine androgen receptor (AR112GFP),Other,,
543,1608,1,1,,8149659,4421,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH016),Other,,
544,1609,1,1,,8149659,4421,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells (LDH08),Other,,
545,1610,1,1,,8149659,4421,Inconclusive,,,,,Protection from expanded polyglutamine huntingtin toxicity in PC12 cells,Other,,
546,1611,1,1,,8149659,4421,Unspecified,,,,,Screen for compounds that induce the human heat shock transcriptional response (HSEluc),Other,,
547,1612,1,1,,8149659,4421,Unspecified,,,,,Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE),Other,,
548,1613,1,1,,8149659,4421,Unspecified,,,,,Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1),Other,,
549,1614,1,1,,8149659,4421,Unspecified,,,,,Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80),Other,,
550,1616,1,1,,8149659,4421,Unspecified,,,,,Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH),Other,,
551,1619,1,2,,855620,4421,Inactive,124809582.0,812021.0,,IC50,Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP),Confirmatory,,
552,1621,1,2,,855620,4421,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
553,1626,1,2,,855620,4421,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
554,1631,3,1,,855620,4421,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
555,1634,3,1,,855620,4421,Inactive,33286418.0,5315.0,,Potency,qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase,Confirmatory,,
556,1654,2,2,,855620,4421,Inactive,4758208.0,1845.0,,IC50,uHTS absorbance assay for the identification of compounds that inhibit VHR1.,Confirmatory,,
557,1656,2,2,,855620,4421,Inactive,,,,,High Throughput Imaging Assay for Hepatic Lipid Droplet Formation,Screening,,
558,1662,1,2,,855620,4421,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
559,1663,1,2,,855620,4421,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
560,1665,2,2,,855620,4421,Inactive,4503131.0,1499.0,,IC50_Mean,High Throughput Imaging Assay for Beta-Catenin,Confirmatory,,
561,1672,1,3,,855620,4421,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
562,1688,1,1,,855620,4421,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
563,1688,1,1,,26751460,4421,Inactive,90903231.0,3064.0,,Potency,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP),Confirmatory,,
564,1700,1,2,,855620,4421,Inactive,124263658.0,688.0,,,Primary cell-based high throughput screening assay to identify inhibitors of kruppel-like factor 5 (KLF5),Screening,,
565,1706,1,2,,855620,4421,Inactive,73745819.0,,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the SARS coronavirus 3C-like Protease (3CLPro),Screening,,
566,1721,1,2,,855620,4421,Inactive,290753097.0,,,Potency,qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
567,1722,1,2,,855620,4421,Inactive,290753097.0,,,Potency,qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK),Confirmatory,,
568,1766,1,1,,855620,4421,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
569,1766,1,1,,855620,4421,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
570,1766,1,1,,26746931,4421,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
571,1766,1,1,,26746931,4421,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
572,1766,1,1,,26751459,4421,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
573,1766,1,1,,26751459,4421,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
574,1766,1,1,,26751460,4421,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
575,1766,1,1,,26751460,4421,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
576,1768,1,1,,855620,4421,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
577,1768,1,1,,855620,4421,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
578,1768,1,1,,26746931,4421,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
579,1768,1,1,,26746931,4421,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
580,1768,1,1,,26751459,4421,Inactive,18860839.0,4221.0,2.8184,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
581,1768,1,1,,26751459,4421,Inactive,56550039.0,4297.0,2.8184,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
582,1768,1,1,,26751460,4421,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
583,1768,1,1,,26751460,4421,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
584,1775,1,2,,855620,4421,Inactive,,,,,Profiling compound fluorescence on Avidin Beads with 488 nm excitation and 530 nm emission,Other,,
585,1776,1,2,,855620,4421,Inactive,,,,,Profiling compound fluorescence on GSH Beads with 488 nm excitation and 530 nm emission,Other,,
586,1777,3,2,,855620,4421,Inactive,39725940.0,4986.0,,EC50,uHTS identification of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
587,1778,3,3,,855620,4421,Inactive,39725940.0,4986.0,,IC50,uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay,Confirmatory,,
588,1779,2,2,,855620,4421,Inactive,224586929.0,26191.0,,IC50,uHTS identification of small molecule inhibitors of LYP via a fluorescence intensity assay,Confirmatory,,
589,1789,1,2,,855620,4421,Inactive,83318444.0,3320.0,,,Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90),Screening,,
590,1792,1,1,,26534558,4421,Inactive,83699673.0,27035.0,,,Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of NADPH oxidase 1 (Nox1): Maybridge Library,Screening,,
591,1800,1,2,,855620,4421,Inactive,125541954.0,,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3),Screening,,
592,1813,1,2,,855620,4421,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
593,1814,1,2,,855620,4421,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
594,1817,2,2,,855620,4421,Inactive,40849930.0,5339.0,,IC50,uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay.,Confirmatory,,
595,1822,1,3,,855620,4421,Inactive,23505220.0,813594.0,,,QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP).,Screening,,
596,1823,1,1,,26534558,4421,Inactive,,,,,Luminescence-based counterscreen for inhibitors of NADPH oxidase 1 (Nox1): biochemical high throughput screening assay to identify inhibitors of luminol (Maybridge Library),Screening,,
597,1825,1,1,,855620,4421,Inactive,,,,,Luminescence-based counterscreen assay for KLF5 inhibitors: cell-based high throughput screening assay to identify cytotoxic compounds using the IEC-6 intestinal epithelial cell line.,Screening,,
598,1832,2,1,,855620,4421,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
599,1845,1,2,,855620,4421,Inactive,125541954.0,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors: biochemical high-throughput screening assay to identify compounds that cause fluorescent intercalator displacement (FID),Screening,,
600,1850,2,1,,855620,4421,Active,,,60.38,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
601,1850,2,1,,56422386,4421,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
602,1861,2,1,,855620,4421,Inactive,119607128.0,2831.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify antagonists of the G-protein coupled receptor 7 (GPR7).,Screening,,
603,1862,1,4,,855620,4421,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_RPL19A,Screening,,
604,1863,2,1,,855620,4421,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
605,1863,2,1,,56422386,4421,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
606,1865,1,1,,855620,4421,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
607,1865,1,1,,26746931,4421,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
608,1865,1,1,,26751459,4421,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
609,1867,1,4,,855620,4421,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_MEP2,Screening,,
610,1868,1,4,,855620,4421,Inactive,4503895.0,2584.0,,Potency,qHTS Assay for Inhibitors of Human Galactokinase (GALK),Confirmatory,,
611,1870,1,4,,855620,4421,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_CIT2,Screening,,
612,1873,1,4,,855620,4421,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_LAP4,Screening,,
613,1875,2,1,,855620,4421,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
614,1885,2,1,,855620,4421,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
615,1887,1,4,,855620,4421,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_AGP1,Screening,,
616,1899,1,3,,56422386,4421,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
617,1903,2,3,,855620,4421,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
618,1903,2,3,,56422386,4421,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
619,1906,1,3,,56422386,4421,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
620,1910,1,2,,855620,4421,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
621,1947,1,2,,56422386,4421,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
622,1948,1,1,,17389812,4421,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
623,1948,1,1,,26746931,4421,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
624,1948,1,1,,26751459,4421,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
625,1950,1,3,,56422386,4421,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
626,1956,1,1,,855620,4421,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
627,1961,2,2,,855620,4421,Inactive,33695107.0,9290.0,,EC50,Image-based HTS for Selective Agonists of GPR55,Confirmatory,,
628,1962,1,2,,56422386,4421,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
629,1974,1,2,,56422386,4421,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
630,1984,1,3,,855620,4421,Inactive,118026946.0,17979.0,,IC50,Fluorescence for the identification of compounds that decrease p/CIP protein stability,Confirmatory,,
631,1985,2,1,,855620,4421,Active,,,76.579,IC50,A screen for inhibitors of the PhoP regulon in Salmonella Typhi using a modified counterscreen,Confirmatory,,
632,1986,1,2,,855620,4421,Inactive,45357394.0,,,IC50,uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors.,Confirmatory,,
633,1987,1,2,,56422386,4421,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
634,2006,3,2,,855620,4421,Inactive,4507785.0,7329.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
635,2006,3,2,,855620,4421,Inactive,13111961.0,10054.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
636,2006,3,2,,855620,4421,Inactive,17390638.0,10055.0,,IC50,uHTS HTRF assay for identification of inhibitors of SUMOylation,Confirmatory,,
637,2012,3,2,,855620,4421,Inactive,45219878.0,7458.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (eIF4H),Confirmatory,,
638,2013,2,2,,855620,4421,Inactive,33695107.0,9290.0,,IC50,Image-Based HTS for Selective Antagonists for GPR55,Confirmatory,,
639,2014,3,2,,855620,4421,Inactive,46367787.0,26986.0,,IC50,uHTS fluorescence polarization assay for the identification of translation initiation inhibitors (PABP),Confirmatory,,
640,2016,1,3,,56422386,4421,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
641,2023,1,3,,56422386,4421,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
642,2025,1,3,,56422386,4421,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
643,2029,1,3,,56422386,4421,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
644,2052,2,1,,56422386,4421,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
645,2057,1,2,,56422386,4421,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
646,2058,3,2,,855620,4421,Inactive,33695097.0,2859.0,,IC50,Image-Based HTS for Selective Antagonists of GPR35,Confirmatory,,
647,2066,1,4,,56422386,4421,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
648,2071,2,2,,855620,4421,Inactive,14719829.0,22861.0,,,Colorimetric  Assay for Inhibitors for NALP1,Screening,,
649,2073,2,3,,855620,4421,Inactive,2625023.0,83589.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
650,2073,2,3,,855620,4421,Inactive,4502523.0,774.0,,IC50,Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay,Confirmatory,,
651,2094,1,2,,855620,4421,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
652,2094,1,2,,855620,4421,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
653,2094,1,2,,855620,4421,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
654,2097,1,2,,855620,4421,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
655,2098,1,1,,855620,4421,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
656,2099,1,1,,855620,4421,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
657,2100,1,1,,855620,4421,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen,Confirmatory,,
658,2101,1,1,,855620,4421,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
659,2101,1,1,,17389812,4421,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
660,2101,1,1,,26746931,4421,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
661,2101,1,1,,26751459,4421,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
662,2107,1,1,,855620,4421,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
663,2107,1,1,,17389812,4421,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
664,2107,1,1,,26746931,4421,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
665,2107,1,1,,26751459,4421,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
666,2112,1,1,,855620,4421,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
667,2112,1,1,,17389812,4421,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
668,2112,1,1,,26746931,4421,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
669,2112,1,1,,26751459,4421,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
670,2120,1,1,,17389812,4421,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
671,2129,1,2,,56422386,4421,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
672,2130,1,3,,56422386,4421,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
673,2147,1,1,,855620,4421,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
674,2147,1,1,,26746931,4421,Inactive,221046486.0,,,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
675,2156,2,2,,855620,4421,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
676,2174,1,3,,56422386,4421,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
677,2177,1,3,,56422386,4421,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
678,2205,1,1,,855620,4421,Inactive,29788785.0,203068.0,,,HCS assay for microtubule stabilizers,Screening,,
679,2216,1,3,,855620,4421,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
680,2221,1,2,,855620,4421,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
681,2227,1,2,,855620,4421,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
682,2234,1,2,,56422386,4421,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
683,2235,1,2,,56422386,4421,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
684,2237,1,2,,855620,4421,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
685,2239,1,2,,855620,4421,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
686,2240,1,1,,85787934,4421,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
687,2241,1,1,,85787934,4421,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
688,2242,1,1,,855620,4421,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease,Confirmatory,,
689,2247,1,2,,855620,4421,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
690,2252,1,1,,855620,4421,Inactive,,,,EC50,A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhi identified in the primary screen,Confirmatory,,
691,2275,1,1,,85787934,4421,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
692,2280,2,3,,56422386,4421,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
693,2288,1,1,,855620,4421,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/orActivators of miR-21,Confirmatory,,
694,2289,1,1,,855620,4421,Inactive,,,,Potency,qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21,Confirmatory,,
695,2291,1,3,,26534558,4421,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based Maybridge primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
696,2300,1,3,,56422386,4421,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
697,2313,1,1,,85787934,4421,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
698,2314,1,2,,855620,4421,Inactive,32400299.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
699,2314,1,2,,855620,4421,Inactive,32400300.0,,,,Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin,Screening,,
700,2315,1,2,,855620,4421,Inactive,32400299.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
701,2315,1,2,,855620,4421,Inactive,32400300.0,,,,A qHTS for Small Molecule Inhibitors of Shiga Toxin,Screening,,
702,2316,1,1,,85787934,4421,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Activators of the Reversal of PD-1 Mediated Inhibitors of T-Cell Inhibition,Screening,,
703,2322,1,1,,85787934,4421,Inactive,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
704,2326,1,1,,855620,4421,Inactive,194352380.0,,2.5119,Potency,qHTS Assay for Inhibitors of Influenza NS1 Protein Function,Confirmatory,,
705,2330,1,1,,85787934,4421,Inactive,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
706,2380,1,2,,855620,4421,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
707,2384,1,1,,855620,4421,Active,,,83.75,IC50,A counter screen for small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
708,2391,1,1,,56422386,4421,Inactive,,,,IC50,A Cell Based HTS Approach for the Discovery of New Inhibitors of Respiratory syncytial virus (RSV),Confirmatory,,
709,2417,1,1,,855620,4421,Inactive,4506243.0,5725.0,,,High Content Assay for Compounds that inhibit the Assembly of the Perinucleolar Compartment,Screening,,
710,2435,1,2,,56422386,4421,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
711,2445,1,2,,56422386,4421,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
712,2451,1,2,,855620,4421,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
713,2451,1,2,,26746931,4421,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
714,2451,1,2,,26751459,4421,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
715,2462,1,1,,56422386,4421,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
716,2462,1,1,,56422386,4421,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
717,2472,1,2,,855620,4421,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
718,2472,1,2,,26746931,4421,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
719,2472,1,2,,26751459,4421,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
720,2517,2,1,,855620,4421,Inactive,6980812.0,,11.2202,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
721,2517,2,1,,17389812,4421,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
722,2517,2,1,,26746931,4421,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
723,2517,2,1,,26751459,4421,Inactive,6980812.0,,0.0089,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
724,2520,1,4,,855620,4421,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
725,2521,1,3,,855620,4421,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
726,2523,1,1,,855620,4421,Inactive,124486680.0,16408.0,,,HTS of MLPCN Validation Compound Set for developing T Cell Immune Modulators,Screening,,
727,2524,1,2,,855620,4421,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
728,2528,1,2,,855620,4421,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
729,2528,1,2,,26746931,4421,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
730,2528,1,2,,26751459,4421,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
731,2528,1,2,,26751460,4421,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
732,2540,1,2,,855620,4421,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
733,2544,1,2,,855620,4421,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
734,2546,1,1,,855620,4421,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
735,2546,1,1,,17389812,4421,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
736,2546,1,1,,26746931,4421,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
737,2546,1,1,,26751459,4421,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
738,2546,1,1,,26751460,4421,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
739,2549,1,1,,855620,4421,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
740,2549,1,1,,17389812,4421,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
741,2549,1,1,,26746931,4421,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
742,2549,1,1,,26751459,4421,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
743,2550,1,3,,855620,4421,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
744,2551,1,1,,855620,4421,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
745,2551,1,1,,17389812,4421,Inconclusive,188536040.0,19885.0,2.8184,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
746,2551,1,1,,26746931,4421,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
747,2551,1,1,,26751459,4421,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
748,2551,1,1,,26751460,4421,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
749,2553,1,2,,855620,4421,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
750,2557,1,3,,56422386,4421,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
751,2563,1,1,,855620,4421,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
752,2599,1,2,,855620,4421,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
753,2606,1,2,,56422386,4421,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
754,2629,1,1,,56422386,4421,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
755,2642,1,2,,855620,4421,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
756,2648,1,2,,855620,4421,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
757,2650,2,1,,56422386,4421,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
758,2661,1,1,,56422386,4421,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
759,2662,2,1,,855620,4421,Inactive,56550039.0,4297.0,,Potency,qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction,Confirmatory,,
760,2674,1,1,,855620,4421,Inactive,34810098.0,,,,HTS for Identification of VLA-4 Allosteric Modulators from Validation Compound Set.,Screening,,
761,2675,1,1,,855620,4421,Inactive,41281591.0,4154.0,8.9125,Potency,qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding,Confirmatory,,
762,2676,1,2,,855620,4421,Inactive,85986601.0,59350.0,,Potency,qHTS Assay for Agonists of the Relaxin Receptor RXFP1,Confirmatory,,
763,2685,1,1,,855620,4421,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells,Confirmatory,,
764,2690,1,2,,56422386,4421,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
765,2706,1,1,,855620,4421,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide for Validation Compound Set,Screening,,
766,2716,1,1,,56422386,4421,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
767,2717,1,2,,56422386,4421,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
768,2718,1,1,,56422386,4421,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
769,2732,1,1,,855620,4421,Inactive,160707929.0,13198.0,,,HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress,Screening,,
770,2751,2,2,,56422386,4421,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
771,2796,1,4,,56422386,4421,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
772,2797,1,2,,56422386,4421,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
773,2805,2,2,,855620,4421,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
774,2806,2,2,,855620,4421,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
775,2825,1,2,,855620,4421,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
776,17991,3,3,,103163814,4421,Unspecified,,,,,Bioavailability,Other,12873497.0,
777,46902,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity against Candida albicans (ATCC 10231),Other,6321736.0,
778,52940,6,2,,103163814,4421,Unspecified,,,,,Evaluated for the minimum inhibitory concentration against Citrobacter freundii BS-16.,Other,2153215.0,
779,53314,5,1,,103163814,4421,Unspecified,,,,,In vitro inhibitory concentration which show total effect against Escherichia coli HR DNA gyrase,Other,,
780,53316,5,1,,103163814,4421,Unspecified,,,,,In vitro inhibitory concentration which show total effect against Escherichia coli HR DNA gyrase,Other,,
781,53321,6,5,,103163814,4421,Unspecified,,,,,Inhibition of DNA gyrase supercoiling in Escherichia coli.,Other,9871636.0,
782,53325,6,6,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity expressed as MIC against Escherichia coli HR DNA gyrase,Other,,
783,53450,5,1,,103163814,4421,Unspecified,,,,,In vitro DNA gyrase inhibition activity,Other,6321736.0,
784,65075,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity was measured against nalidixic acid resistant strain 1 from Escherichia coli KC-14,Other,1310116.0,
785,65196,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity was measured against nalidixic acid resistant strain 2 from Escherichia coli KC-14,Other,1310116.0,
786,65197,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity was measured against nalidixic acid resistant strain 3 from Escherichia coli KC-14,Other,1310116.0,
787,65198,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity was measured against nalidixic acid resistant strain 4 from Escherichia coli KC-14,Other,1310116.0,
788,65199,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity was measured against nalidixic acid resistant strain 5 from Escherichia coli KC-14,Other,1310116.0,
789,65200,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity was measured against nalidixic acid resistant strain 6 from Escherichia coli KC-14,Other,1310116.0,
790,65201,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity was measured against nalidixic acid resistant strain 7 from Escherichia coli KC-14,Other,1310116.0,
791,66244,6,2,,103163814,4421,Unspecified,,,,,Minimum inhibitory concentration against Enterobacter cloacae P99 (Class Ia beta-lactamase overproducer),Other,2153215.0,
792,66757,3,3,,103163814,4421,Active,,,,,The compound has antimicrobial activity against Enterococcus faecalis; Active,Other,12873497.0,
793,67230,6,2,,103163814,4421,Unspecified,,,,,Evaluated for the minimum inhibitory concentration against Enterococcus faecalis ATCC 29212,Other,2153215.0,
794,67545,8,1,,103163814,4421,Unspecified,,,,,Activity against Enterobacter aerogenes,Other,12873497.0,
795,68666,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity was determined against Escherichia coli ATCC 25922,Other,2153215.0,
796,68966,6,2,,103163814,4421,Unspecified,,,,,Median effective dose against Escherichia coli P-5101 causing systemic infections.,Other,6422043.0,
797,69343,6,2,,103163814,4421,Unspecified,,,,,Minimum inhibitory concentration of compound against Escherichia coli,Other,9379449.0,
798,69346,6,2,,103163814,4421,Unspecified,,,,,Minimum inhibitory concentration of compound against KL-16 Escherichia coli strain,Other,9379449.0,
799,69479,8,1,,103163814,4421,Active,,,,,Minimum inhibitory concentration against Escherichia coli ATCC 25922,Other,12729630.0,
800,69746,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli NIHJ JC-2,Other,6422043.0,
801,69782,6,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli (H560),Other,3005575.0,
802,69784,6,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli (vogel),Other,3005575.0,
803,69799,6,3,,103163814,4421,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli KL-16 in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
804,69800,6,3,,103163814,4421,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli KL-16 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
805,69801,6,3,,103163814,4421,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli-ss in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
806,69802,6,3,,103163814,4421,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Escherichia coli-ss in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
807,70407,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity against Escherichia coli (ATCC 9637),Other,6321736.0,
808,70411,6,2,,103163814,4421,Unspecified,,,,,In vitro for antibacterial activity against Gram-negative Escherichia coli NIJH JC-2.,Other,7452690.0,
809,70570,6,2,,103163814,4421,Unspecified,,,,,Compound was tested for inhibition of the gram-negative organism Escherichia coli H560,Other,3007757.0,
810,70571,6,2,,103163814,4421,Unspecified,,,,,Compound was tested for inhibition of the gram-negative organism Escherichia coli vogel,Other,3007757.0,
811,70739,6,2,,103163814,4421,Unspecified,,,,,Evaluated for the minimum inhibitory concentration against Escherichia coli TEM-1,Other,2153215.0,
812,70860,6,3,,103163814,4421,Unspecified,,,,,Compound was tested for inhibition of the gram-negative organism Escherichia cloacae HA 2646,Other,3007757.0,
813,70885,3,3,,103163814,4421,Inactive,,,,,Antimicrobial activity against Escherichia coli;IA is Inactive,Other,12873497.0,
814,71052,3,3,,103163814,4421,Inconclusive,,,,,Compound was tested for photoinhibition of Escherichia coli (CIP 548T); No data,Other,9873665.0,
815,78545,6,5,,103163814,4421,Unspecified,,,,,Concentration facilitating 50% of the maximum of the cleavable complex,Other,,
816,78548,6,4,,103163814,4421,Unspecified,,,,,Inhibition of cleavable complex ability of DNA gyrase in Escherichia coli,Other,9379449.0,
817,78688,6,5,,103163814,4421,Unspecified,,,,,Inhibitory concentration in supercoiling inhibition Escherichia coli DNA gyrase assay,Other,3005575.0,
818,78696,6,6,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity was determined as inhibitory concentration causing 50% DNA-gyrase supercoiling inhibition (SCI),Other,,
819,78701,6,4,,103163814,4421,Unspecified,,,,,Inhibition of supercoiling activity of DNA gyrase in Escherichia coli,Other,9379449.0,
820,78707,6,4,,103163814,4421,Unspecified,,,,,MIC at which cleaved DNA (linear) is observed at an intensity relative to oxolinic acid at 10 ug/mL by using Gyrase Induced DNA-Cleavage assay,Other,3005575.0,
821,78709,5,1,,103163814,4421,Unspecified,,,,,Inhibition of DNA gyrase of Escherichia coli H560 cells,Other,3007757.0,
822,95885,6,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Klebsiella pneumonia (MGH-2),Other,3005575.0,
823,96097,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity against Klebsiella pneumoniae AD (ATCC 10031),Other,6321736.0,
824,96229,6,2,,103163814,4421,Unspecified,,,,,Compound was tested for inhibition of the gram-negative organism Klebsiella pneumoniae MGH-2,Other,3007757.0,
825,116912,6,2,,103163814,4421,Unspecified,,,,,Compound was tested for acute toxicity test with a single oral administration in mice and the median lethal dose as calculated.,Other,6422043.0,
826,133807,3,3,,103163814,4421,Unspecified,,,,,Compound was evaluated for protective dose against Streptococcus pneumoniae SV-1 lethal infection following sc administration,Other,3007757.0,
827,133811,3,3,,103163814,4421,Unspecified,,,,,Compound was evaluated for protective dose against the Escherichia coli vogel lethal infection following peroral administration in mouse,Other,3007757.0,
828,133812,3,3,,103163814,4421,Unspecified,,,,,Compound was evaluated for protective dose against the Escherichia coli vogel lethal infection following sc administration in mouse,Other,3007757.0,
829,133813,3,3,,103163814,4421,Unspecified,,,,,Compound was evaluated for protective dose against the Streptococcus aureus UC-76 lethal infection following po administration in mouse,Other,3007757.0,
830,133815,3,3,,103163814,4421,Unspecified,,,,,Compound was evaluated for protective dose against the Streptococcus aureus UC-76 lethal infection following sc administration in mouse,Other,3007757.0,
831,133817,3,3,,103163814,4421,Unspecified,,,,,Compound was evaluated for protective dose against the Streptococcus pneumoniae SV-1 lethal infection following po administration,Other,3007757.0,
832,144443,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity against Mycobacterium smegmatis (ATCC 607),Other,6321736.0,
833,162729,3,3,,103163814,4421,Active,,,,,The compound has antimicrobial activity against Proteus mirabilis; Active,Other,12873497.0,
834,162748,6,2,,103163814,4421,Unspecified,,,,,Minimum inhibitory concentration against Proteus mirabilis 90,Other,2153215.0,
835,162887,6,2,,103163814,4421,Unspecified,,,,,In vitro minimum inhibitory concentration against Proteus mirabilis,Other,7310807.0,
836,162897,3,4,,103163814,4421,Unspecified,,,,,Minimum inhibitory dilution of medicated rat urine tested in vitro for antibacterial activity against Proteus mirabilis; Equal to 1:128,Other,7310807.0,
837,163239,6,2,,103163814,4421,Unspecified,,,,,Minimum inhibitory concentration against Proteus vulgaris 1028 BC (Class Ic beta-lactamase overproducer),Other,2153215.0,
838,163738,6,2,,103163814,4421,Unspecified,,,,,Compound was tested for inhibition of the gram-negative organism Providencia rettgeri H1771,Other,3007757.0,
839,164067,3,3,,103163814,4421,Inactive,,,,,Antimicrobial activity against Pseudomonas aeruginosa 108;IA is Inactive,Other,12873497.0,
840,164220,6,2,,103163814,4421,Unspecified,,,,,Median effective dose against Pseudomonas aeruginosa 12 causing systemic infections,Other,6422043.0,
841,164236,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa Tsuchijima,Other,6422043.0,
842,164264,6,3,,103163814,4421,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Pseudomonas maltophilia 1057 in the presence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
843,164265,6,3,,103163814,4421,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Pseudomonas maltophilia 1057 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
844,164385,6,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa (UI-18),Other,3005575.0,
845,164550,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity against Gram-negative Pseudomonas aeruginosa V-1.,Other,7452690.0,
846,164709,6,2,,103163814,4421,Unspecified,,,,,Compound was tested for inhibition of the gram-negative organism Pseudomonas aeruginosa UI-18,Other,3007757.0,
847,164876,6,2,,103163814,4421,Unspecified,,,,,Evaluated for the minimum inhibitory concentration against Pseudomonas aeruginosa 18S/H (Class Id beta-lactamase overproducer),Other,2153215.0,
848,164877,6,2,,103163814,4421,Unspecified,,,,,Minimum inhibitory concentration against Pseudomonas aeruginosa ATCC 27853,Other,2153215.0,
849,200513,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity against Salmonella gallinarum (ATCC 9184),Other,6321736.0,
850,200878,6,3,,103163814,4421,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Salmonella Typhimurium 701 in the absence of polymyxin B nonapeptide (PBMN) at 0 ug/mL,Other,,
851,200879,6,3,,103163814,4421,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Salmonella Typhimurium 701 in the presence of polymyxin B nonapeptide (PBMN) at 1 ug/mL,Other,,
852,203134,6,2,,103163814,4421,Unspecified,,,,,Evaluated for the minimum inhibitory concentration against Serratia marcescens 1071,Other,2153215.0,
853,205546,8,1,,103163814,4421,Unspecified,,,,,Minimum inhibitory concentration (MIC) against Staphylococcus aureus ATCC 13709,Other,12729630.0,
854,205848,6,2,,103163814,4421,Unspecified,,,,,In vitro minimum inhibitory concentration against Staphylococcus aureus,Other,7310807.0,
855,205893,6,2,,103163814,4421,Unspecified,,,,,Minimum inhibitory concentration of compound against OC2603 Staphylococcus epidermidis strain,Other,9379449.0,
856,205908,6,3,,103163814,4421,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Staphylococcus epidermidis strain OC2603,Other,,
857,205968,6,2,,103163814,4421,Unspecified,,,,,"Minimum inhibitory concentration against Staphylococcus aureus 1059B (inducible, high level beta-lactamase producer)",Other,2153215.0,
858,205969,6,2,,103163814,4421,Unspecified,,,,,"Minimum inhibitory concentration against Staphylococcus aureus 95 (Methicillin-resistant, high-level beta-lactamase producer)",Other,2153215.0,
859,205971,6,2,,103163814,4421,Unspecified,,,,,"Minimum inhibitory concentration against Staphylococcus aureus ATCC 29213 (inducible, low level beta-lactamase producer)",Other,2153215.0,
860,206159,6,3,,103163814,4421,Unspecified,,,,,Tested for antibacterial activity as minimum inhibitory concentration against Staphylococcus aureus strain OC6538,Other,,
861,206266,3,3,,103163814,4421,Active,,,,,The compound has antimicrobial activity against Staphylococcus aureus; Active,Other,12873497.0,
862,206393,3,3,,103163814,4421,Active,,,,,Compound was tested for photoinhibition of Staphylococcus aureus(CIP 53156); Resistant,Other,9873665.0,
863,206570,6,2,,103163814,4421,Unspecified,,,,,Median effective dose against Staphylococcus aureus 50774 causing systemic infections,Other,6422043.0,
864,206798,3,4,,103163814,4421,Unspecified,,,,,Minimum inhibitory dilution of medicated rat urine tested in vitro for antibacterial activity against Staphylococcus aureus; Equal to 1:16,Other,7310807.0,
865,206858,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus 209PJC-1,Other,6422043.0,
866,207175,6,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus (H228),Other,3005575.0,
867,207933,6,2,,103163814,4421,Unspecified,,,,,"In vitro antibacterial activity against Gram-positive, Staphylococcus aureus 209 P",Other,7452690.0,
868,207936,6,2,,103163814,4421,Unspecified,,,,,In vitro antibacterial activity against Staphylococcus aureus (ATCC 13709),Other,6321736.0,
869,207973,6,2,,103163814,4421,Unspecified,,,,,Minimum inhibitory concentration of compound against OC6538 Staphylococcus aureus strain,Other,9379449.0,
870,208021,6,2,,103163814,4421,Unspecified,,,,,Minimum inhibitory concentration against Streptococcus pneumoniae 6301,Other,2153215.0,
871,208893,6,3,,103163814,4421,Unspecified,,,,,Compound was tested for inhibition of the gram-negative organism Streptococcus aureus H228.,Other,3007757.0,
872,208894,6,3,,103163814,4421,Unspecified,,,,,Compound was tested for inhibition of the gram-negative organism Streptococcus aureus UC-76.,Other,3007757.0,
873,209087,6,2,,103163814,4421,Unspecified,,,,,Compound was tested for inhibition of the gram-negative organism Streptococcus faecalis MGH-2,Other,3007757.0,
874,209302,6,2,,103163814,4421,Unspecified,,,,,Compound was tested for inhibition of the gram-negative organism Streptococcus pyogenes C203.,Other,3007757.0,
875,209449,6,2,,103163814,4421,Unspecified,,,,,Minimum inhibitory concentration against Streptococcus pyogenes 4,Other,2153215.0,
876,210022,6,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae (SV-1),Other,3005575.0,
877,210196,6,2,,103163814,4421,Unspecified,,,,,Compound was tested for inhibition of the gram-negative organism Streptococcus pneumoniae SV-1,Other,3007757.0,
878,251761,3,3,,103163814,4421,Unspecified,,,,,Percent inhibition of filarial parasite Setaria cervi by compound at 10 ug/mL concentration,Other,15582408.0,
879,251762,3,3,,103163814,4421,Unspecified,,,,,Percent inhibition of filarial parasite Setaria cervi by compound at 20 ug/mL concentration,Other,15582408.0,
880,251763,3,3,,103163814,4421,Unspecified,,,,,Percent inhibition of filarial parasite Setaria cervi by compound at 40 ug/mL concentration,Other,15582408.0,
881,251922,6,2,,103163814,4421,Inactive,,,,,Percent inhibition of filarial parasite Setaria cervi by compound at 5 ug/mL concentration; NI = no inhibition,Other,15582408.0,
882,260745,6,2,,103163814,4421,Unspecified,,,,,Inhibition of Bacillus subtilis topoisomerase4 activity,Other,16480282.0,
883,260746,6,2,,103163814,4421,Unspecified,,,,,Inhibition of Bacillus subtilis gyrase activity,Other,16480282.0,
884,278104,6,2,,103163814,4421,Unspecified,,,,,Bacteriostatic activity against Escherichia coli DM4100 in aerobic condition,Other,17043118.0,
885,278105,6,2,,103163814,4421,Unspecified,,,,,Bacteriostatic activity against Escherichia coli DM4100 in anaerobic condition,Other,17043118.0,
886,278106,3,3,,103163814,4421,Active,,,,,Bactericidal activity against Escherichia coli DM4100 in aerobic condition,Other,17043118.0,
887,278107,3,3,,103163814,4421,Inactive,,,,,Bactericidal activity against Escherichia coli DM4100 in saline,Other,17043118.0,
888,278108,3,3,,103163814,4421,Inactive,,,,,Bactericidal activity against Escherichia coli DM4100 in anaerobic condition,Other,17043118.0,
889,278109,3,3,,103163814,4421,Inactive,,,,,Bactericidal activity against Escherichia coli DM4100 in the presence of chloramphenicol,Other,17043118.0,
890,278118,3,3,,103163814,4421,Active,,,,,Chromosome fragmentation in Escherichia coli DM4100 assessed as reduced lysate viscosity at 50 ug/ml after 2 hrs in aerobic condition,Other,17043118.0,
891,278228,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21,Other,17043131.0,
892,278229,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 gyrA+,Other,17043131.0,
893,278230,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 acrAB::Kan,Other,17043131.0,
894,278231,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21 tolC::Kan,Other,17043131.0,
895,278232,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 GyrA S83F mutant,Other,17043131.0,
896,278233,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 gyrA+,Other,17043131.0,
897,278234,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium GyrA S21-1 acrAB::Kan with GyrA S83F mutation,Other,17043131.0,
898,278235,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-1 tolC::Kan with GyrA S83F mutation,Other,17043131.0,
899,278236,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 with GyrA S83F, ParC S80I mutation",Other,17043131.0,
900,278237,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 gyrA+ with ParC S80I mutation,Other,17043131.0,
901,278238,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 acrAB::Kan with GyrA S83F, ParC S80I mutation",Other,17043131.0,
902,278239,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-2 tolC::Kan with GyrA S83F, ParC S80I mutation",Other,17043131.0,
903,278240,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 with GyrA S83F, ParC S80I mutation",Other,17043131.0,
904,278241,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 gyrA+ with ParC S80I mutation,Other,17043131.0,
905,278242,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 acrAB::Kan with GyrA S83F, ParC S80I mutation",Other,17043131.0,
906,278243,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-3 tolC::Kan with GyrA S83F, ParC S80I mutation",Other,17043131.0,
907,278244,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 with GyrA S83F, ParC S80I mutation",Other,17043131.0,
908,278245,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 gyrA+ with ParC S80I mutation,Other,17043131.0,
909,278246,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 acrAB::Kan with GyrA S83F, ParC S80I mutation",Other,17043131.0,
910,278247,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium S21-4 tolC::Kan with GyrA S83F, ParC S80I mutation",Other,17043131.0,
911,278248,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
912,278249,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
913,278250,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
914,278251,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS1 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
915,278252,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
916,278253,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
917,278254,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
918,278255,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS3 tolC::Kan with GyrA S83F, D87N, parC S80I mutation",Other,17043131.0,
919,278256,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
920,278257,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 gyrA+ with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
921,278258,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 acrAB::Kan with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
922,278259,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium CS9 tolC::Kan with GyrA S83F, D87N, ParC S80I mutation",Other,17043131.0,
923,278260,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 with GyrA D87G mutation,Other,17043131.0,
924,278261,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 gyrA+ with GyrA D87G mutation,Other,17043131.0,
925,278262,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 acrAB::Kan with GyrA D87G mutation,Other,17043131.0,
926,278263,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS14 tolC::Kan with GyrA D87G mutant,Other,17043131.0,
927,278264,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 with GyrA S38F mutation,Other,17043131.0,
928,278265,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 gyrA+ with GyrA S38F mutation,Other,17043131.0,
929,278266,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 acrAB::Kan with GyrA S38F mutation,Other,17043131.0,
930,278267,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS18 tolC::Kan with GyrA S38F mutation,Other,17043131.0,
931,278268,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 with GyrA D87G mutation,Other,17043131.0,
932,278269,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 gyrA+ with GyrA D87G mutation,Other,17043131.0,
933,278270,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 acrAB::Kan with GyrA D87G mutation,Other,17043131.0,
934,278271,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium CHS38 tolC::Kan with GyrA D87G mutation,Other,17043131.0,
935,278594,6,2,,103163814,4421,Unspecified,,,,,Inhibitory activity against azide-resistant Escherichia coli J53,Other,17074790.0,
936,278595,6,2,,103163814,4421,Unspecified,,,,,Inhibitory activity against Escherichia coli 12-1502,Other,17074790.0,
937,278596,6,2,,103163814,4421,Unspecified,,,,,Inhibitory activity against Klebsiella pneumoniae 12-1183,Other,17074790.0,
938,278597,6,2,,103163814,4421,Unspecified,,,,,Inhibitory activity against azide-resistant Escherichia coli J53 T12-1183,Other,17074790.0,
939,278598,6,2,,103163814,4421,Unspecified,,,,,Inhibitory activity against Klebsiella pneumoniae 35,Other,17074790.0,
940,278599,6,2,,103163814,4421,Unspecified,,,,,Inhibitory activity against azide-resistant Escherichia coli J53 T35,Other,17074790.0,
941,278600,6,2,,103163814,4421,Unspecified,,,,,Inhibitory activity against Klebsiella pneumoniae 07-006,Other,17074790.0,
942,278601,6,2,,103163814,4421,Unspecified,,,,,Inhibitory activity against azide-resistant Escherichia coli J53 T07-006,Other,17074790.0,
943,278602,6,2,,103163814,4421,Unspecified,,,,,Inhibitory activity against Klebsiella pneumoniae 03-222,Other,17074790.0,
944,278603,6,2,,103163814,4421,Unspecified,,,,,Inhibitory activity against azide-resistant Escherichia coli J53 T03-222,Other,17074790.0,
945,278604,6,2,,103163814,4421,Unspecified,,,,,Inhibitory activity against azide-resistant Escherichia coli J53 T12-1502,Other,17074790.0,
946,278753,6,2,,103163814,4421,Unspecified,,,1090.0,IC50,Inhibition of Bacillus subtilis topoisomerase 4,Confirmatory,17074800.0,
947,278754,6,2,,103163814,4421,Unspecified,,,149.0,IC50,Inhibition of Bacillus subtilis gyrase,Confirmatory,17074800.0,
948,279129,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis ATCC 43765 after 24 hrs,Other,17116660.0,
949,279130,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1001 isolate after 24 hrs,Other,17116660.0,
950,279131,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1002 isolate after 24 hrs,Other,17116660.0,
951,279132,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1003 isolate after 24 hrs,Other,17116660.0,
952,279133,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1004 isolate after 24 hrs,Other,17116660.0,
953,279134,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1005 isolate after 24 hrs,Other,17116660.0,
954,279135,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1006 isolate after 24 hrs,Other,17116660.0,
955,279136,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1007 isolate after 24 hrs,Other,17116660.0,
956,279137,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1008 isolate after 24 hrs,Other,17116660.0,
957,279138,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1009 isolate after 24 hrs,Other,17116660.0,
958,279139,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1010 isolate after 24 hrs,Other,17116660.0,
959,279140,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1011 isolate after 24 hrs,Other,17116660.0,
960,279141,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1012 isolate after 24 hrs,Other,17116660.0,
961,279142,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1013 isolate after 24 hrs,Other,17116660.0,
962,279143,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1014 isolate after 24 hrs,Other,17116660.0,
963,279144,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1015 isolate after 24 hrs,Other,17116660.0,
964,279145,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1016 isolate after 24 hrs,Other,17116660.0,
965,279146,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus suis BB1017 isolate after 24 hrs,Other,17116660.0,
966,279568,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium SMP972 in Caenorhabditis elegans,Other,17116682.0,
967,279569,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium SMP973 in Caenorhabditis elegans,Other,17116682.0,
968,285190,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli AG100 mutant with argE3 thi-3 rpsL xyl mtl supE44 genotype,Other,17220404.0,
969,285191,7,2,,103163814,4421,Inconclusive,,,,,Antimicrobial activity against Escherichia coli M013 mutant with AG100 delta-(lon-hupB-ppiD) dupIS5 genotype,Other,17220404.0,
970,285192,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli M043 mutant with AG100 lon4::IS186 marR::IS2 genotype,Other,17220404.0,
971,285193,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli M044 mutant with AG100 lon4::IS186 marR::IS genotype,Other,17220404.0,
972,285194,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli M064 mutant with AG100 lon1::IS186 acrR::IS genotype,Other,17220404.0,
973,285195,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli M073 mutant with AG100 lon2::IS186 acrR::IS5 genotype,Other,17220404.0,
974,285196,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli M074 mutant with AG100 lon2::IS186 acrR::IS genotype,Other,17220404.0,
975,285197,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli M083 mutant with AG100 lon4::IS186 acrR::IS1 genotype,Other,17220404.0,
976,285198,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli M084 mutant AG100 lon4::IS186 genotype,Other,17220404.0,
977,285199,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli M093 mutant with AG100 lon3::IS186 acrR::IS1 genotype,Other,17220404.0,
978,285200,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli M103 mutant with AG100 lon3::IS186 acrR-acrAB genotype,Other,17220404.0,
979,285201,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli M104 mutant with AG100 dupIS3 genotype,Other,17220404.0,
980,285202,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli M114 mutant with AG100 lon4::IS186 marR::IS2 genotype,Other,17220404.0,
981,285203,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli M124 mutant with AG100 lon4::IS186 acrR::IS genotype,Other,17220404.0,
982,285204,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli AG112 mutant with AG100 marR genotype,Other,17220404.0,
983,285205,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli AG112 mutant with marR genotype after 250 generations in 5 ug/ml presence of tetracycline,Other,17220404.0,
984,285206,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli AG112 mutant with marR genotype after 125 generations in absence of tetracycline,Other,17220404.0,
985,285337,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli qnrA1 producing urinary specimen isolate 13.52 by agar dilution method,Other,17220425.0,
986,285338,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against streptomycin-resistant Escherichia coli J53 transconjugant with qnrA1 producing urinary specimen isolate 13.52 by agar dilution method,Other,17220425.0,
987,285339,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against streptomycin-resistant Escherichia coli J53 by agar dilution method,Other,17220425.0,
988,285363,7,2,,103163814,4421,Unspecified,,,,,Susceptibility of qnr positive Enterobacter cloacae,Other,17242140.0,
989,285364,3,3,,103163814,4421,Unspecified,,,,,Susceptibility of qnr positive Enterobacter cloacae assessed as percentage nonsusceptible isolates,Other,17242140.0,
990,285367,9,1,,103163814,4421,Unspecified,,,,,Decrease in susceptibility of qnrS-positive transconjugant streptomycin-resistant Escherichia coli C600,Other,17242140.0,
991,285368,6,2,,103163814,4421,Unspecified,,,,,Decrease in susceptibility of qnrB-positive transconjugant streptomycin-resistant Escherichia coli C600,Other,17242140.0,
992,285957,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial susceptibility against Haemophilus influenzae A isolate with GyrA Glu83Cys and AcrR 97stop codon mutation,Other,17283196.0,
993,285958,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial susceptibility against Haemophilus influenzae A1 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",Other,17283196.0,
994,285959,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial susceptibility against Haemophilus influenzae A2 with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",Other,17283196.0,
995,285960,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial susceptibility against Haemophilus influenzae A3 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",Other,17283196.0,
996,285961,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial susceptibility against Haemophilus influenzae A4 isolate with GyrA Glu83Cys, ParC Ser84Arg and AcrR 97stop codon mutation",Other,17283196.0,
997,285962,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial susceptibility against Haemophilus influenzae B isolate with AcrR Leu31His mutation,Other,17283196.0,
998,285963,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial susceptibility against Haemophilus influenzae B1 isolate with GyrA Asp88Tyr and AcrR Leu31His mutation,Other,17283196.0,
999,285964,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial susceptibility against Haemophilus influenzae B2 isolate with GyrA Asp88Tyr and AcrR Leu31His mutation,Other,17283196.0,
1000,285965,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial susceptibility against Haemophilus influenzae C isolate with AcrR Leu31His and Arg34Glu mutation,Other,17283196.0,
1001,285966,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial susceptibility against Haemophilus influenzae C1 isolate with GyrA Asp88Asn, AcrR Leu31His and Arg34Glu mutation",Other,17283196.0,
1002,285967,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial susceptibility against Haemophilus influenzae C2 isolate with GyrA Asp88Asn, AcrR Leu31His and Arg34Glu mutation",Other,17283196.0,
1003,285968,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial susceptibility against Haemophilus influenzae C3 isolate with GyrA Asp88Asn, ParC Ser84Ile, AcrR Leu31His and Arg34Glu mutation",Other,17283196.0,
1004,285969,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial susceptibility against Haemophilus influenzae D isolate with AcrR Leu31His, Ile121Val and Gln134Lys mutation",Other,17283196.0,
1005,285970,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial susceptibility against Haemophilus influenzae D1 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",Other,17283196.0,
1006,285971,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial susceptibility against Haemophilus influenzae D2 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",Other,17283196.0,
1007,285972,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial susceptibility against Haemophilus influenzae D3 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",Other,17283196.0,
1008,285973,6,2,,103163814,4421,Unspecified,,,,,"Antimicrobial susceptibility against Haemophilus influenzae D4 isolate with GyrA Ser84Tyr, ParC Glu88Lys and AcrR Leu31His, Ile121Val and Gln134Lys mutation",Other,17283196.0,
1009,321983,3,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli at 50 ug/disk after 24 to 28 hrs,Other,18158248.0,
1010,321984,3,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae at 50 ug/disk after 24 to 28 hrs,Other,18158248.0,
1011,321985,3,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Pseudomonas aeruginosa at 50 ug/disk after 24 to 28 hrs,Other,18158248.0,
1012,321986,3,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus at 50 ug/disk after 24 to 28 hrs,Other,18158248.0,
1013,324745,6,4,,103163814,4421,Unspecified,,,,,Inhibition of Mycobacterium leprae recombinant DNA gyrase expressed in Escherichia coli assessed as inhibition of pBR322 DNA supercoiling,Other,17325221.0,
1014,324746,5,1,,103163814,4421,Inactive,,,,,Effect on Mycobacterium leprae recombinant DNA gyrase expressed in Escherichia coli assessed as enhancement of supercoiled pBR322 DNA cleavage,Other,17325221.0,
1015,324747,3,5,,103163814,4421,Inconclusive,,,,,Antibacterial activity against Mycobacterium leprae at 5 ug/mL after 11 to 18 days,Other,17325221.0,
1016,324754,3,6,,103163814,4421,Inconclusive,,,,,Antibacterial activity in Mycobacterium leprae infected mouse foot-pad model assessed as parasite killing after 9 months,Other,17325221.0,
1017,332074,6,2,,103163814,4421,Unspecified,,,100.0,IC50,Inhibition of transcription-translation activity in Escherichia coli,Confirmatory,18440814.0,
1018,342683,3,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against CTX-M extended-spectrum beta-lactamase producing commensal Escherichia coli isolates from healthy children assessed as percent resistant isolates by disc diffusion method,Other,17548490.0,
1019,342684,3,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against CTX-M-15 extended-spectrum beta-lactamase producing commensal Escherichia coli isolates from healthy children assessed as percent resistant isolates by disc diffusion method,Other,17548490.0,
1020,347460,3,3,,103163814,4421,Active,,,,,Inhibition of DNA gyrase assessed as conversion of relaxed pBR322 to supercoiled form,Other,19097914.0,
1021,347463,3,3,,103163814,4421,Active,,,,,Inhibition of DNA gyrase assessed as pBR322 DNA relaxation at 2.5 uM,Other,19097914.0,
1022,354538,3,4,,103163814,4421,Inactive,,,,,Cytotoxicity against rat C6 cells at 50 ug/mL to 2.5 mg/mL after 3 days treated 4 hrs before db-cAMP challenge by MTT assay,Other,8988604.0,
1023,354542,3,4,,103163814,4421,Inactive,,,,,Inhibition of tubulin polymerization in rat C6 cells at 50 ug/mL to 2.5 mg/mL after 4 hrs,Other,8988604.0,
1024,354543,3,4,,103163814,4421,Inactive,,,,,Cytotoxicity against rat C6 cells assessed as cell release at 50 ug/mL to 2.5 mg/mL after 5 hrs by MTT assay in absence of db-cAMP,Other,8988604.0,
1025,368418,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Escherichia coli C316 pHPA containing mutated GyrA gene by agar dilution method,Other,17548499.0,
1026,368419,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 expressing deltaacrB ydhE hsd gene by agar dilution method,Other,17548499.0,
1027,368420,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 pHPA containing mutated GyrA gene by agar dilution method,Other,17548499.0,
1028,368421,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 pSTV28 containing chloramphenicol-resistant vector by agar dilution method,Other,17548499.0,
1029,368422,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 pSTVqepA containing qepA gene ligated to pSTV28 plasmid by agar dilution method,Other,17548499.0,
1030,368423,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli KAM32 pSTVdeltaqepA containing disrupted qepA gene by agar dilution method,Other,17548499.0,
1031,368424,3,3,,103163814,4421,Unspecified,,,,,Ratio of MIC for Escherichia coli KAM32 pSTVqepA mutant to MIC for Escherichia coli KAM32 pSTV28 mutant,Other,17548499.0,
1032,369249,3,3,,103163814,4421,Active,,,,,Increase in ompX-lacZ expression in Escherichia coli deltaompX mutant assessed as increase in beta-galactosidase activity after 60 mins relative to control,Other,17606680.0,
1033,369250,3,3,,103163814,4421,Active,,,,,Increase in ompX-lacZ expression in Escherichia coli JM109 assessed as ompX upregulation after 60 mins relative to control,Other,17606680.0,
1034,369251,3,3,,103163814,4421,Active,,,,,Increase in ompX-lacZ expression in Escherichia coli JM109 assessed as increase in beta-galactosidase activity after 60 mins relative to control,Other,17606680.0,
1035,369252,3,3,,103163814,4421,Active,,,,,Increase in ompX-lacZ expression in Enterobacter aerogenes ATCC 15038 assessed as ompX upregulation after 60 mins relative to control,Other,17606680.0,
1036,369253,3,3,,103163814,4421,Active,,,,,Increase in ompX-lacZ expression in Enterobacter aerogenes ATCC 15038 assessed as increase in beta-galactosidase activity after 60 mins relative to control,Other,17606680.0,
1037,370645,3,3,,103163814,4421,Unspecified,,,,,Antitrypanosomal activity against Trypanosoma cruzi DM28 epimastigotes at 200 ug/ml after 96 hrs,Other,19095449.0,
1038,396000,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Mycoplasma putrefaciens French isolates after 24 hrs by twofold serial dilution method,Other,17638695.0,
1039,396001,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Mycoplasma putrefaciens Jordanian isolates after 24 hrs by twofold serial dilution method,Other,17638695.0,
1040,396002,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Mycoplasma putrefaciens KS1 after 24 hrs by twofold serial dilution method,Other,17638695.0,
1041,396034,3,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump by standard disk diffusion method,Other,17638702.0,
1042,396035,3,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by standard disk diffusion method,Other,17638702.0,
1043,396036,3,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate by standard disk diffusion method,Other,17638702.0,
1044,396037,3,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate in presence of 20 ug/ml efflux pump inhibitor Phe-Arg-beta-naphthylamide by standard disk diffusion method,Other,17638702.0,
1045,396038,3,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP2 plasmid containing Enterobacter cloacae acrA gene by standard disk diffusion method,Other,17638702.0,
1046,396039,3,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pACYC184 plasmid by standard disk diffusion method,Other,17638702.0,
1047,396040,3,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP3 plasmid containing Enterobacter aerogenes acrR gene by standard disk diffusion method,Other,17638702.0,
1048,396041,3,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pBGS18 plasmid by standard disk diffusion method,Other,17638702.0,
1049,405080,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Citrobacter freundii 33587 isolate by agar dilution method,Other,17438050.0,
1050,405081,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli CAG12177 by agar dilution method,Other,17438050.0,
1051,405082,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli 33587-TC9 by agar dilution method,Other,17438050.0,
1052,405114,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Vibrio splendidus 12B01 expressing plasmid-mediated QnrS-like quinolone resistance determinants,Other,17452482.0,
1053,405115,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Vibrio splendidus LGP32 expressing plasmid-mediated QnrS-like quinolone resistance determinants,Other,17452482.0,
1054,405116,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harbouring pVS1 expressing quinolone resistant Vibrio splendidus 12B01 QnrVS1 gene,Other,17452482.0,
1055,405117,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harbouring pVS2 expressing quinolone resistant Vibrio splendidus LGP32 QnrVS2 gene,Other,17452482.0,
1056,405118,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harbouring pS1 plasmid expressing quinolone resistant QnrS1 gene,Other,17452482.0,
1057,405119,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harbouring pS2 plasmid expressing quinolone resistant QnrS2 gene,Other,17452482.0,
1058,405120,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harbouring p0 plasmid expressing pCR-BluntII-TOPO,Other,17452482.0,
1059,405121,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10,Other,17452482.0,
1060,405454,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli C600Rif by Etest,Other,17470656.0,
1061,405456,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli C600Rif in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,Other,17470656.0,
1062,405457,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli C600Rif in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,Other,17470656.0,
1063,405458,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid by Etest,Other,17470656.0,
1064,405459,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,Other,17470656.0,
1065,405460,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli C600Rif containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,Other,17470656.0,
1066,405461,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 by Etest,Other,17470656.0,
1067,405462,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,Other,17470656.0,
1068,405463,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,Other,17470656.0,
1069,405464,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid by Etest,Other,17470656.0,
1070,405465,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,Other,17470656.0,
1071,405466,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pIP1206 plasmid in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,Other,17470656.0,
1072,405467,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pAT851 plasmid by Etest,Other,17470656.0,
1073,405468,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 40 ug/ml efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine by Etest,Other,17470656.0,
1074,405469,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pAT851 in presence of 50 ug/ml efflux pump inhibitor phenyl-arginine-beta-naphthylamide by Etest,Other,17470656.0,
1075,406633,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Vibrio anguillarum serotype O2b 04/09/363-5036 isolate containing gyrA and parC quinolone resistance mutations from Atlantic cod after 5 days by microplate broth dilution method,Other,17502408.0,
1076,406634,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Vibrio anguillarum serotype O2b 04/09/363-5034 isolate containing gyrA and parC quinolone resistance mutations from Atlantic cod after 5 days by microplate broth dilution method,Other,17502408.0,
1077,406635,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Vibrio anguillarum serotype O2b 04/09/422-5063 isolate containing gyrA and parC quinolone resistance mutations from Atlantic cod after 5 days by microplate broth dilution method,Other,17502408.0,
1078,406636,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Vibrio anguillarum serotype O2b 04/09/367-5042 isolate containing gyrA and parC quinolone resistance mutations from Atlantic cod after 5 days by microplate broth dilution method,Other,17502408.0,
1079,406637,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Vibrio anguillarum serotype O2b 04/09/367-5043 isolate containing gyrA position 83 Ser-Ile substitution mutation from Atlantic cod after 5 days by microplate broth dilution method,Other,17502408.0,
1080,406638,6,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Vibrio anguillarum serotype O2b 04/09/494-5106 isolate containing parC position 83 Ser-Ile substitution mutation from Atlantic cod after 5 days by microplate broth dilution method,Other,17502408.0,
1081,406844,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 by E-test,Other,17502413.0,
1082,406845,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pS1B plasmid expressing quinolone resistance determinant QnrS1 by E-test,Other,17502413.0,
1083,406846,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 containing pS1A plasmid expressing quinolone resistance determinant QnrB4 by E-test,Other,17502413.0,
1084,406847,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Enterobacter cloacae S1 isolate expressing quinolone resistance determinant QnrB4 by E-test,Other,17502413.0,
1085,409954,4,9,,103163814,4421,Inactive,341940599.0,17161.0,,,Inhibition of mouse brain MAOA,Other,18834112.0,
1086,423063,7,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild type Pseudomonas aeruginosa PAO1 H103 after 24 hrs by broth microdilution technique,Other,17893152.0,
1087,423064,7,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against 31_C9 allele containing Pseudomonas aeruginosa PAO1 H1104 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique,Other,17893152.0,
1088,423065,7,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against 74_D9 allele containing Pseudomonas aeruginosa PAO1 H1105 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique,Other,17893152.0,
1089,423066,7,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against 24_A2 allele containing Pseudomonas aeruginosa PAO1 H1106 mutant strain with lon::lux mutation after 24 hrs by broth microdilution technique,Other,17893152.0,
1090,423067,7,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against 69_C12 allele containing Pseudomonas aeruginosa PAO1 H1109 mutant strain with recA::lux mutation after 24 hrs by broth microdilution technique,Other,17893152.0,
1091,423068,7,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against 6_G1 allele containing Pseudomonas aeruginosa PAO1 H1121 mutant strain with PA4961::lux mutation after 24 hrs by broth microdilution technique,Other,17893152.0,
1092,423069,7,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against 53_F11 allele containing Pseudomonas aeruginosa PAO1 H1124 mutant strain with PA5279::lux mutation after 24 hrs by broth microdilution technique,Other,17893152.0,
1093,423070,10,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against 16_G12 allele containing Pseudomonas aeruginosa PAO1 H1125 mutant strain with recG::lux mutation after 24 hrs by broth microdilution technique,Other,17893152.0,
1094,423071,7,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa PAO1 H1105/lon+c mutant strain with lon::lux/lon+ mutation after 24 hrs by broth microdilution technique,Other,17893152.0,
1095,423072,7,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against 70_H3 allele containing Pseudomonas aeruginosa PAO1 H1129 mutant strain with rnt::lux mutation after 24 hrs by broth microdilution technique,Other,17893152.0,
1096,423073,7,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against 63_H5 allele containing Pseudomonas aeruginosa PAO1 H1133 mutant strain with nfxB::lux mutation after 24 hrs by broth microdilution technique,Other,17893152.0,
1097,423074,7,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against 75_F11 allele containing Pseudomonas aeruginosa PAO1 H1136 mutant strain with PA5455::lux mutation after 24 hrs by broth microdilution technique,Other,17893152.0,
1098,423080,3,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against 31_C9 allele containing Pseudomonas aeruginosa PAO1 H1104 mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,Other,17893152.0,
1099,423081,3,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against 74_D9 allele containing Pseudomonas aeruginosa PAO1 H1105 mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,Other,17893152.0,
1100,423082,3,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against 24_A2 allele containing Pseudomonas aeruginosa PAO1 H1106 mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,Other,17893152.0,
1101,423083,3,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa PAO1 H1105/lon+ mutant strain with lon::lux mutation assessed as fold decrease in MIC after 24 hrs by broth microdilution technique relative to wild type,Other,17893152.0,
1102,424866,7,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild type Salmonella enterica serovar Typhimurium ATCC 14028 by modified twofold broth microdilution method,Other,17938183.0,
1103,424867,7,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against bacterial sensory kinase PhoQ deficient Salmonella enterica serovar Typhimurium CS009 by modified twofold broth microdilution method,Other,17938183.0,
1104,424879,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Enterobacter cloacae E705 bearing qnrB10 gene with aac(6)-IId-aadA1a integron in presence of IPTG,Other,17938184.0,
1105,424975,8,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by by CA-SFM and NCCLS-based broth microdilution method,Other,19395263.0,
1106,424976,8,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by by CA-SFM and NCCLS-based broth microdilution method,Other,19395263.0,
1107,424977,8,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 18 to 24 hrs by by CA-SFM and NCCLS-based broth microdilution method,Other,19395263.0,
1108,424978,8,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 18 to 24 hrs by by CA-SFM and NCCLS-based broth microdilution method,Other,19395263.0,
1109,424979,8,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by by CA-SFM and NCCLS-based broth microdilution method,Other,19395263.0,
1110,425069,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Klebsiella pneumoniae M7943 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,Other,17938184.0,
1111,425070,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Escherichia coli M7943-TC2 bearing qnrB10 gene with aac(6)-Ib-cr-blaOXA-30 catB3-arr-3 integron in presence of IPTG,Other,17938184.0,
1112,425071,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J53-AzR in presence of IPTG,Other,17938184.0,
1113,425072,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH10B expressing pCRQB10 in presence of IPTG,Other,17938184.0,
1114,425073,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH10B expressing pCR2.1 in presence of IPTG,Other,17938184.0,
1115,425074,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH10B in presence of IPTG,Other,17938184.0,
1116,425393,3,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against mucosa-associated Escherichia coli isolates isolated from patients with Crohn's disease by disk diffusion method,Other,18070962.0,
1117,425612,3,4,,103163814,4421,Unspecified,,,,,Cytotoxicity against mouse J774A1 cells assessed as release of adenylate kinase at 100 ug/ml after 3 hrs by total cell protein assay relative to control,Other,18070962.0,
1118,425628,3,3,,103163814,4421,Unspecified,,,,,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as effect on average time to detection of growth at >10'2 CFU of inoculum by MGIT 960 susceptibility test,Other,18070971.0,
1119,425629,3,3,,103163814,4421,Unspecified,,,,,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as effect on average time to detection of growth at 10'5 CFU of inoculum by MGIT 960 susceptibility test,Other,18070971.0,
1120,425630,5,1,,103163814,4421,Unspecified,,,,,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as lowest drug level producing inhibition at 10'6 CFU of inoculum by MGIT 960 susceptibility test,Other,18070971.0,
1121,425631,5,1,,103163814,4421,Unspecified,,,,,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as lowest drug level producing inhibition at 10'6 CFU of inoculum by agar counting method,Other,18070971.0,
1122,425632,5,1,,103163814,4421,Unspecified,,,,,Antituberculosis activity against Mycobacterium paratuberculosis ATCC 19698 isolated from bovine assessed as minimum drug level resulting in no detectable growth at 10'6 CFU of inoculum after 56 days by MGIT 960 susceptibility test,Other,18070971.0,
1123,428977,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate D43 harboring DNA gyrase A S83Y mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1124,428978,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate B111 harboring DNA gyrase A S83Y mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1125,428979,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate E86 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1126,428980,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate A102 harboring DNA gyrase A S83Y mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1127,428981,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate C152 harboring DNA gyrase A S83Y mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1128,428982,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate CT29 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1129,428983,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate CT61 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1130,428984,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 102 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1131,428985,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 104 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1132,428986,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 107 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1133,428987,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate nar 108 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1134,428988,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate ipt 2 harboring DNA gyrase A D87G mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1135,428989,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 28 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1136,428990,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 45 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1137,428991,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 46 harboring DNA gyrase A D87G mutation by disk diffusion method,Other,17908946.0,
1138,428992,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 50 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1139,428993,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate nar 51 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1140,428994,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate ipt 32 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1141,428995,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate ipt 33 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1142,428996,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate CT118 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1143,428997,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT142 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1144,428998,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT144 harboring DNA gyrase A D87G mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1145,428999,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate CT145 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1146,429001,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT2 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1147,429002,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT3 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1148,429003,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT9 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1149,429004,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT15 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1150,429005,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT18 harboring DNA gyrase A S83F and D87G mutation by disk diffusion method,Other,17908946.0,
1151,429006,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT37 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1152,429007,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT40 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1153,429008,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT42 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1154,429009,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT47 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1155,429010,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT48 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1156,429011,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT49 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1157,429012,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT54 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1158,429013,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate DT60 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1159,429014,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG3 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1160,429015,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG5 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1161,429016,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG6 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1162,429017,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG7 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1163,429018,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG8 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1164,429019,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG15 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1165,429020,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG16 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1166,429021,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG17 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1167,429022,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG152 harboring DNA gyrase A S83F and D87G mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1168,429023,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG168 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1169,429024,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG169 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1170,429025,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate AG176 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1171,429026,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG182 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1172,429027,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG258 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1173,429028,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate AG259 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1174,429029,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate HTD 798 harboring DNA gyrase A S83F mutation by disk diffusion method,Other,17908946.0,
1175,429030,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica Serovar Typhi isolate BL 21801 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1176,429031,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate BL 21095 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1177,429032,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica Serovar Typhi isolate BL 3769 harboring DNA gyrase A S83F mutation by disk diffusion method in presence of plasmid mediated quinolone-resistant gene qnrA and qnrS,Other,17908946.0,
1178,429062,7,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Proteus mirabilis JIE273 expressing 16S rRNA methyltransferase RmtC,Other,18025117.0,
1179,433400,7,4,,103163814,4421,Unspecified,,,,,Inhibition of Mycobacterium leprae wild type DNA gyrase A2B2 assessed as DNA supercoiling inhibition,Other,18070975.0,
1180,433401,7,4,,103163814,4421,Unspecified,,,,,Inhibition of Mycobacterium leprae DNA gyrase subunit A G89C mutant assessed as DNA supercoiling inhibition,Other,18070975.0,
1181,433402,7,4,,103163814,4421,Unspecified,,,,,Inhibition of Mycobacterium leprae DNA gyrase subunit A A91V mutant assessed as DNA supercoiling inhibition,Other,18070975.0,
1182,433403,7,4,,103163814,4421,Unspecified,,,,,Inhibition of Mycobacterium leprae wild type DNA gyrase subunit B D205N mutant assessed as DNA supercoiling inhibition,Other,18070975.0,
1183,433404,6,1,,103163814,4421,Inactive,,,,,Inhibition of Mycobacterium leprae wild type DNA gyrase A2B2 assessed as formation of DNA cleavable complex,Other,18070975.0,
1184,433578,3,5,,103163814,4421,Inactive,,,,,Inhibition of Mycobacterium leprae wild type DNA gyrase subunit A G89A mutant assessed as formation of DNA cleavable complex,Other,18070975.0,
1185,433579,6,1,,103163814,4421,Inactive,,,,,Inhibition of Mycobacterium leprae wild type DNA gyrase subunit A A91V mutant assessed as formation of DNA cleavable complex,Other,18070975.0,
1186,433580,6,1,,103163814,4421,Inactive,,,,,Inhibition of Mycobacterium leprae wild type DNA gyrase subunit B D205N mutant assessed as formation of DNA cleavable complex,Other,18070975.0,
1187,434955,1,2,,56422386,4421,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
1188,434959,1,1,,85787934,4421,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
1189,434962,1,2,,56422386,4421,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
1190,434973,1,3,,855620,4421,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
1191,434982,1,2,,26534558,4421,Inactive,11275980.0,4851.0,,,Cell-based luminescence-based Maybridge primary high throughput screening assay to identify agonists of NOTCH,Screening,,
1192,434989,1,1,,56422386,4421,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
1193,435003,1,3,,855620,4421,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
1194,435005,1,1,,56422386,4421,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
1195,435022,2,2,,855620,4421,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
1196,435030,1,2,,56422386,4421,Active,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
1197,435030,1,2,,56422386,4421,Active,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
1198,449728,1,2,,56422386,4421,Active,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
1199,449739,1,2,,855620,4421,Inactive,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
1200,449762,1,2,,56422386,4421,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
1201,449763,1,3,,855620,4421,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
1202,449768,1,1,,855620,4421,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
1203,452938,3,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus at 50 ug/disk by agar plate disk diffusion method,Other,19962890.0,
1204,452939,3,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli at 50 ug/disk by agar plate disk diffusion method,Other,19962890.0,
1205,452940,3,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus vulgaris at 50 ug/disk by agar plate disk diffusion method,Other,19962890.0,
1206,452941,3,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa at 50 ug/disk by agar plate disk diffusion method,Other,19962890.0,
1207,463073,1,2,,855620,4421,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4),Screening,,
1208,463075,1,1,,855620,4421,Inactive,,,,,HTS to identify inhibitors of TNF-alpha Induced Cell Death in Jurkat FADD-/- Cells.,Screening,,
1209,463079,1,2,,56422386,4421,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
1210,463082,1,1,,56422386,4421,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
1211,463104,1,2,,855620,4421,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
1212,463111,1,1,,855620,4421,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
1213,463115,1,1,,855620,4421,Inactive,119622516.0,5045.0,,,High throughput fluorescence intensity-based biochemical assay to screen for small molecule inhibitors of Furin conducted by the Pittsburgh Molecular Library Screening Center.,Screening,,
1214,463141,1,2,,56422386,4421,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
1215,463165,1,1,,855620,4421,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
1216,463187,1,1,,855620,4421,Inactive,,,,,384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC,Screening,,
1217,463189,1,1,,855620,4421,Inactive,,,,,96-well format Chlamydomonas reinhardtii Algae Gravitaxis Assay to measure the difference in the absorbance between the small compact plug of WT swimming algae versus the MUT algae lacking cilia.,Screening,,
1218,463190,1,2,,855620,4421,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
1219,463193,1,1,,855620,4421,Inactive,31563518.0,84557.0,,,High-content cell-based screening for modulators of autophagy,Screening,,
1220,463195,1,2,,855620,4421,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
1221,463210,1,2,,56422386,4421,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
1222,463212,1,1,,855620,4421,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
1223,463254,1,1,,855620,4421,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter,Confirmatory,,
1224,477409,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus NCTC 8325 after 16 to 20 hrs by broth microdilution method,Other,20188576.0,
1225,477411,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against MBX-1090-resistant Staphylococcus aureus isolate d20A1 after 16 to 20 hrs by broth microdilution method,Other,20188576.0,
1226,485270,1,1,,56422386,4421,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
1227,485272,1,1,,56422386,4421,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
1228,485273,2,1,,855620,4421,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
1229,485275,1,3,,56422386,4421,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
1230,485281,1,1,,855620,4421,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
1231,485290,1,1,,855620,4421,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1232,485290,1,1,,17389812,4421,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1233,485290,1,1,,26746931,4421,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1234,485290,1,1,,26751459,4421,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1235,485290,1,1,,26751460,4421,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
1236,485294,1,1,,855620,4421,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
1237,485297,1,1,,855620,4421,Inactive,4759012.0,9367.0,,Potency,qHTS Assay for Rab9 Promoter Activators,Confirmatory,,
1238,485298,1,1,,855620,4421,Inactive,,,,Potency,qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion,Confirmatory,,
1239,485313,1,2,,855620,4421,Inactive,255652944.0,4864.0,,Potency,qHTS Assay for NPC1 Promoter Activators,Confirmatory,,
1240,485314,1,1,,855620,4421,Inactive,4505931.0,5423.0,,Potency,qHTS Assay for Inhibitors of DNA Polymerase Beta,Confirmatory,,
1241,485317,1,2,,56422386,4421,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
1242,485341,1,1,,855620,4421,Inactive,119389684.0,,,Potency,qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
1243,485344,1,1,,855620,4421,Active,4503385.0,1813.0,,,HTS Assay for Allosteric Antagonists of the Human D2 Dopamine Receptor: Primary Screen for Antagonists,Screening,,
1244,485346,1,1,,855620,4421,Inactive,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
1245,485346,1,1,,855620,4421,Inactive,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
1246,485347,1,2,,855620,4421,Inactive,4503385.0,1813.0,,,HTS Assay for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Primary Screen for Potentiators,Screening,,
1247,485349,1,1,,855620,4421,Inactive,71902540.0,472.0,,Potency,qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia,Confirmatory,,
1248,485350,1,2,,92124374,4421,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
1249,485353,2,1,,855620,4421,Inactive,30124074.0,1489680.0,,,qHTS of Yeast-based Assay for SARS-CoV PLP,Confirmatory,,
1250,485358,1,1,,855620,4421,Inactive,4503385.0,1813.0,,,HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists,Screening,,
1251,485360,1,1,,855620,4421,Inactive,117938328.0,26013.0,,Potency,qHTS Assay for the Inhibitors of L3MBTL1,Confirmatory,,
1252,485364,1,1,,855620,4421,Inactive,15149312.0,8345881.0,,Potency,qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins,Confirmatory,,
1253,485367,1,2,,855620,4421,Inactive,72386991.0,3656265.0,,Potency,qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase,Confirmatory,,
1254,488806,1,2,,855620,4421,Inactive,148539876.0,156.0,,,RNA aptamer-based validation for inhibitors of GRK2,Screening,,
1255,488837,1,1,,855620,4421,Inactive,26667227.0,2139.0,,Potency,qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2,Confirmatory,,
1256,488839,1,1,,56422386,4421,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1257,488839,1,1,,56422386,4421,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1258,488847,1,3,,56422386,4421,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
1259,488862,1,1,,56422386,4421,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1260,488890,1,2,,56422386,4421,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
1261,488895,1,2,,56422386,4421,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1262,488896,1,1,,56422386,4421,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1263,488899,1,1,,56422386,4421,Inactive,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1264,488922,1,2,,855620,4421,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
1265,488942,1,1,,56422386,4421,Active,15645703.0,899625.0,,,Absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of AddAB recombination protein complex,Screening,,
1266,488942,1,1,,56422386,4421,Active,15646160.0,899738.0,,,Absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of AddAB recombination protein complex,Screening,,
1267,488955,1,1,,56422386,4421,Active,16130723.0,947287.0,,,Counterscreen for AddAB inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of RecBCD,Screening,,
1268,488955,1,1,,56422386,4421,Active,16130724.0,947286.0,,,Counterscreen for AddAB inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of RecBCD,Screening,,
1269,488955,1,1,,56422386,4421,Active,16130726.0,947294.0,,,Counterscreen for AddAB inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of RecBCD,Screening,,
1270,488956,1,1,,56422386,4421,Active,,,,,Counterscreen for AddAB inhibitors: absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of bacterial viability,Screening,,
1271,488965,1,2,,56422386,4421,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1272,488966,1,1,,56422386,4421,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
1273,488975,1,2,,56422386,4421,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
1274,488977,1,2,,56422386,4421,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
1275,489030,2,1,,855620,4421,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
1276,489031,2,1,,855620,4421,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
1277,492947,1,1,,855620,4421,Inactive,4501969.0,154.0,,Potency,qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor,Confirmatory,,
1278,492953,1,1,,56422386,4421,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
1279,492956,1,1,,56422386,4421,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
1280,492967,1,2,,92260276,4421,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
1281,492967,1,2,,99301146,4421,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
1282,492972,1,1,,56422386,4421,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
1283,493005,1,1,,56422386,4421,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
1284,493008,1,1,,56422386,4421,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1285,493008,1,1,,56422386,4421,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1286,493008,1,1,,56422386,4421,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1287,493008,1,1,,56422386,4421,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1288,493011,1,1,,855620,4421,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
1289,493012,1,1,,855620,4421,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
1290,493014,1,1,,855620,4421,Inactive,,,,Potency,qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling,Confirmatory,,
1291,493027,1,2,,56422386,4421,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1)",Screening,,
1292,493027,1,2,,56422386,4421,Inactive,223718203.0,5346.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-1 (PLIN1)",Screening,,
1293,493033,1,2,,92124374,4421,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
1294,493035,1,2,,56422386,4421,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1295,493035,1,2,,56422386,4421,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical high throughput validation assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
1296,493036,1,2,,855620,4421,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
1297,493056,1,1,,855620,4421,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Enhancers,Screening,,
1298,493084,1,1,,855620,4421,Inactive,4507681.0,7201.0,,,qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists.,Screening,,
1299,493087,1,1,,56422386,4421,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
1300,493091,1,1,,56422386,4421,Inactive,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
1301,493098,1,1,,56422386,4421,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
1302,493131,1,1,,56422386,4421,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
1303,493160,1,1,,56422386,4421,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
1304,493162,1,2,,99301146,4421,Inactive,335756.0,,,,A screen for compounds that inhibit processive DNA synthesis of vaccinia virus,Other,,
1305,493187,1,2,,56422386,4421,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
1306,493244,1,1,,56422386,4421,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1307,493244,1,1,,56422386,4421,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1308,493244,1,1,,56422386,4421,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1309,493244,1,1,,56422386,4421,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
1310,495629,2,3,,103163814,4421,Inactive,,,,,Antimicrobial activity against Pseudomonas luteola by disk diffusion method,Other,19884377.0,
1311,495630,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Pseudomonas luteola by Etest method,Other,19884377.0,
1312,495748,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli ATCC 25922 by Etest method,Other,19901088.0,
1313,495749,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serotype Virchow 3464b by Etest method,Other,19901088.0,
1314,495750,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J5 by Etest method,Other,19901088.0,
1315,495751,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J5 transconjugants expressing beta lactamase CTX-M-9 isolated from human flora associated C3H rat infected with Salmonella enterica serotype Virchow by Etest method,Other,19901088.0,
1316,495752,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J5 transconjugants expressing beta lactamase CTX-M-9 isolated from human flora associated C3H rat infected with Salmonella enterica serotype Virchow and treated with Cefixime by Etest method,Other,19901088.0,
1317,495753,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J5 transconjugants expressing beta lactamase CTX-M-9 isolated from human flora associated C3H rat infected with Salmonella enterica serotype Virchow and treated with Cefixime-cluvulanic acid by Etest method,Other,19901088.0,
1318,496396,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against azide-resistant Escherichia coli J53 SXT1 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain,Other,19949057.0,
1319,496397,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against azide-resistant Escherichia coli J53 SXT2 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain,Other,19949057.0,
1320,496398,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against azide-resistant Escherichia coli J53 TET1 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain,Other,19949057.0,
1321,496399,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against azide-resistant Escherichia coli J53 TET2 transconjugant with qnrVC3 gene expressing Vibrio cholerae 59 strain,Other,19949057.0,
1322,498360,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52145R assessed as growth inhibition by Etest method,Other,19858254.0,
1323,498361,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52deltaacrB containing isogenic acrB knockout assessed as growth inhibition by Etest method,Other,19858254.0,
1324,498362,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against rifampin resistant Klebsiella pneumoniae 52deltaacrR containing isogenic acrR knockout assessed as growth inhibition by Etest method,Other,19858254.0,
1325,498798,3,3,,103163814,4421,Unspecified,,,,,Reduction quinolone resistant mutation in wild type Escherichia coli DM4100 assessed as decrease in recovery of resistant bacterial mutant colonies by agar plate assay,Other,19805561.0,
1326,498872,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter baumannii B9 containing carbapenemase blaOXA-23 gene assessed as growth inhibition by Etest method,Other,19884362.0,
1327,504326,1,2,,56422386,4421,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1328,504326,1,2,,56422386,4421,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1329,504327,1,1,,855620,4421,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
1330,504329,1,1,,56422386,4421,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
1331,504332,1,1,,855620,4421,Active,168985070.0,,8.9125,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
1332,504333,1,1,,855620,4421,Active,6683500.0,29994.0,79.4328,Potency,qHTS Assay for Inhibitors of BAZ2B,Confirmatory,,
1333,504339,1,1,,56422386,4421,Inactive,162330054.0,,,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
1334,504357,1,1,,56422386,4421,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1335,504357,1,1,,56422386,4421,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
1336,504406,1,1,,56422386,4421,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
1337,504408,2,1,,855620,4421,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
1338,504411,1,1,,56422386,4421,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
1339,504414,1,1,,56422386,4421,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1340,504414,1,1,,56422386,4421,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1341,504423,1,1,,56422386,4421,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1342,504441,1,1,,56422386,4421,Inactive,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1343,504444,1,1,,56422386,4421,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
1344,504454,1,3,,56422386,4421,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
1345,504459,1,3,,855620,4421,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method from Validation Set,Screening,,
1346,504462,1,1,,56422386,4421,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
1347,504466,1,1,,855620,4421,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1348,504467,1,1,,855620,4421,Inactive,116283940.0,79915.0,,Potency,qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1,Confirmatory,,
1349,504490,1,2,,56422386,4421,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
1350,504523,1,1,,56422386,4421,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1351,504523,1,1,,56422386,4421,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1352,504541,1,1,,855620,4421,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction for Validation Set,Screening,,
1353,504558,1,1,,56422386,4421,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1354,504577,2,2,,56422386,4421,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
1355,504582,2,1,,56422386,4421,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1356,504594,1,1,,56422386,4421,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1357,504600,1,2,,855620,4421,Inactive,6325022.0,855842.0,,,Validation of HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
1358,504621,1,1,,56422386,4421,Inactive,124809506.0,811999.0,,,Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1359,504634,1,1,,56422386,4421,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
1360,504648,1,1,,56422386,4421,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
1361,504651,1,1,,855620,4421,Inactive,4503383.0,1812.0,,,Potentiators of Human D1 Dopamine Receptor: qHTS,Screening,,
1362,504652,1,1,,855620,4421,Inactive,4503383.0,1812.0,,,Antagonist of Human D 1 Dopamine Receptor: qHTS,Screening,,
1363,504660,1,1,,855620,4421,Inactive,4503383.0,1812.0,,,Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS,Screening,,
1364,504690,1,3,,56422386,4421,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
1365,504692,2,2,,56422386,4421,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
1366,504700,1,1,,56422386,4421,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
1367,504700,1,1,,56422386,4421,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
1368,504706,1,1,,855620,4421,Inactive,23491729.0,7157.0,,Potency,qHTS assay for re-activators of p53 using a Luc reporter,Confirmatory,,
1369,504707,1,1,,56422386,4421,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
1370,504707,1,1,,56422386,4421,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
1371,504720,1,1,,56422386,4421,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
1372,504734,1,1,,56422386,4421,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
1373,504749,1,3,,26751460,4421,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1374,504749,1,3,,104171368,4421,Unspecified,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1375,504749,1,3,1.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1376,504749,1,3,2.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1377,504749,1,3,3.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1378,504749,1,3,4.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1379,504749,1,3,5.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1380,504749,1,3,6.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1381,504749,1,3,7.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1382,504749,1,3,8.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1383,504749,1,3,9.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1384,504749,1,3,10.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1385,504749,1,3,11.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1386,504749,1,3,12.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1387,504749,1,3,13.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1388,504749,1,3,14.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1389,504749,1,3,15.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1390,504749,1,3,16.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1391,504749,1,3,17.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1392,504749,1,3,18.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1393,504749,1,3,19.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1394,504749,1,3,20.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1395,504749,1,3,21.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1396,504749,1,3,22.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1397,504749,1,3,23.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1398,504749,1,3,24.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1399,504749,1,3,25.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1400,504749,1,3,26.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1401,504749,1,3,27.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1402,504749,1,3,28.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1403,504749,1,3,29.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1404,504749,1,3,30.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1405,504749,1,3,31.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1406,504749,1,3,32.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1407,504749,1,3,33.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1408,504749,1,3,34.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1409,504749,1,3,35.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1410,504749,1,3,36.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1411,504749,1,3,37.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1412,504749,1,3,38.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1413,504749,1,3,39.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1414,504749,1,3,40.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1415,504749,1,3,41.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1416,504749,1,3,42.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1417,504749,1,3,43.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1418,504749,1,3,44.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1419,504749,1,3,45.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1420,504749,1,3,46.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1421,504749,1,3,47.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1422,504749,1,3,48.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1423,504749,1,3,49.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1424,504749,1,3,50.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1425,504749,1,3,51.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1426,504749,1,3,52.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1427,504749,1,3,53.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1428,504749,1,3,54.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1429,504749,1,3,55.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1430,504749,1,3,56.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1431,504749,1,3,57.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1432,504749,1,3,58.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1433,504749,1,3,59.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1434,504749,1,3,60.0,104171368,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1435,504749,1,3,61.0,26751460,4421,Inactive,,,,,qHTS profiling for inhibitors of Plasmodium falciparum proliferation,Other,21817045.0,
1436,504766,2,1,,56422386,4421,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
1437,504770,1,2,,92124374,4421,Inactive,9657380.0,2612528.0,,,A screen for compounds that inhibit replication of Vibrio cholerae chromosome II,Other,,
1438,504775,1,1,,56422386,4421,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
1439,504803,1,1,,56422386,4421,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
1440,504810,1,2,,855620,4421,Inactive,118341367.0,7253.0,,,Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1441,504812,1,2,,855620,4421,Inactive,118341367.0,7253.0,,,Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign,Screening,20427476.0,
1442,504832,1,1,,855620,4421,Inactive,,,0.1651,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
1443,504832,1,1,,104171368,4421,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation",Confirmatory,,
1444,504834,1,1,,855620,4421,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
1445,504834,1,1,,104171368,4421,Inactive,,,,Potency,"Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation",Confirmatory,,
1446,504842,1,1,,855620,4421,Inactive,4090929.0,10576.0,,Potency,Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS,Confirmatory,,
1447,504845,1,1,,56422386,4421,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
1448,504847,1,1,,56422386,4421,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
1449,504847,1,1,,104171368,4421,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
1450,504865,1,1,,104171368,4421,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
1451,504884,1,2,,56422386,4421,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1452,504891,1,1,,56422386,4421,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
1453,504894,1,1,,56422386,4421,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
1454,504937,1,2,,56422386,4421,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
1455,508591,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild type Salmonella enteritidis 104 harboring gyrA D87Y mutant gene by CLSI method,Other,19917752.0,
1456,508592,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against ciprofloxacin-resistant Salmonella enteritidis 104 harboring gyrA D87Y/S83F mutant, soxR R20H mutant and soxS E52K mutant gene after 200 passages by CLSI method",Other,19917752.0,
1457,508593,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against ciprofloxacin-susceptibility revert strain of Salmonella enteritidis 104 harboring gyrA D87Y/S83F mutant, parC D79N mutant, soxR E16G/R20H mutant and soxS E52K mutant gene after 20 passages by CLSI method",Other,19917752.0,
1458,508594,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against ciprofloxacin-susceptible Salmonella enteritidis 1A-revertC2 harboring gyrA D87Y/S83F mutant, parC D79N mutant, soxR R133C/R20H mutant, soxS E52K mutant and marA I111N/H115Q mutant gene after 70 passages by CLSI method",Other,19917752.0,
1459,508595,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild type Salmonella enteritidis 5408 harboring gyrA D87Y mutant gene by CLSI method,Other,19917752.0,
1460,508596,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against ciprofloxacin-resistant Salmonella enteritidis 5408 harboring gyrA D87Y mutant, gyrB E466D mutant, parE V461G mutant and ramR G25A mutant gene after 200 passages by CLSI method",Other,19917752.0,
1461,508597,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enteritidis NCTC 13349 by CLSI method,Other,19917752.0,
1462,509633,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against tetracycline sulfamethoxazole streptomycin kanamycin-resistant Escherichia coli isolate M66-6 carrying qnrB19 gene,Other,20008783.0,
1463,509634,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against ampicillin tetracycline trimethoprim sulfamethoxazole streptomycin-resistant Escherichia coli isolate Y6-7 carrying qnrB19 gene,Other,20008783.0,
1464,509635,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against tetracycline trimethoprim sulfamethoxazole kanamycin-resistant Escherichia coli isolate C14-9 carrying qnrB19 gene,Other,20008783.0,
1465,509636,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against ampicillin sulfamethoxazole streptomycin kanamycin-resistant Escherichia coli isolate V6-9 carrying qnrB19 gene,Other,20008783.0,
1466,509637,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against ampicillin tetracyclin streptomycin kanamycin-resistant Escherichia coli isolate V32-1 carrying qnrB19 gene,Other,20008783.0,
1467,509638,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli HB101,Other,20008783.0,
1468,515780,5,1,,103163814,4421,Unspecified,,,,,Intrinsic solubility of the compound in water,Other,20810286.0,
1469,518946,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pCR-Blunt2-TOPO carrying qnrB12 gene of Citrobacter werkmanii isolate CIT2 by broth macrodilution method in presence of 64 ug/ml Phe-Arg-beta-naphthylamide,Other,18086833.0,
1470,518947,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 by broth macrodilution method in presence of 64 ug/ml Phe-Arg-beta-naphthylamide,Other,18086833.0,
1471,518948,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring empty vector pCR-Blunt2-TOPO by broth macrodilution method in presence of 64 ug/ml Phe-Arg-beta-naphthylamide,Other,18086833.0,
1472,518949,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pCR-Blunt2-TOPO carrying qnrB12 gene of Citrobacter werkmanii isolate CIT1 by broth macrodilution method in presence of 64 ug/ml Phe-Arg-beta-naphthylamide,Other,18086833.0,
1473,518950,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Citrobacter werkmanii isolate CIT3 harboring parC Leu88Gln mutant gene and qnrB12 gene by broth macrodilution method in presence of 64 ug/ml Phe-Arg-beta-naphthylamide,Other,18086833.0,
1474,518951,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against nalidixic acid-resistant Citrobacter werkmanii isolate CIT1 harboring gyrA Thr83Ile, parC Ser57Thr mutant gene and qnrB12 gene by broth macrodilution method",Other,18086833.0,
1475,518952,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Citrobacter werkmanii isolate CIT2 harboring qnrB12 gene by broth macrodilution method in presence of 64 ug/ml Phe-Arg-beta-naphthylamide,Other,18086833.0,
1476,518953,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pCR-Blunt2-TOPO carrying qnrB12 gene of Citrobacter werkmanii isolate CIT3 by broth macrodilution method,Other,18086833.0,
1477,518954,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pCR-Blunt2-TOPO carrying qnrB12 gene of Citrobacter werkmanii isolate CIT1 by broth macrodilution method,Other,18086833.0,
1478,518955,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pCR-Blunt2-TOPO carrying qnrB12 gene of Citrobacter werkmanii isolate CIT2 by broth macrodilution method,Other,18086833.0,
1479,518956,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring empty vector pCR-Blunt2-TOPO by broth macrodilution method,Other,18086833.0,
1480,518957,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Citrobacter werkmanii isolate CIT3 harboring parC Leu88Gln mutant and qnrB12 gene by broth macrodilution method,Other,18086833.0,
1481,518958,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 by broth macrodilution method,Other,18086833.0,
1482,518959,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Citrobacter werkmanii isolate CIT2 harboring qnrB12 gene by broth macrodilution method,Other,18086833.0,
1483,518960,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pCR-Blunt2-TOPO carrying qnrB12 gene of Citrobacter werkmanii isolate CIT3 by broth macrodilution method in presence of 64 ug/ml Phe-Arg-beta-naphthylamide,Other,18086833.0,
1484,518961,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against nalidixic acid-resistant Citrobacter werkmanii isolate CIT1 harboring gyrA Thr83Ile, parC Ser57Thr mutant gene and qnrB12 gene by broth macrodilution method in presence of 64 ug/ml Phe-Arg-beta-naphthylamide",Other,18086833.0,
1485,519106,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli 10418 after 18 hrs by Etest method,Other,18180352.0,
1486,519107,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis B2 after 18 hrs by Etest method,Other,18180352.0,
1487,519108,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 44 mutant after 18 hrs by Etest method,Other,18180352.0,
1488,519109,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 48 mutant after 18 hrs by Etest method,Other,18180352.0,
1489,519110,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 55 mutant after 18 hrs by Etest method,Other,18180352.0,
1490,519111,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis NP14 after 18 hrs by Etest method,Other,18180352.0,
1491,519112,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 19 mutant after 18 hrs by Etest method,Other,18180352.0,
1492,519113,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 21 mutant after 18 hrs by Etest method,Other,18180352.0,
1493,519114,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 23 mutant after 18 hrs by Etest method,Other,18180352.0,
1494,519115,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis NP37 after 18 hrs by Etest method,Other,18180352.0,
1495,519117,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 29 mutant after 18 hrs by Etest method,Other,18180352.0,
1496,519118,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 31 mutant after 18 hrs by Etest method,Other,18180352.0,
1497,519119,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis NP43 after 18 hrs by Etest method,Other,18180352.0,
1498,519120,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 12 mutant after 18 hrs by Etest method,Other,18180352.0,
1499,519121,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 17 mutant after 18 hrs by Etest method,Other,18180352.0,
1500,519122,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis NP55 after 18 hrs by Etest method,Other,18180352.0,
1501,519123,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 35 mutant after 18 hrs by Etest method,Other,18180352.0,
1502,519124,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 40 mutant after 18 hrs by Etest method,Other,18180352.0,
1503,519125,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 42 mutant after 18 hrs by Etest method,Other,18180352.0,
1504,519252,7,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus mirabilis M 26 mutant after 18 hrs by Etest method,Other,18180352.0,
1505,521966,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Campylobacter jejuni assessed as resistant isolates by disk diffusion method,Other,20038624.0,
1506,521967,2,5,,103163814,4421,Unspecified,,,,,Antibacterial activity against Campylobacter coli assessed as resistant isolates by disk diffusion method,Other,20038624.0,
1507,521968,4,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Campylobacter sp. assessed as resistance breakpoint by CLSI method,Other,20038624.0,
1508,522111,1,3,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Escherichia coli isolates producing extended-spectrum beta-lactamases bla(CTX-M-1), bla(CTX-M-32) and bla(SHV-12) assessed as resistant isolates isolated from Italian broiler flocks by agar dilution method",Other,20100875.0,
1509,522875,3,6,,103163814,4421,Active,,,,,Antibacterial activity against uropathogenic Escherichia coli UTI89 infected in human 5637 cells assessed as decrease in intracellular bacterial level at 800 to 1200 ug/ml after 12 hrs by serial dilution method,Other,20231390.0,
1510,523001,1,4,,103163814,4421,Unspecified,,,,,Cytotoxicity against human 5637 cells assessed as mild induction of cell death by trypan blue exclusion assay,Other,20231390.0,
1511,523002,1,4,,103163814,4421,Unspecified,,,,,Cytotoxicity against human 5637 cells assessed as mild induction of cell death by LDH release assay,Other,20231390.0,
1512,523004,2,5,,103163814,4421,Active,,,,,Antibacterial activity against uropathogenic Escherichia coli UTI89 assessed as degradation of preexisting biofilm after 24 hrs by microscopy,Other,20231390.0,
1513,524824,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against erythromycin resistant Campylobacter sp. by agar plate dilution method,Other,20038624.0,
1514,524825,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against erythromycin susceptible Campylobacter sp. by agar plate dilution method,Other,20038624.0,
1515,524826,2,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against erythromycin resistant Campylobacter sp. assessed as resistance breakpoint by CLSI method,Other,20038624.0,
1516,524827,2,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against erythromycin susceptible Campylobacter sp. assessed as resistance breakpoint by CLSI method,Other,20038624.0,
1517,525040,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against fluoroquinolone-susceptible Escherichia coli PS5 harboring GyrA S83L mutant gene by Etest,Other,20008776.0,
1518,525041,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against fluoroquinolone-resistant Escherichia coli NorE5 harboring GyrA S83L mutant, ParC S80R mutant, truncated SoxR and constitutively active SoxS by Etest",Other,20008776.0,
1519,528742,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 95 harboring GyrA Ser83Leu, Asp78Asn, Ala171Ser and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1520,528743,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 863 harboring GyrA Ser83Leu, Asp78Asn, Ala171Ser and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1521,528744,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 149 harboring GyrA Ser83Leu, Asp78Asn, Ala171Ser and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1522,528745,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 103 harboring GyrA Ser83Leu, Asp78Asn, Ala171Ser and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1523,528746,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 663 harboring GyrA Ser83Leu, Asp78Asn, Ala171Ser and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1524,528747,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 94 harboring GyrA Ser83Leu, Asp78Asn, Ala171Ser and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1525,528748,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 779 harboring GyrA Ser83Leu, Asp78Asn, Ala171Ser and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1526,528749,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 234 harboring GyrA Ser83Leu, Asp78Asn, Ala171Ser and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1527,528750,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 3 harboring GyrA Ser83Leu, Asp78Asn, Ala171Ser and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1528,528751,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 27 harboring GyrA Ser83Leu, Asp78Asn, Ala171Ser and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1529,528752,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 719 harboring GyrA Ser83Leu, Asp78Asn, Ala171Ser and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1530,528753,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 205 harboring GyrA Ser83Leu, Asp78Asn, Ala171Ser and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1531,528754,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 769 harboring GyrA Ser83Ile and Gly177Arg mutant gene by agar dilution method,Other,18505849.0,
1532,528755,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 828 harboring GyrA Ser83Ile and Gly177Arg mutant gene by agar dilution method,Other,18505849.0,
1533,528756,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 827 harboring GyrA Ser83Ile mutant gene by agar dilution method,Other,18505849.0,
1534,528757,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 772 harboring GyrA Ser83Ile mutant gene by agar dilution method,Other,18505849.0,
1535,528758,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 721 harboring GyrA Ala171Ser, Leu187Ile and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1536,528759,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-resistant Klebsiella pneumoniae isolate 836 by agar dilution method,Other,18505849.0,
1537,528760,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-intermediate resistant Klebsiella pneumoniae isolate 753 harboring GyrA Ser83Ile mutant gene by agar dilution method,Other,18505849.0,
1538,528761,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-intermediate resistant Klebsiella pneumoniae isolate 21 by agar dilution method,Other,18505849.0,
1539,528762,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-intermediate resistant Klebsiella pneumoniae isolate 715 by agar dilution method,Other,18505849.0,
1540,528763,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-susceptible Klebsiella pneumoniae isolate 840 harboring GyrA Ala171Ser, Leu187Ile and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1541,528764,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-susceptible Klebsiella pneumoniae isolate 685 harboring GyrA Ala171Ser, Leu187Ile and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1542,528765,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-susceptible Klebsiella pneumoniae isolate 212 harboring GyrA Ala171Ser, Leu187Ile and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1543,528766,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-susceptible Klebsiella pneumoniae isolate 517 harboring GyrA Ala171Ser, Leu187Ile and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1544,528767,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-susceptible Klebsiella pneumoniae isolate 838 harboring GyrA Ser83Tyr, Ala171Ser, Leu187Ile and Val198Ile mutant gene by agar dilution method",Other,18505849.0,
1545,528768,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-susceptible Klebsiella pneumoniae isolate 49 harboring GyrA Asp87Asn, Arg154Ser and Ala171Ser mutant gene by agar dilution method",Other,18505849.0,
1546,528769,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-susceptible Klebsiella pneumoniae isolate 182 harboring GyrA Ser83Thr and Ala171Ser mutant gene by agar dilution method,Other,18505849.0,
1547,528770,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-susceptible Klebsiella pneumoniae isolate 737 harboring GyrA Ser83Leu and Val198Ile mutant gene by agar dilution method,Other,18505849.0,
1548,528771,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-susceptible Klebsiella pneumoniae isolate 724 harboring GyrA Ser83Ile mutant gene by agar dilution method,Other,18505849.0,
1549,528772,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-susceptible Klebsiella pneumoniae isolate 738 by agar dilution method,Other,18505849.0,
1550,528773,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-susceptible Klebsiella pneumoniae isolate 577 by agar dilution method,Other,18505849.0,
1551,528774,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-susceptible Klebsiella pneumoniae isolate 760 by agar dilution method,Other,18505849.0,
1552,529307,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against QnrS2-negative Aeromonas veronii CECT 4258 harboring GyrA Ser83 and ParC Ser80 mutant gene by Etest,Other,18505860.0,
1553,529308,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against QnrS2-negative Aeromonas veronii CECT 4260 harboring GyrA Ser83 and ParC Ser80 mutant gene by Etest,Other,18505860.0,
1554,529309,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against QnrS2-positive Aeromonas veronii A272 harboring GyrA Ile83 and ParC Ile80 mutant gene by Etest,Other,18505860.0,
1555,529310,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J53 by Etest,Other,18505860.0,
1556,529311,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J53 harboring QnrS2 and GyrA Ile83 and ParC Ile80 mutant gene by Etest,Other,18505860.0,
1557,529456,4,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Klebsiella pneumoniae containing PFGE clone A expressing beta-lactamase Oxa-48, TEM-1, SHV-12 and Oxa-9 by Etest",Other,18519712.0,
1558,529457,4,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Klebsiella pneumoniae containing PFGE clone B expressing beta-lactamase Oxa-48, TEM-1, CTX-M-15 and Oxa-1 by Etest",Other,18519712.0,
1559,529480,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 1 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1560,529481,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 18 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1561,529482,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 140 containing PFGE genetic clone A expressing beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1562,529483,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 151 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 gene by Etest,Other,18519713.0,
1563,529484,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 185 containing PFGE genetic clone A expressing qnrB2 aac(6')-Ib-cr and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1564,529485,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 293 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1565,529486,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 533 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1566,529487,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 622 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1567,529488,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 625 containing PFGE genetic clone A expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1568,529489,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 656 containing PFGE genetic clone A expressing beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1569,529490,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 354 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1570,529491,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 649 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1571,529492,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 658 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1572,529493,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 781 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1573,529494,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 837 containing PFGE genetic clone B expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1574,529495,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 4469 containing PFGE genetic clone C expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1575,529496,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli T-622 harboring expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1576,529497,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli T-625 harboring expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1577,529498,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli T-781 harboring expressing qnrB2 and beta-lactamase KPC-2 and SHV-12 gene by Etest,Other,18519713.0,
1578,529499,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli GeneHogs by Etest,Other,18519713.0,
1579,529669,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli R4525 expressing gyrA S83L and D87Y and parC S80I and E84G mutant gene by CLSI method,Other,18519717.0,
1580,529670,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J53 transconjugate by CLSI method,Other,18519717.0,
1581,529671,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against azide-resistant Escherichia coli J53 by CLSI method,Other,18519717.0,
1582,529885,5,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus RN4220 by broth microdilution method,Other,18519725.0,
1583,530050,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus 286607-R1 by broth microdilution method,Other,18519725.0,
1584,530051,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus 286607-R1 harboring wild type gyrB by broth microdilution method,Other,18519725.0,
1585,530052,5,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus RN4220 expressing gyrB D437N mutant gene by broth microdilution method,Other,18519725.0,
1586,530286,5,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against PR-39-resistant Salmonella enterica serovar Typhimurium LT2 DA10899 harboring Q179Stop mutant gene by Etest,Other,18519732.0,
1587,530287,5,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against PR-39-resistant sbmA-deficient Salmonella enterica serovar Typhimurium LT2 DA12088 by Etest,Other,18519732.0,
1588,530288,5,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against PR-39-resistant Salmonella enterica serovar Typhimurium LT2 DA6192 by Etest,Other,18519732.0,
1589,530345,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Escherichia coli BicA expressing blaTEM-1, blaCTX-M-15 and qepA2 gene by disk diffusion method",Other,18644958.0,
1590,530346,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against azide-resistant Escherichia coli J53 harboring pCTX-M plasmid carrying blaCTX-M-15 gene by disk diffusion method,Other,18644958.0,
1591,530347,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against azide-resistant Escherichia coli J53 harboring pCTX-M carrying blaCTX-M-15 and pQep plasmid carrying qepA2 gene by disk diffusion method,Other,18644958.0,
1592,530348,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against azide-resistant Escherichia coli J53 by disk diffusion method,Other,18644958.0,
1593,530349,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pQep plasmid carrying qepA2 gene by disk diffusion method,Other,18644958.0,
1594,530350,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 by disk diffusion method,Other,18644958.0,
1595,530368,6,2,,103163814,4421,Unspecified,,,4750.0,IC50,Inhibition of Mycobacterium tuberculosis DNA gyrase GyrA/GyrB,Confirmatory,18426901.0,
1596,530369,4,2,,103163814,4421,Unspecified,,,950.0,IC50,Inhibition of Mycobacterium tuberculosis DNA gyrase GyrB/GyrA A83S mutant,Confirmatory,18426901.0,
1597,530370,4,2,,103163814,4421,Unspecified,,,2800.0,IC50,"Inhibition of Mycobacterium tuberculosis DNA gyrase GyrB/GyrA A83S, S84A and I85V mutant",Confirmatory,18426901.0,
1598,530371,4,2,,103163814,4421,Unspecified,,,1080.0,IC50,"Inhibition of Mycobacterium tuberculosis DNA gyrase GyrB/GyrA A83S, S84A, I85V, F96W and P101M mutant",Confirmatory,18426901.0,
1599,530372,4,2,,103163814,4421,Unspecified,,,3450.0,IC50,Inhibition of Mycobacterium tuberculosis DNA gyrase GyrB/GyrA M74I mutant,Confirmatory,18426901.0,
1600,530373,4,2,,103163814,4421,Unspecified,,,850.0,IC50,Inhibition of Mycobacterium tuberculosis DNA gyrase GyrB/GyrA M74I and A83S mutant,Confirmatory,18426901.0,
1601,530374,2,3,,103163814,4421,Inactive,,,,,"Inhibition of Mycobacterium tuberculosis DNA gyrase GyrB/GyrA S69V, A71G, E72D, T73V, M74I, N76K, A83S, S84A, I85V, F96W and P101M mutant",Other,18426901.0,
1602,530375,4,2,,103163814,4421,Unspecified,,,1080.0,IC50,Inhibition of Mycobacterium tuberculosis DNA gyrase GyrA/GyrB R447K mutant gene,Confirmatory,18426901.0,
1603,530376,4,2,,103163814,4421,Unspecified,,,4100.0,IC50,Inhibition of Mycobacterium tuberculosis DNA gyrase GyrA/GyrB N464S mutant gene,Confirmatory,18426901.0,
1604,530377,4,2,,103163814,4421,Unspecified,,,850.0,IC50,Inhibition of Mycobacterium tuberculosis DNA gyrase GyrA A83S mutant/GyrB R447K mutant gene,Confirmatory,18426901.0,
1605,530378,4,2,,103163814,4421,Unspecified,,,520.0,IC50,Inhibition of Mycobacterium tuberculosis DNA gyrase GyrA M74I and A83S mutant/GyrB R447K mutant gene,Confirmatory,18426901.0,
1606,530379,6,2,,103163814,4421,Unspecified,,,215.0,IC50,Inhibition of Escherichia coli DNA gyrase GyrA/GyrB,Confirmatory,18426901.0,
1607,530588,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 by Etest,Other,18644963.0,
1608,530589,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr1 carrying Smqnr gene by Etest,Other,18644963.0,
1609,530590,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr2 carrying Smqnr gene by Etest,Other,18644963.0,
1610,530591,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr3 carrying Smqnr gene by Etest,Other,18644963.0,
1611,530592,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr4 carrying Smqnr gene by Etest,Other,18644963.0,
1612,530593,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr5 carrying Smqnr gene by Etest,Other,18644963.0,
1613,530594,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr6 carrying Smqnr gene by Etest,Other,18644963.0,
1614,530595,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr7 carrying Smqnr gene by Etest,Other,18644963.0,
1615,530596,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr8 carrying Smqnr gene by Etest,Other,18644963.0,
1616,530597,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr9 carrying Smqnr gene by Etest,Other,18644963.0,
1617,530598,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr10 carrying Smqnr gene by Etest,Other,18644963.0,
1618,530599,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pSmQnr11 carrying Smqnr gene by Etest,Other,18644963.0,
1619,532027,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Kluyvera georgiana 14751 expressing beta-lactamase CTX-M-78 obtained from bloodstream of patient by disk diffusion method,Other,20421403.0,
1620,532029,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10F' transformant harboring beta-lactamase CTX-M-78 by disk diffusion method,Other,20421403.0,
1621,532031,5,2,,103163814,4421,Inconclusive,,,,,Antimicrobial activity against Escherichia coli TOP10F' by disk diffusion method,Other,20421403.0,
1622,532033,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Citrobacter werkmanii PS012 expressing PMQR determinant qnrB22 gene by Etest,Other,20421404.0,
1623,532034,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Citrobacter freundii S008 expressing PMQR determinant qnrB23 gene by Etest,Other,20421404.0,
1624,532035,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against azide-resistant Escherichia coli J53 TrcPS012 harboring PMQR determinant qnrB22 by Etest,Other,20421404.0,
1625,532036,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against azide-resistant Escherichia coli J53 TrcS008 harboring PMQR determinant qnrB23 by Etest,Other,20421404.0,
1626,532037,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against azide-resistant Escherichia coli J53 by Etest,Other,20421404.0,
1627,532038,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against azide-resistant Escherichia coli DH5alpha TrfPS012 harboring PMQR determinant qnrB22 by Etest,Other,20421404.0,
1628,532039,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against azide-resistant Escherichia coli DH5alpha TrfS008 harboring PMQR determinant qnrB23 by Etest,Other,20421404.0,
1629,532040,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against azide-resistant Escherichia coli DH5alpha by Etest,Other,20421404.0,
1630,532573,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 by broth dilution method,Other,18694955.0,
1631,532580,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant by broth dilution method,Other,18694955.0,
1632,532762,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 by broth dilution method in presence of chlorpromazine,Other,18694955.0,
1633,532763,2,4,,103163814,4421,Inconclusive,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph mutant by broth dilution method in presence of chlorpromazine,Other,18694955.0,
1634,532764,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method,Other,18694955.0,
1635,532765,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method in presence of IPTG,Other,18694955.0,
1636,532766,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella serovar Typhimurium SL1344 expressing ramA::aph-pTRC hisA:ramA mutant by broth dilution method in presence of chlorpromzine,Other,18694955.0,
1637,534090,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against rifampin resistant Escherichia coli RG488 receiving Klebsiella pneumoniae qnrB4 by agar dilution method,Other,18725444.0,
1638,534091,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against rifampin resistant Escherichia coli RG488 receiving Klebsiella pneumoniae qnrB6 by agar dilution method,Other,18725444.0,
1639,534092,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against rifampin resistant Escherichia coli RG488 receiving Klebsiella pneumoniae qnrS1 by agar dilution method,Other,18725444.0,
1640,534093,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against rifampin resistant Escherichia coli RG488 receiving Escherichia coli qnrB4 by agar dilution method,Other,18725444.0,
1641,534094,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against rifampin resistant Escherichia coli RG488 receiving Enterobacter cloacae qnrB4 by agar dilution method,Other,18725444.0,
1642,534095,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli J53 by agar dilution method,Other,18725444.0,
1643,534096,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli RG488 by agar dilution method,Other,18725444.0,
1644,534106,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pasteurella multocida AL435 after 24 hrs by broth dilution method,Other,18725450.0,
1645,534107,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against TolC deficient Pasteurella multocida pm0527 after 24 hrs by broth dilution method,Other,18725450.0,
1646,534108,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pasteurella multocida pm0527 after 24 hrs by broth dilution method,Other,18725450.0,
1647,534109,1,3,,103163814,4421,Unspecified,,,,,Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm0527,Other,18725450.0,
1648,534110,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against TolC deficient Pasteurella multocida pm1980 after 24 hrs by broth dilution method,Other,18725450.0,
1649,534111,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pasteurella multocida pm1980 after 24 hrs by broth dilution method,Other,18725450.0,
1650,534112,1,3,,103163814,4421,Unspecified,,,,,Ratio of MIC for Pasteurella multocida AL435 to MIC for TolC deficient Pasteurella multocida pm1980,Other,18725450.0,
1651,535567,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar blockley harboring G235A mutation in rlpD gene by agar dilution method,Other,20498312.0,
1652,535568,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica subsp. enterica serovar Saintpaul harboring G235A mutation in rlpD gene by agar dilution method,Other,20498312.0,
1653,535569,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Typhimurium harboring G235A mutation in rlpD gene by agar dilution method,Other,20498312.0,
1654,535570,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar montevideo harboring rlpD GC379T and rlpV G25A mutant gene by agar dilution method,Other,20498312.0,
1655,535571,4,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-resistant Salmonella enterica,Other,20498312.0,
1656,535691,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against beta-lactamase CTX-M-15-producing fluoroquinolone-resistant Escherichia coli FMV5825 expressing qnrB2 and aac(6')-Ib-cr and harboring gyrA Ser83Ile and Asp87Asn mutant gene and ParC Ser80Ile and Glu84Val mutant gene obtained from dog with urinary tract infection by broth microdilution method,Other,19001117.0,
1657,535694,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Azide-resistant Escherichia coli J53 transconjugant harboring Escherichia coli DH5alpha-5825 qnrB2 gene by broth microdilution method,Other,19001117.0,
1658,535697,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Azide-resistant Escherichia coli J53 by broth microdilution method,Other,19001117.0,
1659,535700,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli harboring qnr gene assessed as resistant isolate,Other,19001117.0,
1660,540253,1,1,,56422386,4421,Inactive,5031833.0,10073.0,4.1095,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
1661,540253,1,1,,56422386,4421,Inactive,5453555.0,5901.0,4.1095,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
1662,540253,1,1,,56422386,4421,Inactive,19923142.0,3837.0,4.1095,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
1663,540256,1,2,,855620,4421,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1664,540263,1,1,,56422386,4421,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
1665,540263,1,1,,56422386,4421,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
1666,540267,1,1,,56422386,4421,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
1667,540275,1,1,,855620,4421,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1,Screening,,
1668,540276,1,2,,855620,4421,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1669,540276,1,2,,17389812,4421,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1670,540276,1,2,,26746931,4421,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1671,540276,1,2,,26746932,4421,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1672,540276,1,2,,26751459,4421,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1673,540276,1,2,,26751460,4421,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1674,540276,1,2,,50100898,4421,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1675,540276,1,2,,56422386,4421,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1676,540276,1,2,,104171368,4421,Inactive,420597.0,,,Potency,qHTS for inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1677,540277,1,1,,855620,4421,Inactive,74315350.0,7442.0,,,HTS Assay for Compounds that Act as Potentiators of the Vanilloid Receptor 1,Screening,,
1678,540295,1,1,,56422386,4421,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
1679,540299,1,2,,92124374,4421,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
1680,540303,1,1,,56422386,4421,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
1681,540303,1,1,,56422386,4421,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
1682,540303,1,1,,56422386,4421,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
1683,540308,1,1,,56422386,4421,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
1684,540317,1,1,,56422386,4421,Inactive,187960037.0,10951.0,,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
1685,540336,1,1,,56422386,4421,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1686,540336,1,1,,56422386,4421,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1687,540364,1,2,,56422386,4421,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
1688,540816,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against marA::aph-deficient ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 104-cip harboring gyrA D87Y,S83F mutant gene by Etest",Other,19104017.0,
1689,540818,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar enteritidis isolate 5408 harboring gyrA gene by Etest,Other,19104017.0,
1690,540819,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against acrB::aph-deficient Salmonella enterica serovar enteritidis isolate 5408 harboring gyrA D87Y mutant gene by Etest,Other,19104017.0,
1691,540822,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 5408-cip harboring gyrA gene, gyrB E466D, parE V461G mutant gene by Etest",Other,19104017.0,
1692,540823,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 5408-cip harboring gyrB gene gyrA D87Y, parE V461G mutant gene by Etest",Other,19104017.0,
1693,540824,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 5408-cip harboring parE gene gyrA D87Y, gyrB E466D mutant gene by Etest",Other,19104017.0,
1694,540825,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against acrB::aph-deficient ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 5408-cip harboring gyrA D87Y, gyrB E466D, parE V461G mutant gene by Etest",Other,19104017.0,
1695,540826,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ramA::aph-deficient ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 5408-cip harboring gyrA D87Y, gyrB E466D, parE V461G mutant gene by Etest",Other,19104017.0,
1696,540827,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar enteritidis isolate CUH48 by Etest,Other,19104017.0,
1697,540828,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar enteritidis isolate CUH52 by Etest,Other,19104017.0,
1698,540829,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar enteritidis isolate NCTC 13349 by Etest,Other,19104017.0,
1699,540830,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar enteritidis isolate 54 harboring gyrA D87Y mutant gene by Etest,Other,19104017.0,
1700,540831,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar enteritidis isolate 58 harboring gyrA D87Y mutant gene by Etest,Other,19104017.0,
1701,540832,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar enteritidis isolate 51 harboring gyrA D87Y mutant gene by Etest,Other,19104017.0,
1702,540833,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar enteritidis isolate CUH60 harboring gyrA D87Y mutant gene by Etest,Other,19104017.0,
1703,540834,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar enteritidis isolate 4931 harboring gyrA D87Y mutant gene by Etest,Other,19104017.0,
1704,540835,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar enteritidis isolate 104 harboring gyrA D87Y mutant gene by Etest,Other,19104017.0,
1705,540836,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 5408-cip harboring gyrA D87Y, gyrB E466D, parE V461G mutant gene by Etest",Other,19104017.0,
1706,540837,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar enteritidis isolate 5408 harboring gyrA D87Y mutant gene by Etest,Other,19104017.0,
1707,540865,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar enteritidis isolate 104-cip harboring gyrA D87Y,S83F mutant gene by Etest",Other,19104017.0,
1708,541138,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against acrB::aph-deficient Salmonella enterica serovar enteritidis isolate 51 harboring gyrA D87Y mutant gene by Etest,Other,19104017.0,
1709,541140,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against acrB::aph-deficient Salmonella enterica serovar enteritidis isolate CUH60 harboring gyrA D87Y mutant gene by Etest,Other,19104017.0,
1710,541142,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against acrB::aph-deficient Salmonella enterica serovar enteritidis isolate 4931 harboring gyrA D87Y mutant gene by Etest,Other,19104017.0,
1711,541144,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar enteritidis isolate 104 harboring gyrA gene by Etest,Other,19104017.0,
1712,541145,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against acrB::aph-deficient Salmonella enterica serovar enteritidis isolate 104 harboring gyrA D87Y mutant gene by Etest,Other,19104017.0,
1713,541147,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 104-cip harboring gyrA gene by Etest,Other,19104017.0,
1714,541148,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against acrB::aph-deficient ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 104-cip harboring gyrA D87Y,S83F mutant gene by Etest",Other,19104017.0,
1715,541149,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against soxS::aph-deficient ciprofloxacin-resistant Salmonella enterica serovar enteritidis isolate 104-cip harboring gyrA D87Y,S83F mutant gene by Etest",Other,19104017.0,
1716,542138,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Bovismorbificans by broth microdilution assay,Other,19029321.0,
1717,542143,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH10B by broth microdilution assay,Other,19029321.0,
1718,542144,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH10B harboring pBR322 by broth microdilution assay,Other,19029321.0,
1719,542145,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH10B harboring pBR322 with Salmonella enterica HN-GSS-2007-057 qnrA1 gene by broth microdilution assay,Other,19029321.0,
1720,542146,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH10B harboring pBR322 with Salmonella enterica HN-GSS-2007-057 qnrS1 gene by broth microdilution assay,Other,19029321.0,
1721,542147,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH10B harboring pBR322 with Salmonella enterica HN-GSS-2007-057 qnrD gene by broth microdilution assay,Other,19029321.0,
1722,542148,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH10B harboring p2007057 by broth microdilution assay,Other,19029321.0,
1723,542420,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter sp. N2 isolate C439 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1724,542735,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Klebsiella pneumoniae D10 expressing aac(6')-Ib-cr, qnrB4, CTX-M-1G and DHA-1 genes by agar dilution method",Other,18936192.0,
1725,542737,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae D24 expressing aac(6')-Ib-cr and CTX-M-9G genes by agar dilution method,Other,18936192.0,
1726,542742,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Citrobacter freundii D26 expressing qnrB6 and CTX-M-9G genes by agar dilution method,Other,18936192.0,
1727,542759,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli Du19 expressing qnrB6 and CTX-M-9G genes by agar dilution method,Other,18936192.0,
1728,542766,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Escherichia coli PA11 expressing aac(6')-Ib-cr, qnrS1 and qepA genes by agar dilution method",Other,18936192.0,
1729,542768,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J53 by agar dilution method,Other,18936192.0,
1730,542769,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J53 transformed with pHND1 carrying DHA-1 gene by agar dilution method,Other,18936192.0,
1731,542770,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J53 transformed with pHND2 carrying qnrB6 and CTX-M-9G genes by agar dilution method,Other,18936192.0,
1732,542771,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J53 transformed with pHND3 carrying qnrB6 gene by agar dilution method,Other,18936192.0,
1733,542772,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J53 transformed with pHNDU1 carrying qnrB6 gene by agar dilution method,Other,18936192.0,
1734,542773,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J53 transformed with pHNPA1 carrying qnrB6 gene by agar dilution method,Other,18936192.0,
1735,543102,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Pseudomonas lini isolate C701 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1736,544004,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Aerococcus viridans isolate PGS22 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1737,544007,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Bacillus sphaericus isolate C237 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1738,544008,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter lwoffii isolate C2 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1739,544012,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Arthrobacter arilaitensis isolate C361 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1740,544013,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Pseudomonas putida isolate C231 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1741,544014,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter sp. An9 isolate PGS49 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1742,544016,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter lwoffii isolate PGS47 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1743,544019,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter lwoffii isolate C15 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1744,544020,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Psychrobacter ikaite isolate C20 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1745,544021,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Psychrobacter sp. DY9-2 isolate C711 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1746,544022,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Psychrobacter frigidicola isolate C712 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1747,544023,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Psychrobacter ikaite isolate C713 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1748,544024,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter calcoaceticus isolate C35 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1749,544025,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter calcoaceticus isolate C36 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1750,544026,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter lwoffii isolate C37 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1751,544027,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter rhizosphaerae isolate C44 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1752,544028,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter lwoffii isolate C141 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1753,544029,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Bacillus psychrodurans isolate C328 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1754,544030,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter baumannii isolate C442 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1755,544058,4,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Shigella flexneri isolate C506 harboring sul1 to sul3 genes assessed as antibiotic resistance breakpoint by agar dilution method,Other,19064898.0,
1756,544261,4,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against fluoroquinolone-susceptible Neisseria meningitidis by disk diffusion method,Other,19015355.0,
1757,544264,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against fluoroquinolone-resistant Neisseria meningitidis expressing gyrA mutant at 30 ug by disk diffusion method,Other,19015355.0,
1758,544475,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against fluoroquinolone-susceptible Neisseria meningitidis at 30 ug by disk diffusion method,Other,19015355.0,
1759,544831,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae CIP104485 by agar disk diffusion method,Other,18725440.0,
1760,544832,2,6,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae R6 by agar disk diffusion method,Other,18725440.0,
1761,544833,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae CP1000 by agar disk diffusion method,Other,18725440.0,
1762,544834,2,6,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae R6 Tr6 harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,Other,18725440.0,
1763,544835,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae U2A1686 harboring gyrA Glu85Lys mutant gene by agar disk diffusion method,Other,18725440.0,
1764,544836,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae U2A1050 harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,Other,18725440.0,
1765,544837,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae U2A1051 harboring gyrA Ser81Tyr mutant gene by agar disk diffusion method,Other,18725440.0,
1766,544838,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae U2A1266 harboring gyrA Ser81Cys mutant gene by agar disk diffusion method,Other,18725440.0,
1767,544839,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae H548 clinical isolate harboring gyrA Ser81Phe mutant gene by agar disk diffusion method,Other,18725440.0,
1768,544840,2,6,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae R6 Tr1 harboring parC Ser79Tyr mutant gene by agar disk diffusion method,Other,18725440.0,
1769,544841,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae U2A1053 harboring parC Ser79Phe mutant gene by agar disk diffusion method,Other,18725440.0,
1770,544842,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae U2A1413 harboring parC Ser79Tyr mutant gene by agar disk diffusion method,Other,18725440.0,
1771,544843,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae U2A1693 harboring parC Asp83Asn mutant gene by agar disk diffusion method,Other,18725440.0,
1772,544844,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae U2A1411 harboring parC Asp83Gly mutant gene by agar disk diffusion method,Other,18725440.0,
1773,544845,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae U2A1681 harboring parC Ser79Tyr Asp83Ala mutant gene by agar disk diffusion method,Other,18725440.0,
1774,544846,2,6,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae R6 Tr10 harboring gyrA Ser81Tyr parC Ser79Tyr mutant gene by agar disk diffusion method,Other,18725440.0,
1775,544847,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae U2A1056 harboring gyrA Ser81Tyr parC Asp83His mutant gene by agar disk diffusion method,Other,18725440.0,
1776,544848,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae U2A1060 harboring gyrA Ser81Phe parC Asp83His mutant gene by agar disk diffusion method,Other,18725440.0,
1777,544849,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus pneumoniae U2A1414 harboring gyrA Glu85Lys parC Ser79Phe mutant gene by agar disk diffusion method,Other,18725440.0,
1778,546921,8,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli by broth microdilution method,Other,19114678.0,
1779,546922,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1780,546923,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1781,546924,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Typhimurium by broth microdilution method,Other,19114678.0,
1782,546925,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Typhimurium assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1783,546926,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Typhimurium assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1784,546927,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Enteritidis by broth microdilution method,Other,19114678.0,
1785,546928,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Enteritidis assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1786,546929,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Enteritidis assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1787,546930,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Typhi by broth microdilution method,Other,19114678.0,
1788,546931,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Typhi assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1789,546932,2,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Typhi assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1790,546933,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Paratyphi by broth microdilution method,Other,19114678.0,
1791,546934,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Paratyphi assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1792,546935,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Paratyphi assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1793,546936,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Choleraesuis by broth microdilution method,Other,19114678.0,
1794,546937,2,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Choleraesuis assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1795,546938,2,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Choleraesuis assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1796,546939,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Newport by broth microdilution method,Other,19114678.0,
1797,546940,2,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Newport assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1798,546941,2,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Newport assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1799,546942,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Virchow by broth microdilution method,Other,19114678.0,
1800,546943,2,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Virchow assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1801,546944,2,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Virchow assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1802,546945,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Heidelberg by broth microdilution method,Other,19114678.0,
1803,546946,2,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Heidelberg assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1804,546947,2,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Heidelberg assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1805,546948,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Shigella sonnei by broth microdilution method,Other,19114678.0,
1806,546949,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Shigella sonnei assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1807,546950,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Shigella sonnei assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1808,546951,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Shigella flexneri by broth microdilution method,Other,19114678.0,
1809,546952,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Shigella flexneri assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1810,546953,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Shigella flexneri assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1811,546954,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Shigella boydii by broth microdilution method,Other,19114678.0,
1812,546955,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Shigella boydii assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1813,546956,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Shigella boydii assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1814,546957,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Shigella dysenteriae by broth microdilution method,Other,19114678.0,
1815,546958,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Shigella dysenteriae assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1816,546959,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Shigella dysenteriae assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1817,546960,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Yersinia enterocolitica by broth microdilution method,Other,19114678.0,
1818,546961,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Yersinia enterocolitica assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1819,546962,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Yersinia enterocolitica assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1820,546963,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Yersinia pseudotuberculosis by broth microdilution method,Other,19114678.0,
1821,546964,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Yersinia pseudotuberculosis assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1822,546965,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Yersinia pseudotuberculosis assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1823,546966,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Aeromonas hydrophila by broth microdilution method,Other,19114678.0,
1824,546967,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Aeromonas hydrophila assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1825,546968,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Aeromonas hydrophila assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1826,546969,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Aeromonas caviae by broth microdilution method,Other,19114678.0,
1827,546970,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Aeromonas caviae assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1828,546971,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Aeromonas caviae assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1829,546972,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Aeromonas sobria by broth microdilution method,Other,19114678.0,
1830,546973,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Aeromonas sobria assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1831,546974,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Aeromonas sobria assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1832,546975,6,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Aeromonas veronii by broth microdilution method,Other,19114678.0,
1833,546976,2,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Aeromonas veronii assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1834,547169,2,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Aeromonas veronii assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1835,547170,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Plesiomonas shigelloides by broth microdilution method,Other,19114678.0,
1836,547171,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Plesiomonas shigelloides assessed as percent susceptible isolates by broth microdilution method,Other,19114678.0,
1837,547172,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against Plesiomonas shigelloides assessed as percent resistant isolates by broth microdilution method,Other,19114678.0,
1838,547173,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Vibrio cholerae by broth microdilution method,Other,19114678.0,
1839,547176,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Vibrio parahaemolyticus by broth microdilution method,Other,19114678.0,
1840,547179,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Vibrio alginolyticus by broth microdilution method,Other,19114678.0,
1841,547182,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Vibrio fluvialis by broth microdilution method,Other,19114678.0,
1842,547185,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Vibrio vulnificus by broth microdilution method,Other,19114678.0,
1843,547188,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Vibrio sp. by broth microdilution method,Other,19114678.0,
1844,547191,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Campylobacter jejuni by broth microdilution method,Other,19114678.0,
1845,547194,6,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Campylobacter coli by broth microdilution method,Other,19114678.0,
1846,557796,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Proteus mirabilis 06-489 isolated from infected human urinary tract by Etest,Other,19258263.0,
1847,557798,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J53 transconjugated with Proteus mirabilis pHS10 carrying qnrC gene by Etest,Other,19258263.0,
1848,557800,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli J53 by Etest,Other,19258263.0,
1849,557801,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying qnrC gene by CLSI agar dilution method,Other,19258263.0,
1850,557802,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying ATG to ACG substituted qnrC gene by CLSI agar dilution method,Other,19258263.0,
1851,557803,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying TTG to ATG substituted qnrC gene by CLSI agar dilution method,Other,19258263.0,
1852,557804,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying TTG to TCG substituted qnrC gene by CLSI agar dilution method,Other,19258263.0,
1853,557805,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying TTG to TTA substituted qnrC gene by CLSI agar dilution method,Other,19258263.0,
1854,557806,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying ATT to ATG substituted qnrC gene by CLSI agar dilution method,Other,19258263.0,
1855,557807,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli TOP10 harboring pHS12 carrying ATT to TTA substituted qnrC gene by CLSI agar dilution method,Other,19258263.0,
1856,557808,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli ATCC 25922 by CLSI agar dilution method,Other,19258263.0,
1857,559418,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate Y2 harboring qnrS1 gene by agar dilution method,Other,19364872.0,
1858,559419,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Citrobacter freundii isolate V1 harboring qnrB10 gene by agar dilution method,Other,19364872.0,
1859,559420,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella oxytoca isolate M1 harboring qnrB19 gene by agar dilution method,Other,19364872.0,
1860,559421,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate V1 harboring qnrB2 gene by agar dilution method,Other,19364872.0,
1861,559422,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia hermannii isolate C1 harboring qnrB19 gene by agar dilution method,Other,19364872.0,
1862,559423,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae isolate V1 harboring qnrB2 gene by agar dilution method,Other,19364872.0,
1863,559424,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae isolate M1 harboring qnrB19 gene by agar dilution method,Other,19364872.0,
1864,559425,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae isolate Y1 harboring qnrB19 gene by agar dilution method,Other,19364872.0,
1865,559426,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate V1 harboring qnrB19 gene by agar dilution method,Other,19364872.0,
1866,559427,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate M1 harboring qnrB19 gene by agar dilution method,Other,19364872.0,
1867,559428,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate C1 harboring qnrB19 gene by agar dilution method,Other,19364872.0,
1868,559429,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate Y1 harboring qnrB19 gene by agar dilution method,Other,19364872.0,
1869,559430,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate Y3 harboring qnrS1 gene by agar dilution method,Other,19364872.0,
1870,559431,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate M2 harboring qnrS1 gene by agar dilution method,Other,19364872.0,
1871,559432,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate M3 harboring qnrS1 gene by agar dilution method,Other,19364872.0,
1872,559433,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae isolate Y2 harboring qnrS1 gene by agar dilution method,Other,19364872.0,
1873,559603,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae isolate M2 harboring qnrS1 gene by agar dilution method,Other,19364872.0,
1874,559604,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae isolate C2 harboring qnrS1 gene by agar dilution method,Other,19364872.0,
1875,559605,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae isolate V2 harboring qnrS1 gene by agar dilution method,Other,19364872.0,
1876,559606,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella oxytoca isolate M2 harboring qnrS1 gene by agar dilution method,Other,19364872.0,
1877,559607,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrB-positive Escherichia coli clinical isolate by agar dilution method,Other,19364872.0,
1878,559608,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrB-positive Escherichia coli clinical isolate assessed as resistant isolate,Other,19364872.0,
1879,559609,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrB-positive Escherichia coli clinical isolate assessed as susceptible isolate,Other,19364872.0,
1880,559610,4,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Escherichia coli clinical isolate by agar dilution method,Other,19364872.0,
1881,559611,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Escherichia coli clinical isolate assessed as resistant isolate,Other,19364872.0,
1882,559612,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Escherichia coli clinical isolate assessed as susceptible isolate,Other,19364872.0,
1883,559613,4,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrB/S-positive Escherichia coli clinical isolate by agar dilution method,Other,19364872.0,
1884,559614,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrB/S-positive Escherichia coli clinical isolate assessed as resistant isolate,Other,19364872.0,
1885,559615,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrB/S-positive Escherichia coli clinical isolate assessed as susceptible isolate,Other,19364872.0,
1886,559616,4,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrB-positive Klebsiella pneumoniae clinical isolate by agar dilution method,Other,19364872.0,
1887,559617,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrB-positive Klebsiella pneumoniae clinical isolate assessed as resistant isolate,Other,19364872.0,
1888,559618,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrB-positive Klebsiella pneumoniae clinical isolate assessed as susceptible isolate,Other,19364872.0,
1889,559619,4,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Klebsiella pneumoniae clinical isolate by agar dilution method,Other,19364872.0,
1890,559620,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Klebsiella pneumoniae clinical isolate assessed as resistant isolate,Other,19364872.0,
1891,559621,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Klebsiella pneumoniae clinical isolate assessed as susceptible isolate,Other,19364872.0,
1892,559622,4,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella oxytoca clinical isolate by agar dilution method,Other,19364872.0,
1893,559623,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella oxytoca clinical isolate assessed as resistant isolate,Other,19364872.0,
1894,559624,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella oxytoca clinical isolate assessed as susceptible isolate,Other,19364872.0,
1895,559625,4,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae clinical isolate by agar dilution method,Other,19364872.0,
1896,559626,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae clinical isolate assessed as resistant isolate,Other,19364872.0,
1897,559627,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae clinical isolate assessed as susceptible isolate,Other,19364872.0,
1898,559628,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia hermannii clinical isolate by agar dilution method,Other,19364872.0,
1899,559629,2,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia hermannii clinical isolate assessed as resistant isolate,Other,19364872.0,
1900,559630,2,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia hermannii clinical isolate assessed as susceptible isolate,Other,19364872.0,
1901,559631,4,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Citrobacter freundii clinical isolate by agar dilution method,Other,19364872.0,
1902,559632,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Citrobacter freundii clinical isolate assessed as resistant isolate,Other,19364872.0,
1903,559633,1,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Citrobacter freundii clinical isolate assessed as susceptible isolate,Other,19364872.0,
1904,559696,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli 3963 by Etest method,Other,19451298.0,
1905,559697,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli TOP10 by Etest method,Other,19451298.0,
1906,559698,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-resistant Escherichia coli TOP10-3963 transformant harboring qnrS1 gene by Etest method,Other,19451298.0,
1907,560222,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Typhimurium 01-4 by CLSI M7-A7 agar dilution method,Other,19470505.0,
1908,560223,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Typhimurium R200 expressing Outer membrane protein STM3031 by CLSI M7-A7 agar dilution method,Other,19470505.0,
1909,560224,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica serovar Typhimurium R200 expressing stm3031 gene deletion mutant by CLSI M7-A7 agar dilution method,Other,19470505.0,
1910,560259,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium STYM61/9 expressing qnrB19 gene variant carried by IncL/M-like plasmid by Etest,Other,19528272.0,
1911,560260,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium transconjugant p61/9T expressing qnrB19 gene variant carried by IncL/M-like plasmid by Etest,Other,19528272.0,
1912,560261,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli CSH26RifR receiving qnrB19 gene variant carried by IncL/M-like plasmid from Salmonella enterica serovar Typhimurium STYM61/9 by Etest,Other,19528272.0,
1913,561313,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 37 expressing aac(6')-Ib-cr gene,Other,19289526.0,
1914,561314,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 37 transconjugant expressing aac(6')-Ib-cr gene,Other,19289526.0,
1915,561315,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 101 expressing aac(6')-Ib-cr gene,Other,19289526.0,
1916,561316,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 101 transconjugant expressing aac(6')-Ib-cr gene,Other,19289526.0,
1917,561317,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 153 expressing aac(6')-Ib-cr gene,Other,19289526.0,
1918,561318,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Enterobacter cloacae isolate 153 transconjugant expressing aac(6')-Ib-cr gene,Other,19289526.0,
1919,561319,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate 17 expressing aac(6')-Ib-cr gene,Other,19289526.0,
1920,561320,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate 17 transconjugant expressing aac(6')-Ib-cr gene,Other,19289526.0,
1921,561321,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate 48 expressing aac(6')-Ib-cr gene,Other,19289526.0,
1922,561322,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate 48 transconjugant expressing aac(6')-Ib-cr gene,Other,19289526.0,
1923,561323,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae isolate 132 expressing aac(6')-Ib-cr gene,Other,19289526.0,
1924,561324,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae isolate 132 transconjugant expressing aac(6')-Ib-cr gene,Other,19289526.0,
1925,561325,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae isolate 135 expressing aac(6')-Ib-cr gene,Other,19289526.0,
1926,561326,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae isolate 135 transconjugant expressing aac(6')-Ib-cr gene,Other,19289526.0,
1927,561327,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae isolate 202 expressing aac(6')-Ib-cr gene,Other,19289526.0,
1928,561328,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae isolate 202 transconjugant expressing aac(6')-Ib-cr gene,Other,19289526.0,
1929,561329,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against azide-resistant Escherichia coli J53,Other,19289526.0,
1930,561388,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis CCUG 30837 by Etest method,Other,19414571.0,
1931,561389,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP101 by Etest method,Other,19414571.0,
1932,561390,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP106 by Etest method,Other,19414571.0,
1933,561391,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP109 by Etest method,Other,19414571.0,
1934,561392,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP111 by Etest method,Other,19414571.0,
1935,561393,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP112 by Etest method,Other,19414571.0,
1936,561394,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP113 by Etest method,Other,19414571.0,
1937,561395,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP115 by Etest method,Other,19414571.0,
1938,561396,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP128 by Etest method,Other,19414571.0,
1939,561397,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP58 by Etest method,Other,19414571.0,
1940,561398,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP99 by Etest method,Other,19414571.0,
1941,561399,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP117 by Etest method,Other,19414571.0,
1942,561400,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP118 by Etest method,Other,19414571.0,
1943,561401,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP121 by Etest method,Other,19414571.0,
1944,561402,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP122 by Etest method,Other,19414571.0,
1945,561403,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis CCUG 30837 by Etest method in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide,Other,19414571.0,
1946,561404,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP113 by Etest method in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide,Other,19414571.0,
1947,561405,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP58 by Etest method in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide,Other,19414571.0,
1948,561406,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP99 by Etest method in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide,Other,19414571.0,
1949,561407,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP117 by Etest method in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide,Other,19414571.0,
1950,561408,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP118 by Etest method in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide,Other,19414571.0,
1951,561409,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP121 by Etest method in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide,Other,19414571.0,
1952,561410,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against quinolone-susceptible Bordetella pertussis BP122 by Etest method in presence of efflux pump inhibitor phenyl-arginine-beta-naphthylamide,Other,19414571.0,
1953,561411,1,3,,103163814,4421,Active,,,,,Antibacterial activity against Escherichia coli K-12 harboring lon lexA3 mutant gene,Other,19414573.0,
1954,561412,1,3,,103163814,4421,Active,,,,,Antibacterial activity against Escherichia coli K-12 harboring gyrA67/gyrB225 mutant gene,Other,19414573.0,
1955,561413,2,3,,103163814,4421,Active,,,,,Antibacterial activity against lon-deficient Escherichia coli KD2372,Other,19414573.0,
1956,561414,1,3,,103163814,4421,Active,,,,,Antibacterial activity against Escherichia coli K-12 harboring lon sulA double mutant gene,Other,19414573.0,
1957,561415,1,3,,103163814,4421,Inactive,,,,,Antibacterial activity against Escherichia coli K-12 by viscometric assay,Other,19414573.0,
1958,561416,2,3,,103163814,4421,Active,,,,,Antibacterial activity against lon-deficient Escherichia coli KD2372 by viscometric assay,Other,19414573.0,
1959,563500,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Serratia marcescens ATCC 13880 by broth dilution method,Other,19752278.0,
1960,563501,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against cetylpyridinium chloride-resistant Serratia marcescens 01 by broth dilution method,Other,19752278.0,
1961,563502,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against cetylpyridinium chloride-sensitive Serratia marcescens 71 by broth dilution method,Other,19752278.0,
1962,563503,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against cetylpyridinium chloride-sensitive Serratia marcescens 79 by broth dilution method,Other,19752278.0,
1963,563518,4,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa PAO1 by broth dilution method,Other,19752280.0,
1964,563519,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa NY214 by broth dilution method,Other,19752280.0,
1965,563520,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa NY215 by broth dilution method,Other,19752280.0,
1966,563521,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa NY217 by broth dilution method,Other,19752280.0,
1967,563522,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa NY219 by broth dilution method,Other,19752280.0,
1968,563523,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa NY220 by broth dilution method,Other,19752280.0,
1969,564885,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against wild-type Escherichia coli AG100 harboring IS186 insertion in lon3 gene, Tn5 insertion in ycgE gene, plasmid pET21b carrying ompF gene and pACT7SP at 26 degC by Etest method",Other,19721064.0,
1970,564886,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against wild-type Escherichia coli AG100 harboring IS186 insertion in lon3 gene, Tn5 insertion in ycgE gene, plasmid pET21b and pACT7SP at 26 degC by Etest method",Other,19721064.0,
1971,564887,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against wild-type Escherichia coli AG100 harboring IS186 insertion in lon3 gene, Tn5 insertion in ycgE gene and plasmid pMPM carrying ompF gene at 26 degC by Etest method",Other,19721064.0,
1972,564888,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against wild-type Escherichia coli AG100 harboring IS186 insertion in lon3 gene, Tn5 insertion in ycgE gene and plasmid pMPM at 26 degC by Etest method",Other,19721064.0,
1973,564889,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against ompF-deficient Escherichia coli AG100 harboring IS186 insertion in lon3 gene and Tn5 insertion in ycgE gene at 26 degC by Etest method,Other,19721064.0,
1974,564890,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against ompF-deficient Escherichia coli AG100 harboring IS186 insertion in lon3 gene and Tn5 insertion in ycgE gene at 37 degC by Etest method,Other,19721064.0,
1975,564891,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against ompF-deficient Escherichia coli AG100 at 26 degC by Etest method,Other,19721064.0,
1976,564892,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against ompF-deficient Escherichia coli AG100 at 37 degC by Etest method,Other,19721064.0,
1977,564893,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild-type Escherichia coli AG100 harboring marR mutant gene at 26 degC by Etest method,Other,19721064.0,
1978,564894,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild-type Escherichia coli AG100 harboring marR mutant gene at 37 degC by Etest method,Other,19721064.0,
1979,564895,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild-type Escherichia coli AG100 harboring IS186 insertion in lon3 gene and Tn5 insertion in ycgE gene at 26 degC by Etest method,Other,19721064.0,
1980,565056,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild-type Escherichia coli AG100 harboring IS186 insertion in lon3 gene and Tn5 insertion in ycgE gene at 37 degC by Etest method,Other,19721064.0,
1981,565057,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild-type Escherichia coli AG100 harboring Tn5 insertion in ycgE gene at 37 degC by Etest method,Other,19721064.0,
1982,565058,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild-type Escherichia coli AG100 harboring Tn5 insertion in ycgE gene at 26 degC by Etest method,Other,19721064.0,
1983,565059,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild-type Escherichia coli AG100 harboring IS186 insertion in lon3 gene at 26 degC by Etest method,Other,19721064.0,
1984,565060,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild-type Escherichia coli AG100 harboring IS186 insertion in lon3 gene at 37 degC by Etest method,Other,19721064.0,
1985,565061,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild-type Escherichia coli AG100 at 26 degC by Etest method,Other,19721064.0,
1986,565062,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against wild-type Escherichia coli AG100 at 37 degC by Etest method,Other,19721064.0,
1987,565063,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against CTX-M-15 ESBL producing Enterobacter cloacae assessed as resistant isolates by disk diffusion method,Other,19721071.0,
1988,565064,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against SHV-12 ESBL producing Enterobacter cloacae assessed as resistant isolates by disk diffusion method,Other,19721071.0,
1989,565065,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against CTX-M-14 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method,Other,19721071.0,
1990,565066,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against CTX-M-15 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method,Other,19721071.0,
1991,565067,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against CTX-M-15 and SHV-27 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method,Other,19721071.0,
1992,565068,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against CTX-M-15 and SHV-12 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method,Other,19721071.0,
1993,565069,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against SHV-12 ESBL producing Escherichia coli assessed as resistant isolates by disk diffusion method,Other,19721071.0,
1994,565070,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against CTX-M-14 ESBL producing Klebsiella pneumoniae assessed as resistant isolates by disk diffusion method,Other,19721071.0,
1995,565071,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against CTX-M-15 ESBL producing Klebsiella pneumoniae assessed as resistant isolates by disk diffusion method,Other,19721071.0,
1996,565072,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against SHV-12 ESBL producing Klebsiella pneumoniae assessed as resistant isolates by disk diffusion method,Other,19721071.0,
1997,565073,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against CTX-M-14 ESBL producing Morganella morganii assessed as resistant isolates by disk diffusion method,Other,19721071.0,
1998,565074,1,3,,103163814,4421,Unspecified,,,,,Antibacterial activity against CTX-M-14 ESBL producing Proteus mirabilis assessed as resistant isolates by disk diffusion method,Other,19721071.0,
1999,565191,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 expressing open reading frame orf3 encoded efflux pump CraA by Etest,Other,19581458.0,
2000,565192,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Acinetobacter baumannii JVAB01 expressing disrupted open reading frame orf3 mutant deficient in efflux pump CraA by Etest,Other,19581458.0,
2001,565193,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against efflux pump CraA deficient Acinetobacter baumannii JVAB01 receiving pJV103 harboring open reading frame orf3 encoded efflux pump CraA by Etest,Other,19581458.0,
2002,566586,1,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Bacillus subtilis at 50 mg/disk after 24 to 28 hrs by agar disk diffusion method,Other,21074295.0,
2003,566587,1,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus lactis at 50 mg/disk after 24 to 28 hrs by agar disk diffusion method,Other,21074295.0,
2004,566588,1,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli at 50 mg/disk after 24 to 28 hrs by agar disk diffusion method,Other,21074295.0,
2005,566589,1,4,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa at 50 mg/disk after 24 to 28 hrs by agar disk diffusion method,Other,21074295.0,
2006,567457,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhi isolate 080049Ty by broth microdilution method,Other,20585124.0,
2007,567458,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhi isolate 080048Ty by broth microdilution method,Other,20585124.0,
2008,567459,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli W3110 transformant harboring bla CTX-M-15 gene by broth microdilution method,Other,20585124.0,
2009,567460,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhi isolate 080048Ty transconjugant harboring bla CTX-M-15 gene by broth microdilution method,Other,20585124.0,
2010,571882,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli KAM32 harboring plasmid pUC18 by CLSI broth microdilution method,Other,19770280.0,
2011,571884,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene by CLSI broth microdilution method,Other,19770280.0,
2012,572058,2,3,,103163814,4421,Unspecified,,,,,Ratio of MIC for Escherichia coli KAM32 harboring plasmid pUC18 to MIC for Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene,Other,19770280.0,
2013,572059,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Acinetobacter baumannii AC0037 by CLSI broth microdilution method,Other,19770280.0,
2014,572060,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against abeS-deficient Acinetobacter baumannii AC0037 by CLSI broth microdilution method,Other,19770280.0,
2015,572061,2,3,,103163814,4421,Unspecified,,,,,Ratio of MIC for Acinetobacter baumannii AC0037 to MIC for abeS-deficient Acinetobacter baumannii AC0037,Other,19770280.0,
2016,572062,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against abeS sigma abeS-deficient Acinetobacter baumannii AC0037 by CLSI broth microdilution method,Other,19770280.0,
2017,572147,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomeganorM plasmid containing Neisseria gonorrhoeae multidrug efflux pump NorM after 18 to 24 hrs by two fold dilution method,Other,18591276.0,
2018,572150,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBAD plasmid after 18 to 24 hrs by two fold dilution method,Other,18591276.0,
2019,572151,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomegaydhE plasmid containing Escherichia coli multidrug efflux pump YdhE after 18 to 24 hrs by two fold dilution method,Other,18591276.0,
2020,572498,2,4,,103163814,4421,Inconclusive,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Stanley isolate s2043 plasmid encoded Parc QRDR Thre57Ser mutant gene by agar dilution method,Other,19596880.0,
2021,572499,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Montevideo isolate s2944 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,Other,19596880.0,
2022,572500,2,4,,103163814,4421,Inconclusive,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Braenderup isolate s2856 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,Other,19596880.0,
2023,572501,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Typhimurium isolate s2705 plasmid encoded qnrS and Parc gene by agar dilution method,Other,19596880.0,
2024,572502,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Typhimurium isolate s2425 plasmid encoded qnrS and Parc gene by agar dilution method,Other,19596880.0,
2025,572503,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Virginia isolate s2219 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,Other,19596880.0,
2026,572504,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Montevideo isolate s2209 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,Other,19596880.0,
2027,572505,2,4,,103163814,4421,Inconclusive,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Mbandaka isolate s2093 plasmid encoded qnrA and Parc QRDR Thre57Ser mutant gene by agar dilution method,Other,19596880.0,
2028,572506,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Corvallis isolate s2052 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,Other,19596880.0,
2029,572507,2,4,,103163814,4421,Inconclusive,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Stanley isolate s2018 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,Other,19596880.0,
2030,572508,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Corvallis isolate s2017 plasmid encoded qnrS and Parc QRDR Thre57Ser mutant gene by agar dilution method,Other,19596880.0,
2031,572509,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium isolate SL1344 harboring wild type ParC gene by agar dilution method,Other,19596880.0,
2032,572510,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Braenderup isolate s2906 harboring ParC QRDR mutant gene by agar dilution method,Other,19596880.0,
2033,572511,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium isolate s2878 harboring wild type ParC gene by agar dilution method,Other,19596880.0,
2034,572512,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Montevideo isolate s2317 harboring ParC QRDR mutant gene by agar dilution method,Other,19596880.0,
2035,572513,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Mbandaka isolate s2159 harboring ParC QRDR mutant gene by agar dilution method,Other,19596880.0,
2036,572514,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Corvallis isolate s2064 harboring ParC QRDR mutant gene by agar dilution method,Other,19596880.0,
2037,572515,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Stanley isolate s2043 harboring ParC QRDR mutant gene by agar dilution method,Other,19596880.0,
2038,572516,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Montevideo isolate s2944 harboring ParC QRDR mutant gene by agar dilution method,Other,19596880.0,
2039,572517,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Braenderup isolate s2856 harboring ParC QRDR mutant gene by agar dilution method,Other,19596880.0,
2040,572518,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Typhimurium isolate s2705 harboring wild type ParC gene by agar dilution method,Other,19596880.0,
2041,572519,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Typhimurium isolate s2425 harboring wild type ParC gene by agar dilution method,Other,19596880.0,
2042,572520,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Virginia isolate s2219 harboring ParC QRDR mutant gene by agar dilution method,Other,19596880.0,
2043,572521,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Montevideo isolate s2209 harboring ParC QRDR mutant gene by agar dilution method,Other,19596880.0,
2044,572522,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrA-positive Salmonella enterica serovar Mbandaka isolate s2093 harboring ParC QRDR mutant gene by agar dilution method,Other,19596880.0,
2045,572523,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Corvallis isolate s2052 harboring ParC QRDR mutant gene by agar dilution method,Other,19596880.0,
2046,572524,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Stanley isolate s2018 harboring ParC QRDR mutant gene by agar dilution method,Other,19596880.0,
2047,572525,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Corvallis isolate s2017 harboring ParC QRDR mutant gene by agar dilution method,Other,19596880.0,
2048,572526,2,4,,103163814,4421,Inconclusive,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Corvallis isolate s2064 plasmid encoded Parc QRDR Thre57Ser mutant gene by agar dilution method,Other,19596880.0,
2049,572527,2,4,,103163814,4421,Inconclusive,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Mbandaka isolate s2159 plasmid encoded Parc QRDR Thre57Ser mutant gene by agar dilution method,Other,19596880.0,
2050,572528,2,4,,103163814,4421,Inconclusive,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Montevideo isolate s2317 plasmid encoded Parc QRDR Thre57Ser mutant gene by agar dilution method,Other,19596880.0,
2051,572529,2,4,,103163814,4421,Inconclusive,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Typhimurium isolate s2878 plasmid encoded Parc gene by agar dilution method,Other,19596880.0,
2052,572530,2,4,,103163814,4421,Inconclusive,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Braenderup isolate s2906 plasmid encoded Parc QRDR Thre57Ser mutant gene by agar dilution method,Other,19596880.0,
2053,572593,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 902SA92 harboring GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method",Other,18443112.0,
2054,572594,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 902SA92 harboring plasmid encoded RamR gene, GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method",Other,18443112.0,
2055,572595,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium 902SA92 harboring GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method",Other,18443112.0,
2056,572596,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 102SA00 harboring GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method",Other,18443112.0,
2057,572597,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 102SA00 harboring plasmid encoded RamR gene, GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method",Other,18443112.0,
2058,572598,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium 102SA00 harboring GyrA S83A and D87N, GyrB S464F and ParC S80I mutant genes by agar doubling dilution method",Other,18443112.0,
2059,572599,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN10055 harboring GyrA S83Y mutant gene by agar doubling dilution method,Other,18443112.0,
2060,572600,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN10055 harboring plasmid encoded RamR gene, GyrA S83Y mutant gene by agar doubling dilution method",Other,18443112.0,
2061,572726,2,4,,103163814,4421,Inconclusive,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] transformed with Salmonella enterica serovar Typhimurium isolate SL1344 plasmid encoded Parc gene by agar dilution method,Other,19596880.0,
2062,572786,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN10055 harboring GyrA S83Y mutant gene by agar doubling dilution method,Other,18443112.0,
2063,572787,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 543SA98 harboring GyrA S83F mutant gene by agar doubling dilution method,Other,18443112.0,
2064,572788,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium 543SA98 harboring plasmid encoded RamR gene, GyrA S83Y mutant gene by agar doubling dilution method",Other,18443112.0,
2065,572789,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium 543SA98 harboring GyrA S83Y mutant gene by agar doubling dilution method,Other,18443112.0,
2066,572790,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN9945 by agar doubling dilution method,Other,18443112.0,
2067,572791,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN9945 harboring plasmid encoded RamR gene by agar doubling dilution method,Other,18443112.0,
2068,572792,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN9945 by agar doubling dilution method,Other,18443112.0,
2069,572793,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN9181 by agar doubling dilution method,Other,18443112.0,
2070,572794,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against multidrug-resistant Salmonella enterica serovar Typhimurium BN9181 harboring plasmid encoded RamR gene by agar doubling dilution method,Other,18443112.0,
2071,572795,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN9181 by agar doubling dilution method,Other,18443112.0,
2072,572796,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,Other,18443112.0,
2073,572797,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against marR::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,Other,18443112.0,
2074,572798,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against marR-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,Other,18443112.0,
2075,572799,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against marA::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,Other,18443112.0,
2076,572800,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against soxR::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,Other,18443112.0,
2077,572801,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against soxS::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,Other,18443112.0,
2078,572802,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium S/921495 harboring plasmid encoded RamR gene by agar doubling dilution method,Other,18443112.0,
2079,572803,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ramR-deficient Salmonella enterica serovar Typhimurium S/921495 harboring plasmid encoded RamR gene by agar doubling dilution method,Other,18443112.0,
2080,572804,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,Other,18443112.0,
2081,572805,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18 by agar doubling dilution method,Other,18443112.0,
2082,572806,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18 harboring plasmid encoded RamR gene by agar doubling dilution method,Other,18443112.0,
2083,572807,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN18 by agar doubling dilution method,Other,18443112.0,
2084,572808,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/21 by agar doubling dilution method,Other,18443112.0,
2085,572809,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/21 harboring plasmid encoded RamR gene by agar doubling dilution method,Other,18443112.0,
2086,572810,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN18/21 by agar doubling dilution method,Other,18443112.0,
2087,572811,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/41 harboring GyrA G81C,acrR mutant genes by agar doubling dilution method",Other,18443112.0,
2088,572812,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/41 harboring plasmid encoded RamR gene, GyrA G81C,acrR mutant genes by agar doubling dilution method",Other,18443112.0,
2089,572813,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN18/41 harboring plasmid encoded RamR gene, GyrA G81C,acrR mutant genes by agar doubling dilution method",Other,18443112.0,
2090,572814,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/71 harboring GyrA G81C, acrR mutant genes by agar doubling dilution method",Other,18443112.0,
2091,572815,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Salmonella enterica serovar Typhimurium BN18/71 harboring plasmid encoded RamR gene, GyrA G81C,acrR mutant genes by agar doubling dilution method",Other,18443112.0,
2092,572816,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against ramA::kan-deficient Salmonella enterica serovar Typhimurium BN18/71 harboring plasmid encoded RamR gene, GyrA G81C,acrR mutant genes by agar doubling dilution method",Other,18443112.0,
2093,572817,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ramR::kan-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,Other,18443112.0,
2094,572818,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against ramR-deficient Salmonella enterica serovar Typhimurium S/921495 by agar doubling dilution method,Other,18443112.0,
2095,573297,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ3 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2096,573298,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ4 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2097,573299,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ5 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2098,573300,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ6 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2099,573301,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ8 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2100,573302,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ9 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2101,573303,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ11 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2102,573304,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ12 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2103,573305,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ13 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2104,573306,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ14 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2105,573307,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ15 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2106,573308,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ16 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2107,573309,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate CQ15 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2108,573310,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate CQ18 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2109,573311,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate CQ2 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2110,573312,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate CQ5 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2111,573313,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate CQ4 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2112,573314,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate CQ20 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2113,573315,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate CQ26 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2114,573316,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate CQ10 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2115,573317,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate CQ14 transconjugant harboring 16S rRNA methylase RmtB and qepA by agar dilution method relative to recipient strain,Other,18490500.0,
2116,573318,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ7 transconjugant harboring 16S rRNA methylase RmtB and qepA and qnrS1 by agar dilution method relative to recipient strain,Other,18490500.0,
2117,573319,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ1 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,Other,18490500.0,
2118,573320,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate GZ2 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,Other,18490500.0,
2119,573321,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate CQ22 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,Other,18490500.0,
2120,573322,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate CQ13 transconjugant harboring 16S rRNA methylase RmtB and qnrS1 by agar dilution method relative to recipient strain,Other,18490500.0,
2121,573323,2,4,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Escherichia coli isolate CQ6 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",Other,18490500.0,
2122,573324,2,4,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Escherichia coli isolate CQ7 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",Other,18490500.0,
2123,573325,2,4,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Escherichia coli isolate CQ12 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",Other,18490500.0,
2124,573326,2,4,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Escherichia coli isolate CQ16 transconjugant harboring 16S rRNA methylase RmtB and qepA, qnrS2, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",Other,18490500.0,
2125,573327,2,4,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Escherichia coli isolate GZ10 transconjugant harboring 16S rRNA methylase RmtB and qepA, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",Other,18490500.0,
2126,573328,2,4,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Escherichia coli isolate CQ19 transconjugant harboring 16S rRNA methylase RmtB and qepA, aac(6')-Ib-cr gene by agar dilution method relative to recipient strain",Other,18490500.0,
2127,573329,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli isolate CQ1 transconjugant harboring 16S rRNA methylase RmtB and qnrB6 by agar dilution method relative to recipient strain,Other,18490500.0,
2128,575169,2,4,,103163814,4421,Unspecified,,,,,Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 1000 uM by spectrofluorometric assay,Other,20606071.0,
2129,575170,2,4,,103163814,4421,Inconclusive,,,,,Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 200 uM by spectrofluorometric assay,Other,20606071.0,
2130,582763,1,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against eaeA positive verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates,Other,20733038.0,
2131,582764,1,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against eaeA negative verocytotoxin-producing non-O157 Escherichia coli isolates obtained from human assessed as percentage of resistant isolates,Other,20733038.0,
2132,584486,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae ATCC 138821 by disk agar diffusion method",Other,20679507.0,
2133,584487,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj1 expressing efflux system by disk agar diffusion method",Other,20679507.0,
2134,584488,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method",Other,20679507.0,
2135,584489,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj1 expressing efflux system by disk agar diffusion method,Other,20679507.0,
2136,584490,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method,Other,20679507.0,
2137,584491,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against porin, OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 by disk agar diffusion method",Other,20679507.0,
2138,584492,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against porin, OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method",Other,20679507.0,
2139,584493,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against porin deficient OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 expressing efflux system by disk agar diffusion method,Other,20679507.0,
2140,584494,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against porin deficient OmpA positive extended-spectrum beta-lactamase producing Klebsiella pneumoniae KPBj1 revertant by disk agar diffusion method,Other,20679507.0,
2141,584495,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj3 expressing efflux system by disk agar diffusion method",Other,20679507.0,
2142,584496,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj3 revertant by disk agar diffusion method",Other,20679507.0,
2143,584497,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj3 expressing efflux system by disk agar diffusion method,Other,20679507.0,
2144,584498,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj3 revertant by disk agar diffusion method,Other,20679507.0,
2145,584499,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj5 expressing efflux system by disk agar diffusion method",Other,20679507.0,
2146,584500,5,2,,103163814,4421,Unspecified,,,,,"Antibacterial activity against porin, OmpA positive Klebsiella pneumoniae KPBj5 revertant by disk agar diffusion method",Other,20679507.0,
2147,584501,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj5 expressing efflux system by disk agar diffusion method,Other,20679507.0,
2148,584502,5,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against porin deficient OmpA positive Klebsiella pneumoniae KPBj5 revertant by disk agar diffusion method,Other,20679507.0,
2149,585418,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli C600 by CLSI agar dilution method,Other,20696876.0,
2150,585419,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against oqxAB positive Escherichia coli C600 W281-T transconjugant by CLSI agar dilution method,Other,20696876.0,
2151,585420,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against oqxAB positive Escherichia coli C600 W191-T transconjugant by CLSI agar dilution method,Other,20696876.0,
2152,585421,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against oqxAB positive Escherichia coli C600 W322-T transconjugant by CLSI agar dilution method,Other,20696876.0,
2153,585422,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against oqxAB positive Escherichia coli C600 W245-T transconjugant by CLSI agar dilution method,Other,20696876.0,
2154,585423,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against oqxAB positive Escherichia coli C600 G262-T transconjugant by CLSI agar dilution method,Other,20696876.0,
2155,585424,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against oqxAB positive Escherichia coli C600 G062-T transconjugant by CLSI agar dilution method,Other,20696876.0,
2156,585425,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against oqxAB positive Escherichia coli C600 G375-T transconjugant by CLSI agar dilution method,Other,20696876.0,
2157,585426,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against oqxAB positive Escherichia coli C600 X1B1-T transconjugant by CLSI agar dilution method,Other,20696876.0,
2158,585427,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against oqxAB positive Escherichia coli C600 XT11-T transconjugant by CLSI agar dilution method,Other,20696876.0,
2159,585428,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against oqxAB positive Escherichia coli C600 SW8-T transconjugant by CLSI agar dilution method,Other,20696876.0,
2160,585429,5,2,,103163814,4421,Unspecified,,,,,"Antimicrobial activity against Escherichia coli C600 ST2-T transconjugant harboring oqxAB, qnrB6 and aac(6')-Ib-cr genes by CLSI agar dilution method",Other,20696876.0,
2161,585430,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against oqxAB positive Escherichia coli C600 SP8-T transconjugant by CLSI agar dilution method,Other,20696876.0,
2162,585431,5,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against oqxAB positive Escherichia coli C600 D83-T transconjugant by CLSI agar dilution method,Other,20696876.0,
2163,585432,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against oqxAB positive Escherichia coli DH5[alpha] harboring pMD18-T::oqxAB by CLSI agar dilution method,Other,20696876.0,
2164,585433,5,3,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli DH5[alpha] by CLSI agar dilution method,Other,20696876.0,
2165,586085,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from human assessed as percentage of resistant isolates by disk diffusion method,Other,20733038.0,
2166,586086,2,4,,103163814,4421,Unspecified,,,,,Antimicrobial activity against verocytotoxin-producing Escherichia coli isolate O157 obtained from animals and food assessed as percentage of resistant isolates by disk diffusion method,Other,20733038.0,
2167,588209,2,3,,103163814,4421,Unspecified,,,,,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,Other,20553011.0,
2168,588210,2,4,,103163814,4421,Unspecified,,,,,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,Other,20843939.0,
2169,588211,2,3,,103163814,4421,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",Other,20014752.0,
2170,588212,2,3,,103163814,4421,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",Other,20014752.0,
2171,588213,2,3,,103163814,4421,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",Other,20014752.0,
2172,588220,2,3,,103163814,4421,Unspecified,,,,,Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset,Other,20020916.0,
2173,588334,1,1,,56422386,4421,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
2174,588335,1,1,,56422386,4421,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
2175,588342,1,1,,855620,4421,Inactive,160794.0,,,Potency,qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project),Confirmatory,,
2176,588352,1,2,,56422386,4421,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
2177,588354,1,1,,56422386,4421,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
2178,588368,1,2,,855620,4421,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies from validation set,Screening,,
2179,588391,1,1,,56422386,4421,Inactive,14790033.0,5034.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of Protein Disulfide Isomerase Measured in Biochemical System Using Plate Reader - 2137-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2180,588405,1,1,,56422386,4421,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
2181,588413,1,2,,56422386,4421,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
2182,588436,1,1,,56422386,4421,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
2183,588453,1,1,,56422386,4421,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
2184,588456,1,1,,56422386,4421,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
2185,588458,1,1,,56422386,4421,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
2186,588459,1,2,,855620,4421,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,16604538.0,
2187,588459,1,2,,855620,4421,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,20035615.0,
2188,588459,1,2,,855620,4421,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, Validation compound set",Screening,20938917.0,
2189,588460,1,2,,855620,4421,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,16604538.0,
2190,588460,1,2,,855620,4421,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,20035615.0,
2191,588460,1,2,,855620,4421,Inactive,,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, Validation Compound Set",Screening,20938917.0,
2192,588461,1,2,,855620,4421,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,16604538.0,
2193,588461,1,2,,855620,4421,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,20035615.0,
2194,588461,1,2,,855620,4421,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, Validation compound set",Screening,20938917.0,
2195,588473,1,1,,56422386,4421,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
2196,588473,1,1,,56422386,4421,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
2197,588475,1,2,,56422386,4421,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
2198,588475,1,2,,56422386,4421,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
2199,588478,1,2,,124800164,4421,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
2200,588489,1,1,,56422386,4421,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
2201,588492,1,1,,56422386,4421,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
2202,588493,1,2,,56422386,4421,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
2203,588497,1,2,,56422386,4421,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
2204,588497,1,2,,56422386,4421,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
2205,588497,1,2,,56422386,4421,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
2206,588499,1,3,,56422386,4421,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
2207,588499,1,3,,56422386,4421,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
2208,588499,1,3,,56422386,4421,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
2209,588501,1,2,,56422386,4421,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
2210,588501,1,2,,56422386,4421,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
2211,588501,1,2,,56422386,4421,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
2212,588506,1,2,,855620,4421,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors with Validation compound Set,Screening,,
2213,588511,1,2,,56422386,4421,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
2214,588513,1,1,,17389812,4421,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
2215,588513,1,1,,26751460,4421,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
2216,588514,1,1,,17389812,4421,Inconclusive,348019627.0,2099.0,12.5893,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
2217,588514,1,1,,26751460,4421,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
2218,588515,1,1,,17389812,4421,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
2219,588515,1,1,,26751460,4421,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
2220,588516,1,1,,17389812,4421,Inconclusive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
2221,588516,1,1,,26751460,4421,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
2222,588519,1,2,,92124374,4421,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
2223,588526,1,1,,17389812,4421,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
2224,588526,1,1,,26751460,4421,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
2225,588527,1,1,,17389812,4421,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
2226,588527,1,1,,26751460,4421,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
2227,588532,1,1,,17389812,4421,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
2228,588532,1,1,,26751460,4421,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
2229,588533,1,1,,17389812,4421,Inconclusive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
2230,588533,1,1,,26751460,4421,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
2231,588534,1,1,,17389812,4421,Inconclusive,216409690.0,5467.0,7.0795,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
2232,588534,1,1,,26751460,4421,Inconclusive,216409690.0,5467.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
2233,588535,1,1,,17389812,4421,Inconclusive,216409690.0,5467.0,31.6228,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
2234,588535,1,1,,26751460,4421,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
2235,588536,1,1,,17389812,4421,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
2236,588536,1,1,,26751460,4421,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
2237,588537,1,1,,17389812,4421,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
2238,588537,1,1,,26751460,4421,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
2239,588541,1,1,,17389812,4421,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
2240,588541,1,1,,26751460,4421,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
2241,588543,1,1,,17389812,4421,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
2242,588543,1,1,,26751460,4421,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
2243,588544,1,1,,17389812,4421,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
2244,588544,1,1,,26751460,4421,Inconclusive,325495497.0,6256.0,3.9811,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
2245,588545,1,1,,17389812,4421,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
2246,588545,1,1,,26751460,4421,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
2247,588546,1,1,,17389812,4421,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
2248,588546,1,1,,26751460,4421,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
2249,588547,1,1,,17389812,4421,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
2250,588547,1,1,,26751460,4421,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
2251,588549,1,1,,56422386,4421,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2252,588550,1,1,,855620,4421,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for Validation Compound Set,Screening,,
2253,588579,1,1,,56422386,4421,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
2254,588579,1,1,,104171368,4421,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
2255,588579,1,1,,124883418,4421,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
2256,588579,1,1,,124883420,4421,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
2257,588590,1,1,,56422386,4421,Inactive,154350220.0,11201.0,,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
2258,588591,1,1,,56422386,4421,Inactive,5729982.0,5429.0,,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
2259,588621,1,1,,56422386,4421,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
2260,588627,1,1,,56422386,4421,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
2261,588664,1,2,,56422386,4421,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
2262,588664,1,2,,56422386,4421,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
2263,588674,1,2,,56422386,4421,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
2264,588675,1,1,,56422386,4421,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
2265,588676,1,1,,56422386,4421,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
2266,588685,1,1,,855620,4421,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with Validation compound set,Screening,,
2267,588689,1,1,,56422386,4421,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
2268,588692,2,1,,56422386,4421,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
2269,588726,1,2,,56422386,4421,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
2270,588727,1,1,,56422386,4421,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
2271,588795,1,1,,56422386,4421,Inactive,4758356.0,2237.0,,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
2272,588814,1,3,,56422386,4421,Inactive,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
2273,588819,1,4,,56422386,4421,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
2274,588834,2,1,,17389812,4421,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
2275,588834,2,1,,26751460,4421,Inactive,325651834.0,3757.0,,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
2276,588850,1,1,,56422386,4421,Inactive,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
2277,588852,1,3,,56422386,4421,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
2278,588855,1,1,,56422386,4421,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
2279,588856,1,1,,56422386,4421,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
2280,602123,1,1,,56422386,4421,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
2281,602141,1,1,,56422386,4421,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
2282,602162,1,1,,56422386,4421,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
2283,602163,1,1,,56422386,4421,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
2284,602179,1,2,,56422386,4421,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
2285,602229,1,1,,56422386,4421,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
2286,602233,1,1,,56422386,4421,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
2287,602244,1,2,,56422386,4421,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
2288,602247,1,2,,56422386,4421,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
2289,602248,1,2,,56422386,4421,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
2290,602250,1,2,,56422386,4421,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
2291,602252,1,1,,56422386,4421,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2292,602252,1,1,,56422386,4421,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2293,602261,1,1,,56422386,4421,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
2294,602274,1,2,,56422386,4421,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
2295,602276,1,1,,855620,4421,Inactive,20140422.0,7098.0,,,Novel Modifiers of Toll-like and RIG-like Receptor Signaling-SeV Stimulus,Screening,,
2296,602277,1,1,,855620,4421,Inactive,20140422.0,7098.0,,,Novel Modifiers of Toll-like and RIG-like Receptor Signaling-Poly IC Stimulus,Screening,,
2297,602281,1,1,,56422386,4421,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
2298,602281,1,1,,56422386,4421,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
2299,602310,1,2,,56422386,4421,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
2300,602313,1,1,,56422386,4421,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
2301,602314,1,2,,92124374,4421,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
2302,602314,1,2,,92260276,4421,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
2303,602329,1,1,,56422386,4421,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2304,602332,1,1,,56422386,4421,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
2305,602332,1,1,,104171368,4421,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
2306,602332,1,1,,124883418,4421,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
2307,602332,1,1,,124883420,4421,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
2308,602340,1,2,,56422386,4421,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
2309,602342,2,1,,56422386,4421,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2310,602346,1,1,,56422386,4421,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2311,602363,1,1,,56422386,4421,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
2312,602393,1,1,,56422386,4421,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2313,602396,1,2,,56422386,4421,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
2314,602399,1,2,,56422386,4421,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
2315,602405,1,1,,56422386,4421,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2316,602410,1,1,,56422386,4421,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
2317,602429,1,1,,56422386,4421,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
2318,602438,1,1,,56422386,4421,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
2319,602440,1,1,,56422386,4421,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
2320,602449,1,2,,56422386,4421,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
2321,602481,1,1,,56422386,4421,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2322,603953,1,3,,103163814,4421,Unspecified,,,,,"In-vivo plasma to lung partition coefficients of the compound, logP(lung) in rat",Other,17544548.0,
2323,623870,1,1,,56422386,4421,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2324,623870,1,1,,56422386,4421,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2325,623877,1,1,,56422386,4421,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
2326,623901,1,1,,56422386,4421,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
2327,624030,1,2,,104171368,4421,Inactive,160794.0,,,Potency,Biochemical firefly luciferase enzyme assay for NPC,Confirmatory,,
2328,624031,1,2,,104171368,4421,Inactive,,,,Potency,S16 Schwann cell viability assay (CellTiter-Glo assay),Confirmatory,,
2329,624032,1,2,,104171368,4421,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element firefly luciferase assay,Confirmatory,,
2330,624037,1,3,,56422386,4421,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
2331,624038,1,3,,56422386,4421,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
2332,624040,1,3,,56422386,4421,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
2333,624044,1,2,,104171368,4421,Inactive,8393992.0,24660.0,,Potency,S16 Schwann cell PMP22 intronic element beta-lactamase assay,Confirmatory,,
2334,624101,1,2,,85787934,4421,Inactive,62203298.0,3417.0,,,Development of  IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2335,624125,1,4,,56422386,4421,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
2336,624126,1,3,,56422386,4421,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
2337,624127,1,2,,56422386,4421,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
2338,624136,1,1,,85787934,4421,Inactive,208342286.0,7157.0,,,mutant P53 Measured in Biochemical System Using Small Molecule MicroArray - 2077-01_Other_SinglePoint_HTS_Activity,Screening,,
2339,624138,1,1,,85787934,4421,Inactive,21618340.0,6774.0,,,SMM STAT-3 Measured in Biochemical System Using Small Molecule MicroArray - 2076-01_Other_SinglePoint_HTS_Activity_Set2,Screening,,
2340,624139,1,1,,85787934,4421,Inactive,34577122.0,4790.0,,,NF-KappaB Measured in Biochemical System Using Small Molecule MicroArray - 2080-01_Other_SinglePoint_HTS_Activity,Screening,,
2341,624141,1,1,,85787934,4421,Inactive,71774083.0,4609.0,,,SMM c-myc Measured in Biochemical System Using Small Molecule MicroArray - 2081-01_Other_SinglePoint_HTS_Activity,Screening,,
2342,624151,1,1,,85787934,4421,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Re-Activators of the P53 Mutant Pathway Measured in Cell-Based System Using Plate Reader - 2071-01_Activator_SinglePoint_HTS_Activity,Screening,,
2343,624156,1,1,,85787934,4421,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
2344,624168,1,1,,56422386,4421,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
2345,624169,1,1,,56422386,4421,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
2346,624170,1,1,,56422386,4421,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
2347,624170,1,1,,104171368,4421,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
2348,624171,1,1,,56422386,4421,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
2349,624172,1,1,,56422386,4421,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
2350,624172,1,1,,104171368,4421,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
2351,624173,1,3,,56422386,4421,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
2352,624173,1,3,,104171368,4421,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
2353,624178,1,1,,56422386,4421,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
2354,624202,1,1,,56422386,4421,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
2355,624204,1,2,,56422386,4421,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
2356,624246,1,1,,56422386,4421,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
2357,624256,1,2,,56422386,4421,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
2358,624263,1,1,,56422386,4421,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
2359,624263,1,1,,56422386,4421,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
2360,624267,1,2,,56422386,4421,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
2361,624267,1,2,,56422386,4421,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
2362,624268,1,3,,56422386,4421,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
2363,624288,1,1,,56422386,4421,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
2364,624296,1,1,,855620,4421,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
2365,624296,1,1,,56422386,4421,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
2366,624296,1,1,,104171368,4421,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
2367,624297,1,1,,855620,4421,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
2368,624297,1,1,,56422386,4421,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
2369,624297,1,1,,104171368,4421,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
2370,624304,1,2,,56422386,4421,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
2371,624330,1,2,,56422386,4421,Inactive,21361397.0,29127.0,,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
2372,624349,1,2,,92124374,4421,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
2373,624349,1,2,,92307714,4421,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
2374,624349,1,2,,121362613,4421,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
2375,624352,1,1,,56422386,4421,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
2376,624354,1,1,,56422386,4421,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
2377,624377,1,1,,855620,4421,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
2378,624414,1,1,,56422386,4421,Inactive,10092597.0,57192.0,,,qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
2379,624415,1,2,,56422386,4421,Inactive,10092597.0,57192.0,,,qHTS for Inhibitors of the Human Mucolipin Transient Receptor Potential 1 (TRPML1),Screening,,
2380,624416,1,1,,855620,4421,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
2381,624417,1,1,,56422386,4421,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
2382,624418,1,1,,56422386,4421,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
2383,624463,1,1,,56422386,4421,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
2384,624464,1,1,,56422386,4421,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
2385,624465,1,1,,56422386,4421,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
2386,624466,1,3,,855620,4421,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
2387,624467,1,1,,855620,4421,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
2388,624483,1,1,,56422386,4421,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
2389,625279,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,Other,22194678.0,
2390,625280,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,Other,22194678.0,
2391,625281,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,Other,22194678.0,
2392,625282,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,Other,22194678.0,
2393,625283,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,Other,22194678.0,
2394,625284,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,Other,22194678.0,
2395,625285,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,Other,22194678.0,
2396,625286,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,Other,22194678.0,
2397,625287,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,Other,22194678.0,
2398,625288,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,Other,22194678.0,
2399,625289,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,Other,22194678.0,
2400,625290,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,Other,22194678.0,
2401,625291,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,Other,22194678.0,
2402,625292,1,3,,103163814,4421,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,Other,22194678.0,
2403,641559,1,4,,103163814,4421,Active,,,,,Antibacterial activity against Escherichia coli ATCC 25922 at 1.88 mg/mL after 24 hrs by disk diffusion assay,Other,22075235.0,
2404,641561,1,4,,103163814,4421,Inactive,,,,,Antibacterial activity against Enterococcus faecalis ATCC 29212 at 1.88 mg/mL after 24 hrs by disk diffusion assay,Other,22075235.0,
2405,641563,1,4,,103163814,4421,Active,,,,,Antibacterial activity against Staphylococcus aureus ATCC 29213 at 1.88 mg/mL after 24 hrs by disk diffusion assay,Other,22075235.0,
2406,641565,1,4,,103163814,4421,Active,,,,,Antibacterial activity against Staphylococcus aureus ATCC 25923 at 1.88 mg/mL after 24 hrs by disk diffusion assay,Other,22075235.0,
2407,641567,1,4,,103163814,4421,Inactive,,,,,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 at 1.88 mg/mL after 24 hrs by disk diffusion assay,Other,22075235.0,
2408,648147,3,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Bacillus subtilis after 24 to 28 hrs by agar diffusion method,Other,22385674.0,
2409,648148,3,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Streptococcus lactis after 24 to 28 hrs by agar diffusion method,Other,22385674.0,
2410,648149,3,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli after 24 to 28 hrs by agar diffusion method,Other,22385674.0,
2411,648150,3,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa after 24 to 28 hrs by agar diffusion method,Other,22385674.0,
2412,651550,1,1,,56422386,4421,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
2413,651560,1,1,,56422386,4421,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
2414,651572,1,2,,855620,4421,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
2415,651582,1,1,,56422386,4421,Inactive,,,,,uHTS identification of small molecule Triacylglycerol inhbitors in a fluoresence assay,Screening,,
2416,651602,1,1,,855620,4421,Active,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
2417,651602,1,1,,855620,4421,Active,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
2418,651602,1,1,,855620,4421,Active,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
2419,651610,2,1,,855620,4421,Inactive,,,,,HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2420,651631,4,1,,144204386,4421,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
2421,651631,4,1,,144208675,4421,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
2422,651631,4,1,,144213071,4421,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
2423,651632,4,1,,144204386,4421,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
2424,651632,4,1,,144208675,4421,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
2425,651632,4,1,,144213071,4421,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
2426,651633,4,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
2427,651633,4,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
2428,651633,4,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
2429,651634,4,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
2430,651634,4,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
2431,651634,4,1,,144213071,4421,Inactive,,,27.305999999999997,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
2432,651635,1,3,,56422386,4421,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
2433,651636,1,1,,56422386,4421,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
2434,651640,1,1,,855620,4421,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
2435,651644,1,1,,56422386,4421,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
2436,651647,1,1,,56422386,4421,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
2437,651654,1,1,,56422386,4421,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2438,651658,1,1,,855620,4421,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2439,651660,1,1,,56422386,4421,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors             Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2440,651661,2,1,,855620,4421,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2441,651687,1,1,,56422386,4421,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2442,651699,1,1,,56422386,4421,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
2443,651699,1,1,,56422386,4421,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
2444,651702,1,2,,56422386,4421,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
2445,651704,2,1,,855620,4421,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2446,651704,2,1,,56422386,4421,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2447,651710,1,1,,855620,4421,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
2448,651711,2,1,,855620,4421,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2449,651718,1,2,,855620,4421,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
2450,651723,1,1,,56422386,4421,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
2451,651724,1,1,,56422386,4421,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
2452,651725,1,1,,56422386,4421,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
2453,651741,1,1,,17389812,4421,Inconclusive,20149576.0,4780.0,,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
2454,651741,1,1,,144204386,4421,Inactive,20149576.0,4780.0,,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
2455,651743,1,1,,17389812,4421,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
2456,651743,1,1,,26751460,4421,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
2457,651749,1,1,,17389812,4421,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
2458,651749,1,1,,26751460,4421,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
2459,651751,1,1,,17389812,4421,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
2460,651751,1,1,,26751460,4421,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
2461,651754,1,1,,17389812,4421,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
2462,651755,1,1,,17389812,4421,Inactive,,,,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
2463,651757,1,1,,17389812,4421,Inconclusive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
2464,651758,1,1,,17389812,4421,Inconclusive,186368.0,3576.0,74.97800000000001,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
2465,651768,1,2,,56422386,4421,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
2466,651777,1,1,,17389812,4421,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
2467,651777,1,1,,26751460,4421,Inactive,51095037.0,196.0,,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
2468,651778,1,1,,17389812,4421,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
2469,651778,1,1,,26751460,4421,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
2470,651800,1,1,,855620,4421,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
2471,651802,1,1,,17389812,4421,Inactive,49066040.0,6097.0,,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
2472,651819,1,1,,56422386,4421,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
2473,651820,1,1,,855620,4421,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
2474,651820,1,1,,56422386,4421,Inactive,,,,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
2475,651821,2,4,,855620,4421,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
2476,651828,1,2,,121362613,4421,Inactive,127925.0,,,,A screen for compounds that inhibit nucleocapsid/RNA interactions in Rift Valley Fever Virus,Other,,
2477,651838,1,1,,17389812,4421,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2478,651838,1,1,,26751460,4421,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2479,651838,1,1,1.0,17389812,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2480,651838,1,1,1.0,26751460,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2481,651838,1,1,2.0,17389812,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2482,651838,1,1,2.0,26751460,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2483,651838,1,1,3.0,17389812,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2484,651838,1,1,3.0,26751460,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2485,651838,1,1,4.0,17389812,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2486,651838,1,1,4.0,26751460,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2487,651838,1,1,5.0,17389812,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2488,651838,1,1,5.0,26751460,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2489,651838,1,1,6.0,17389812,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2490,651838,1,1,6.0,26751460,4421,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2491,651838,1,1,7.0,17389812,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2492,651838,1,1,7.0,26751460,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2493,651838,1,1,8.0,17389812,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2494,651838,1,1,8.0,26751460,4421,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
2495,651957,1,1,,855620,4421,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
2496,651958,1,1,,855620,4421,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
2497,651965,1,1,,56422386,4421,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
2498,651982,1,1,,855620,4421,Active,16130723.0,947287.0,,,Absorbance-based bacterial cell-based high throughput confirmation assay to identify inhibitors of RecBCD,Screening,,
2499,651982,1,1,,855620,4421,Active,16130724.0,947286.0,,,Absorbance-based bacterial cell-based high throughput confirmation assay to identify inhibitors of RecBCD,Screening,,
2500,651982,1,1,,855620,4421,Active,16130726.0,947294.0,,,Absorbance-based bacterial cell-based high throughput confirmation assay to identify inhibitors of RecBCD,Screening,,
2501,651983,1,1,,855620,4421,Active,,,,,Counterscreen for inhibitors of RecBCD: Absorbance-based cell-based high throughput assay to identify inhibitors of bacterial viability,Screening,,
2502,651984,1,1,,855620,4421,Active,15645703.0,899625.0,,,Counterscreen for RECBCD inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of AddAB recombination protein complex,Screening,,
2503,651984,1,1,,855620,4421,Active,15646160.0,899738.0,,,Counterscreen for RECBCD inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of AddAB recombination protein complex,Screening,,
2504,651999,1,1,,56422386,4421,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
2505,652010,1,1,,855620,4421,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
2506,652017,1,1,,855620,4421,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
2507,652025,1,1,,56422386,4421,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
2508,652031,1,1,,26534558,4421,Inactive,119607129.0,4986.0,,,Maybridge screen to identify antagonists of kappa opioid receptor 1 (OPRK1): fluorescence-based cell-based assay,Screening,,
2509,652039,1,1,,855620,4421,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
2510,652048,1,2,,56422386,4421,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
2511,652048,1,2,,144204386,4421,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
2512,652051,1,1,,56422386,4421,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
2513,652051,1,1,,144204386,4421,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
2514,652054,1,1,,56422386,4421,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
2515,652067,1,4,,855620,4421,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
2516,652104,1,1,,56422386,4421,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
2517,652105,1,1,,56422386,4421,Inactive,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
2518,652106,1,1,,56422386,4421,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
2519,652115,1,1,,855620,4421,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
2520,652126,1,3,,855620,4421,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
2521,652154,1,1,,855620,4421,Inactive,998701.0,7849.0,,,HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2522,652162,2,1,,855620,4421,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2523,652163,1,1,,855620,4421,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2524,652163,1,1,,56422386,4421,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2525,652197,1,1,,855620,4421,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2526,652257,1,1,,855620,4421,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
2527,660264,1,3,,103163814,4421,Unspecified,,,,,Ratio of MIC for wild type Escherichia coli HS414 to MIC for acrB-deficient Escherichia coli HS832 by agar dilution method,Other,22483632.0,
2528,660265,2,2,,103163814,4421,Unspecified,,,,,Antimicrobial activity against wild type Escherichia coli expressing AcrAB-TolC efflux pump,Other,22483632.0,
2529,681773,1,7,,103163814,4421,Unspecified,81886651.0,29509.0,,,"TP_TRANSPORTER: inhibition of PAH uptake (PAH: 2 uM, Nalidixate; 2000 uM) in Xenopus laevis oocytes",Other,9228014.0,
2530,686940,1,1,,855620,4421,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
2531,686964,1,1,,855620,4421,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
2532,686970,1,2,,56422386,4421,Inactive,49168486.0,3417.0,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
2533,686971,1,2,,56422386,4421,Inactive,,,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
2534,686978,1,1,,56422386,4421,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
2535,686978,1,1,,124883418,4421,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
2536,686978,1,1,,144204386,4421,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
2537,686979,1,1,,56422386,4421,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
2538,686979,1,1,,124883418,4421,Inconclusive,79154014.0,55775.0,2.3109,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
2539,686979,1,1,,144204386,4421,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
2540,686992,2,1,,855620,4421,Inactive,187960042.0,6401.0,,,Identification of agents that induce E-selectin on human endothelial cells Measured in Cell-Based System Using Imaging - 2152-01_Activator_SinglePoint_HTS_Activity,Screening,,
2541,686996,1,1,,855620,4421,Inactive,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
2542,687014,1,1,,855620,4421,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
2543,687016,1,1,,855620,4421,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
2544,697852,1,7,,103163814,4421,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
2545,697853,1,7,,103163814,4421,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
2546,720504,1,1,,56422386,4421,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
2547,720508,1,1,,855620,4421,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
2548,720509,1,1,,855620,4421,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
2549,720511,1,1,,855620,4421,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
2550,720516,2,1,,144204386,4421,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
2551,720516,2,1,,144208675,4421,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
2552,720516,2,1,,144213071,4421,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
2553,720532,1,1,,124883418,4421,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
2554,720532,1,1,,124883420,4421,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
2555,720532,1,1,,144204386,4421,Inactive,420597.0,,,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
2556,720533,1,1,,124883418,4421,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
2557,720533,1,1,,124883420,4421,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
2558,720533,1,1,,144204386,4421,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
2559,720542,1,2,,56422386,4421,Inactive,23496270.0,810891.0,,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
2560,720543,1,1,,855620,4421,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
2561,720551,1,2,,56422386,4421,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
2562,720552,2,1,,144204386,4421,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
2563,720552,2,1,,144208675,4421,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
2564,720552,2,1,,144213071,4421,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
2565,720553,1,2,,56422386,4421,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
2566,720554,1,3,,121362613,4421,Inactive,52423132.0,3087402.0,,,Inhibition of the Burkholderia mallei acyl-homoserine lactone synthase BmaI1,Other,,
2567,720579,2,1,,56422386,4421,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
2568,720579,2,1,,124883418,4421,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
2569,720580,1,1,,56422386,4421,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
2570,720580,1,1,,124883418,4421,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
2571,720582,1,1,,855620,4421,Inactive,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
2572,720596,1,1,,855620,4421,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
2573,720634,2,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
2574,720634,2,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
2575,720634,2,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
2576,720635,2,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
2577,720635,2,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
2578,720635,2,1,,144213071,4421,Inconclusive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
2579,720636,1,1,,17389812,4421,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
2580,720636,1,1,,144204386,4421,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
2581,720637,2,1,,144204386,4421,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
2582,720637,2,1,,144208675,4421,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
2583,720637,2,1,,144213071,4421,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
2584,720641,1,2,,92307714,4421,Inactive,15923709.0,,,,A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus,Other,,
2585,720648,1,1,,855620,4421,Inactive,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
2586,720652,1,1,,17389812,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
2587,720653,1,1,,17389812,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
2588,720653,1,1,,26751460,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
2589,720659,1,1,,17389812,4421,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
2590,720659,1,1,,26751460,4421,Inactive,325495557.0,8856.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
2591,720674,2,2,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
2592,720674,2,2,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
2593,720674,2,2,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
2594,720675,2,2,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
2595,720675,2,2,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
2596,720675,2,2,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
2597,720678,2,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
2598,720678,2,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
2599,720678,2,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
2600,720679,2,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
2601,720679,2,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
2602,720679,2,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
2603,720680,2,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
2604,720680,2,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
2605,720680,2,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
2606,720681,2,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
2607,720681,2,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
2608,720681,2,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
2609,720682,2,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
2610,720682,2,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
2611,720682,2,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
2612,720683,2,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
2613,720683,2,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
2614,720683,2,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
2615,720684,2,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
2616,720684,2,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
2617,720684,2,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
2618,720685,2,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
2619,720685,2,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
2620,720685,2,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
2621,720686,2,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
2622,720686,2,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
2623,720686,2,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
2624,720687,2,2,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
2625,720687,2,2,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
2626,720687,2,2,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
2627,720691,4,1,,144204386,4421,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
2628,720691,4,1,,144208675,4421,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
2629,720691,4,1,,144213071,4421,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
2630,720692,3,1,,144204386,4421,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
2631,720692,3,1,,144208675,4421,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
2632,720692,3,1,,144213071,4421,Inconclusive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
2633,720693,3,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
2634,720693,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
2635,720693,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
2636,720700,1,4,,855620,4421,Active,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
2637,720702,1,1,,855620,4421,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
2638,720704,1,4,,855620,4421,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
2639,720706,1,2,,855620,4421,Inactive,,,,,HTS for Bacterial rRNA inhibitors Measured in Microorganism-Based System Using Plate Reader - 7056-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2640,720707,1,2,,56422386,4421,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
2641,720708,1,2,,56422386,4421,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
2642,720709,1,2,,56422386,4421,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
2643,720711,1,2,,56422386,4421,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
2644,720717,1,3,,92124374,4421,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
2645,720717,1,3,,92307714,4421,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
2646,720719,2,1,,144204386,4421,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
2647,720719,2,1,,144208675,4421,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
2648,720719,2,1,,144213071,4421,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
2649,720725,2,1,,144204386,4421,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
2650,720725,2,1,,144208675,4421,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
2651,720725,2,1,,144213071,4421,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
2652,723106,2,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Enterobacter aerogenes CM-64 overexpressing AcrAB-TolC assessed as growth inhibition after 18 hrs by CLSI broth dilution method,Other,23218781.0,
2653,723107,2,1,,103163814,4421,Active,,,,,Antibacterial activity against wild type Enterobacter aerogenes ATCC 13048 assessed as growth inhibition after 18 hrs by CLSI broth dilution method,Other,23218781.0,
2654,727094,2,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica Typhimurium BN10055 harboring deltaacrB after 18 hrs by broth dilution method,Other,23352753.0,
2655,727095,2,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella enterica Typhimurium BN10055 after 18 hrs by broth dilution method,Other,23352753.0,
2656,727096,2,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Enterobacter aerogenes Ea289 after 18 hrs by broth dilution method,Other,23352753.0,
2657,727097,2,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Enterobacter aerogenes Ea294 harboring Ea289deltaacrB after 18 hrs by broth dilution method,Other,23352753.0,
2658,743012,3,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
2659,743012,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
2660,743012,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
2661,743014,3,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
2662,743014,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
2663,743014,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
2664,743015,3,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
2665,743015,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
2666,743015,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
2667,743033,3,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
2668,743033,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
2669,743033,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
2670,743035,2,1,,144204386,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
2671,743035,2,1,,144208675,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
2672,743035,2,1,,144213071,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
2673,743036,2,1,,144204386,4421,Inconclusive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
2674,743036,2,1,,144208675,4421,Inconclusive,124375976.0,367.0,17.3611,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
2675,743036,2,1,,144213071,4421,Inconclusive,124375976.0,367.0,9.77,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
2676,743040,3,1,,144204386,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
2677,743040,3,1,,144208675,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
2678,743040,3,1,,144213071,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
2679,743041,3,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
2680,743041,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
2681,743041,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
2682,743042,3,1,,144204386,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
2683,743042,3,1,,144208675,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
2684,743042,3,1,,144213071,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
2685,743053,2,1,,144204386,4421,Inconclusive,124375976.0,367.0,4.50464,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
2686,743053,2,1,,144208675,4421,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
2687,743053,2,1,,144213071,4421,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
2688,743054,2,1,,144204386,4421,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
2689,743054,2,1,,144208675,4421,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
2690,743054,2,1,,144213071,4421,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
2691,743063,2,1,,144204386,4421,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
2692,743063,2,1,,144208675,4421,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
2693,743063,2,1,,144213071,4421,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
2694,743064,3,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
2695,743064,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
2696,743064,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
2697,743065,3,1,,144204386,4421,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
2698,743065,3,1,,144208675,4421,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
2699,743065,3,1,,144213071,4421,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
2700,743066,3,1,,144204386,4421,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
2701,743066,3,1,,144208675,4421,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
2702,743066,3,1,,144213071,4421,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
2703,743067,2,1,,144204386,4421,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
2704,743067,2,1,,144208675,4421,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
2705,743067,2,1,,144213071,4421,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
2706,743069,2,1,,144204386,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
2707,743069,2,1,,144208675,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
2708,743069,2,1,,144213071,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
2709,743074,2,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
2710,743074,2,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
2711,743074,2,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
2712,743075,2,1,,144204386,4421,Inactive,348019627.0,2099.0,1.693,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
2713,743075,2,1,,144208675,4421,Inactive,348019627.0,2099.0,3.0873,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
2714,743075,2,1,,144213071,4421,Inactive,348019627.0,2099.0,0.2187,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
2715,743077,2,1,,144204386,4421,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
2716,743077,2,1,,144208675,4421,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
2717,743077,2,1,,144213071,4421,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
2718,743078,2,1,,144204386,4421,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
2719,743078,2,1,,144208675,4421,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
2720,743078,2,1,,144213071,4421,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
2721,743079,3,1,,144204386,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
2722,743079,3,1,,144208675,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
2723,743079,3,1,,144213071,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
2724,743080,3,1,,144204386,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
2725,743080,3,1,,144208675,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
2726,743080,3,1,,144213071,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
2727,743081,3,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
2728,743081,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
2729,743081,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
2730,743083,3,1,,144204386,4421,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
2731,743083,3,1,,144208675,4421,Inactive,119597822.0,1588.0,76.8806,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
2732,743083,3,1,,144213071,4421,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
2733,743084,3,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
2734,743084,3,1,,144208675,4421,Inconclusive,,,17.2114,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
2735,743084,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
2736,743085,3,1,,144204386,4421,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
2737,743085,3,1,,144208675,4421,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
2738,743085,3,1,,144213071,4421,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
2739,743086,3,1,,144204386,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
2740,743086,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
2741,743086,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
2742,743091,2,1,,144204386,4421,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
2743,743091,2,1,,144208675,4421,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
2744,743091,2,1,,144213071,4421,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
2745,743094,3,1,,144204386,4421,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
2746,743094,3,1,,144208675,4421,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
2747,743094,3,1,,144213071,4421,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
2748,743122,2,1,,144204386,4421,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
2749,743122,2,1,,144208675,4421,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
2750,743122,2,1,,144213071,4421,Inconclusive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
2751,743126,1,1,,855620,4421,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
2752,743139,2,1,,144204386,4421,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
2753,743139,2,1,,144208675,4421,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
2754,743139,2,1,,144213071,4421,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
2755,743140,2,1,,144204386,4421,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2756,743140,2,1,,144208675,4421,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2757,743140,2,1,,144213071,4421,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2758,743191,3,1,,144208675,4421,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
2759,743191,3,1,,144213071,4421,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
2760,743191,3,1,,170465215,4421,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
2761,743194,3,1,,144208675,4421,Inconclusive,,,6.16,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
2762,743194,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
2763,743194,3,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
2764,743199,2,1,,144208675,4421,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2765,743199,2,1,,144213071,4421,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2766,743199,2,1,,170465215,4421,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
2767,743202,4,1,,144208675,4421,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
2768,743202,4,1,,144213071,4421,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
2769,743202,4,1,,170465215,4421,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
2770,743203,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
2771,743203,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
2772,743203,3,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
2773,743209,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
2774,743209,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
2775,743209,3,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
2776,743210,4,1,,144208675,4421,Inconclusive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
2777,743210,4,1,,144213071,4421,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
2778,743210,4,1,,170465215,4421,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
2779,743211,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2780,743211,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2781,743211,3,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2782,743212,3,1,,144208675,4421,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2783,743212,3,1,,144213071,4421,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2784,743212,3,1,,170465215,4421,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2785,743213,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2786,743213,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2787,743213,3,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
2788,743215,3,1,,144208675,4421,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2789,743215,3,1,,144213071,4421,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2790,743215,3,1,,170465215,4421,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
2791,743217,3,1,,144208675,4421,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2792,743217,3,1,,144213071,4421,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2793,743217,3,1,,170465215,4421,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2794,743218,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2795,743218,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2796,743218,3,1,,170465215,4421,Inconclusive,,,8.412,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2797,743219,3,1,,144208675,4421,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
2798,743219,3,1,,144213071,4421,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
2799,743219,3,1,,170465215,4421,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
2800,743220,3,1,,144208675,4421,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2801,743220,3,1,,144213071,4421,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2802,743220,3,1,,170465215,4421,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
2803,743221,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2804,743221,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2805,743221,3,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
2806,743222,3,1,,144208675,4421,Inconclusive,216409708.0,7421.0,2.4523,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2807,743222,3,1,,144213071,4421,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2808,743222,3,1,,170465215,4421,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2809,743223,3,1,,144208675,4421,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2810,743223,3,1,,144213071,4421,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2811,743223,3,1,,170465215,4421,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
2812,743224,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2813,743224,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2814,743224,3,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2815,743225,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2816,743225,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2817,743225,3,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
2818,743226,2,1,,144208675,4421,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2819,743226,2,1,,144213071,4421,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2820,743226,2,1,,170465215,4421,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2821,743227,2,1,,144208675,4421,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2822,743227,2,1,,144213071,4421,Inconclusive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2823,743227,2,1,,170465215,4421,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
2824,743228,3,1,,144208675,4421,Inconclusive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
2825,743228,3,1,,144213071,4421,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
2826,743228,3,1,,170465215,4421,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
2827,743238,1,1,,855620,4421,Inactive,,,,,High Content Cell-Based Imaging Primary HTS to Identify Small Molecules Involved in X-Chromosome Reactivation and Reprogramming Measured in Cell-Based System Using Imaging - 7015-01_Activator_SinglePoint_HTS_Activity_Set2,Screening,,
2828,743239,2,1,,144208675,4421,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2829,743239,2,1,,144213071,4421,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2830,743239,2,1,,170465215,4421,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2831,743240,2,1,,144208675,4421,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2832,743240,2,1,,144213071,4421,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2833,743240,2,1,,170465215,4421,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
2834,743241,2,1,,144208675,4421,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2835,743241,2,1,,144213071,4421,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2836,743241,2,1,,170465215,4421,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2837,743242,2,1,,144208675,4421,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2838,743242,2,1,,144213071,4421,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2839,743242,2,1,,170465215,4421,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
2840,743244,1,1,,144204386,4421,Inactive,,,,Potency,qHTS Assay for Identifying Gametocytocidal Compounds,Confirmatory,,
2841,743247,1,2,,855620,4421,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2842,743247,1,2,,56422386,4421,Inactive,,,,,Inhibition of Alexa 488-Fibronectin deposition #on AH1F cell monolayers Measured in Cell-Based System Using Plate Reader - 7059-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2843,743255,1,1,,56422386,4421,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
2844,743258,1,2,,855620,4421,Inactive,223459640.0,5335.0,,,Counterscreen for inhibitors of phospholipase C isozymes (PLC-B3): Fluorescence-based biochemical high throughput assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1),Screening,,
2845,743261,1,2,,855620,4421,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput confirmation assay to identify inhibitors of phospholipase C isozymes (PLC-B3),Screening,,
2846,743266,1,2,,56422386,4421,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
2847,743268,1,1,,172080617,4421,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: biochemical high-throughput screening assay to identify compounds that enhance or quench fluorescence of a Cy5-labeled substrate oligonucliotide bound to E. coli SSB,Screening,,
2848,743269,1,1,,855620,4421,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
2849,743269,1,1,,855620,4421,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
2850,743270,1,1,,172080617,4421,Inactive,125541954.0,,,,Fluorescence polarization based primary biochemical high throughput screening  assay of the NIH Clinical Collections to identify inhibitors of hepatitis C non-structural protein 3 helicase,Screening,,
2851,743271,1,1,,172080617,4421,Inactive,,,,,Biochemical high throughput counterscreening assay of the NIH Clinical Collection for inhibitors of the Hepatitis C Virus non-structural protein 3 helicase (NS3): fluorescence polarization based assay to identify compounds that can displace E. coli single stranded binding protein,Screening,,
2852,743272,1,1,,172080617,4421,Inactive,,,,,Fluorescence-based counterscreen assay for HCV NS3 helicase inhibitors of the NIH Clinical Collection: a biochemical high-throughput screening assay to identify compounds that cause fluorescent interference,Screening,,
2853,743279,1,2,,56422386,4421,Inactive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
2854,743288,1,1,,17389812,4421,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
2855,743288,1,1,,26751460,4421,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
2856,743292,1,1,,17389812,4421,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
2857,743292,1,1,,26751460,4421,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
2858,743344,1,1,,174006246,4421,Inactive,,,0.0012,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
2859,743345,1,1,,174006246,4421,Inactive,,,0.0067,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
2860,743346,1,1,,174006246,4421,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
2861,743347,1,1,,174006246,4421,Inactive,,,0.0011,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
2862,743397,1,1,,855620,4421,Inactive,,,,,HTS for Inhibition of CaV1.3 ICDI/IQ interaction using a live-cell FRET assay Measured in Cell-Based System Using Plate Reader - 7081-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2863,743398,1,1,,855620,4421,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
2864,743398,1,1,,56422386,4421,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
2865,778913,1,1,,103163814,4421,Unspecified,,,,,Induction of mutagenicity in Escherichia coli BL21(DE3) expressing pRAC-gfp assessed as induction of reporter protein GFP synthesis at 10 ug/ml incubated for 1.5 hrs followed by plasmid maturation measured after 1.5 hrs by fluorophotometry,Other,23993669.0,
2866,781326,1,2,,103163814,4421,Unspecified,,,,,pKa (acid-base dissociation constant) as determined by Avdeef ref: DOI: 10.1002/047145026X,Other,24249037.0,
2867,977599,1,1,,103163814,4421,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
2868,977602,1,2,,103163814,4421,Unspecified,,,,,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Other,23571415.0,
2869,1053175,2,1,,178127345,4421,Active,,,,,A screen for compounds that inhibit growth of Escherichia coli,Other,,
2870,1053188,2,1,,56422386,4421,Inactive,,,,,Primary Screen Inhibitors of CD40 Signaling in BL2 Cells Measured in Cell-Based System Using Plate Reader - 7124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
2871,1053197,1,1,,855620,4421,Inactive,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
2872,1053268,1,4,,103163814,4421,Unspecified,3915797.0,5743.0,,,Inhibition of COX-2 (unknown origin) using arachidonic acid as substrate assessed as formation of prostanoid products at 500 uM preincubated for 10 mins prior to substrate addition measured after 2 mins by Ellman's method relative to control,Other,24088053.0,
2873,1053269,1,4,,103163814,4421,Unspecified,317373262.0,5742.0,,,Inhibition of COX-1 (unknown origin) using arachidonic acid as substrate assessed as formation of prostanoid products at 500 uM preincubated for 10 mins prior to substrate addition measured after 2 mins by Ellman's method relative to control,Other,24088053.0,
2874,1077673,1,2,,103163814,4421,Unspecified,,,,,Cytotoxicity against human THLE cells assessed as ATP depletion by CellTitre-Glo assay,Other,,
2875,1077674,1,2,,103163814,4421,Unspecified,,,300.0,EC50,Cytotoxicity against human THLE cells assessed as ATP depletion after 72 hrs by CellTitre-Glo assay,Confirmatory,,
2876,1077675,1,2,,103163814,4421,Unspecified,,,300.0,EC50,Cytotoxicity against human THLE cells assessed as ATP depletion after 24 hrs by CellTitre-Glo assay,Confirmatory,,
2877,1077676,1,2,,103163814,4421,Unspecified,,,300.0,EC50,Cytotoxicity against human THLE cells assessed as ATP depletion after 4 hrs by CellTitre-Glo assay,Confirmatory,,
2878,1077677,1,2,,103163814,4421,Unspecified,,,1000.0,EC50,Induction of ROS generation assessed as generation of H2O2 measured as oxidation of phenol red after 60 mins by phenol red assay,Confirmatory,,
2879,1079931,1,1,,103163814,4421,Unspecified,,,,,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",Other,15646539.0,
2880,1079932,1,1,,103163814,4421,Unspecified,,,,,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",Other,15646539.0,
2881,1079933,1,1,,103163814,4421,Unspecified,,,,,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",Other,15646539.0,
2882,1079934,1,1,,103163814,4421,Unspecified,,,,,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",Other,15646539.0,
2883,1079935,1,1,,103163814,4421,Unspecified,,,,,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",Other,15646539.0,
2884,1079936,1,1,,103163814,4421,Unspecified,,,,,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",Other,15646539.0,
2885,1079937,1,1,,103163814,4421,Unspecified,,,,,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",Other,15646539.0,
2886,1079938,1,1,,103163814,4421,Unspecified,,,,,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",Other,15646539.0,
2887,1079939,1,1,,103163814,4421,Unspecified,,,,,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",Other,15646539.0,
2888,1079940,1,1,,103163814,4421,Unspecified,,,,,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",Other,15646539.0,
2889,1079941,1,1,,103163814,4421,Unspecified,,,,,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",Other,15646539.0,
2890,1079942,1,1,,103163814,4421,Unspecified,,,,,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",Other,15646539.0,
2891,1079943,1,1,,103163814,4421,Unspecified,,,,,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",Other,15646539.0,
2892,1079944,1,1,,103163814,4421,Unspecified,,,,,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",Other,15646539.0,
2893,1079945,1,1,,103163814,4421,Unspecified,,,,,Animal toxicity known. [column 'TOXIC' in source],Other,15646539.0,
2894,1079946,1,1,,103163814,4421,Unspecified,,,,,Presence of at least one case with successful reintroduction. [column 'REINT' in source],Other,15646539.0,
2895,1079947,1,1,,103163814,4421,Unspecified,,,,,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],Other,15646539.0,
2896,1079948,1,1,,103163814,4421,Unspecified,,,,,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",Other,15646539.0,
2897,1079949,1,1,,103163814,4421,Unspecified,,,,,Proposed mechanism(s) of liver damage. [column 'MEC' in source],Other,15646539.0,
2898,1084881,1,2,,103163814,4421,Unspecified,,,,,"Antimycobacterial activity against rifampicin,amphiciline and kanamycin-resistant Mycobacterium smegmatis MDR-40 after 24 hr by two-fold serial micro broth dilution method",Other,,
2899,1084882,1,2,,103163814,4421,Unspecified,,,,,"Antimycobacterial activity against rifampicin,tetracycline and chloramphenicol-resistant Mycobacterium smegmatis MDR-R after 24 hr by two-fold serial micro broth dilution method",Other,,
2900,1084883,1,2,,103163814,4421,Unspecified,,,,,Antimycobacterial activity against quinolones and ciprofloxacin-resistant Mycobacterium smegmatis MDRQ after 24 hr by two-fold serial micro broth dilution method,Other,,
2901,1084884,1,2,,103163814,4421,Unspecified,,,,,Antimycobacterial activity against lomofloxacin-resistant Mycobacterium smegmatis Lom R5 after 24 hr by two-fold serial micro broth dilution method,Other,,
2902,1084885,1,2,,103163814,4421,Unspecified,,,,,"Antimycobacterial activity against ciprofloxacin,lomofloxacin and norflaxacin-resistant Mycobacterium smegmatis CSC-101 after 24 hr by two-fold serial micro broth dilution method",Other,,
2903,1084886,1,2,,103163814,4421,Unspecified,,,,,Antimycobacterial activity against Mycobacterium smegmatis str. MC2 155 after 24 hr by two-fold serial micro broth dilution method,Other,,
2904,1087109,1,2,,103163814,4421,Unspecified,,,,,Bactericidal activity against Klebsiella pneumoniae wound isolate after 24 hr by NCCLS dilution tube method,Other,,
2905,1087110,1,2,,103163814,4421,Unspecified,,,,,Bactericidal activity against Klebsiella pneumoniae urine isolate after 24 hr by NCCLS dilution tube method,Other,,
2906,1087111,1,2,,103163814,4421,Unspecified,,,,,Bactericidal activity against Pseudomonas aeruginosa wound isolate after 24 hr by NCCLS dilution tube method,Other,,
2907,1087112,1,2,,103163814,4421,Unspecified,,,,,Bactericidal activity against Pseudomonas aeruginosa urine isolate after 24 hr by NCCLS dilution tube method,Other,,
2908,1087113,1,2,,103163814,4421,Unspecified,,,,,Bactericidal activity against Staphylococcus saprophyticus bronchi isolate after 24 hr by NCCLS dilution tube method,Other,,
2909,1087114,1,2,,103163814,4421,Unspecified,,,,,Bactericidal activity against Staphylococcus epidermidis eye isolate after 24 hr by NCCLS dilution tube method,Other,,
2910,1087115,1,2,,103163814,4421,Unspecified,,,,,Bactericidal activity against Staphylococcus aureus urine isolate after 24 hr by NCCLS dilution tube method,Other,,
2911,1087116,1,2,,103163814,4421,Unspecified,,,,,Bactericidal activity against Staphylococcus aureus wound isolate after 24 hr by NCCLS dilution tube method,Other,,
2912,1087117,1,2,,103163814,4421,Unspecified,,,,,Bactericidal activity against Escherichia coli bronchi isolate after 24 hr by NCCLS dilution tube method,Other,,
2913,1087118,1,2,,103163814,4421,Unspecified,,,,,Bactericidal activity against Escherichia coli urine isolate after 24 hr by NCCLS dilution tube method,Other,,
2914,1087119,1,2,,103163814,4421,Unspecified,,,,,Bactericidal activity against multidrug-resistant Acinetobacter baumannii urine isolate after 24 hr by NCCLS dilution tube method,Other,,
2915,1087120,1,2,,103163814,4421,Unspecified,,,,,Bactericidal activity against multidrug-resistant Acinetobacter baumannii wound isolate after 24 hr by NCCLS dilution tube method,Other,,
2916,1087121,1,2,,103163814,4421,Unspecified,,,,,Bactericidal activity against multidrug-resistant Acinetobacter baumannii bronchi isolate after 24 hr by NCCLS dilution tube method,Other,,
2917,1097222,1,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hr by two-fold serial dilution method,Other,,
2918,1097223,1,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hr by two-fold serial dilution method,Other,,
2919,1097224,1,2,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli ATCC 25922 after 24 hr by two-fold serial dilution method,Other,,
2920,1117298,1,2,,170465215,4421,Inactive,,,39.8107,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel",Confirmatory,,
2921,1117304,1,2,,170465215,4421,Inactive,,,39.8107,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel",Confirmatory,,
2922,1117305,1,2,,170465215,4421,Inactive,,,0.631,AC50 (uM),"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel",Confirmatory,,
2923,1117310,1,1,,170465215,4421,Inactive,,,39.8107,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel",Confirmatory,,
2924,1117312,1,1,,170465215,4421,Inactive,,,0.630957,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel",Confirmatory,,
2925,1117314,1,1,,170465215,4421,Inactive,,,39.8107,Ac50,"qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel",Confirmatory,,
2926,1117326,1,1,,170465215,4421,Inactive,,,,,nuclear beta catenin stimulation in WNT3A conditioned C2C12 cells-screen,Screening,,
2927,1117329,1,1,,170465215,4421,Inactive,,,,,insulin secretion from INS-1E cells in the presence of 5 mM glucose-screen,Screening,,
2928,1117336,1,1,,170465215,4421,Inactive,,,,,GSK3B-pretreated HCT116 viability from Cell TiterGlo-screen,Screening,,
2929,1117340,1,1,,170465215,4421,Inactive,,,,,VEGF stimulated ADSC/ECFC co-culture CD31-stained tube area decrease-screen,Screening,,
2930,1117341,1,1,,170465215,4421,Inactive,,,,,GLP1 secretion from NCI-H716 cells-screen,Screening,,
2931,1117342,1,1,,170465215,4421,Inactive,,,,,HCT116 viability from Cell TiterGlo-screen,Screening,,
2932,1117343,1,1,,170465215,4421,Inactive,,,,,SW480 viability from Cell TiterGlo-screen,Screening,,
2933,1117346,1,1,,170465215,4421,Inactive,,,,,DLD-1 viability from Cell TiterGlo-screen,Screening,,
2934,1122485,1,1,,103163814,4421,Unspecified,,,,,Antimycobacterial against Mycobacterium smegmatis,Other,,
2935,1159387,1,2,,103163814,4421,Unspecified,,,,,"ASTRAZENECA: Octan-1-ol/water (pH7.4) distribution coefficent measured  by a shake flask method described in J. Biomol. Screen. 2011, 16, 348-355. Experimental range -1.5 to 4.5",Other,,
2936,1159394,1,2,,103163814,4421,Unspecified,,,,,"ASTRAZENECA: Intrinsic clearance measured in human liver microsomes following incubation at 37C. Experimental range <3 to >150 microL/min/mg. Rapid Commun. Mass Spectrom. 2010, 24, 1730-1736.",Other,,
2937,1159396,1,2,,103163814,4421,Unspecified,,,,,"ASTRAZENECA: Intrinsic clearance measured in human hepatocytes following incubation at 37C. Experimental range <3 to >150 microL/min/1E6 cells. Rapid Commun. Mass Spectrom. 2010, 24, 1730-1736.",Other,,
2938,1159509,1,1,,144208675,4421,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
2939,1159509,1,1,,144213071,4421,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
2940,1159509,1,1,,170465215,4421,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
2941,1159515,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
2942,1159515,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
2943,1159515,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
2944,1159516,1,1,,144208675,4421,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
2945,1159516,1,1,,144213071,4421,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
2946,1159516,1,1,,170465215,4421,Inconclusive,119611100.0,22926.0,0.8485,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
2947,1159517,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
2948,1159517,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
2949,1159517,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
2950,1159518,1,1,,144208675,4421,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
2951,1159518,1,1,,144213071,4421,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
2952,1159518,1,1,,170465215,4421,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
2953,1159519,1,1,,144208675,4421,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
2954,1159519,1,1,,144213071,4421,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
2955,1159519,1,1,,170465215,4421,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
2956,1159520,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
2957,1159520,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
2958,1159520,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
2959,1159521,1,1,,144208675,4421,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
2960,1159521,1,1,,144213071,4421,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
2961,1159521,1,1,,170465215,4421,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
2962,1159523,1,1,,144208675,4421,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
2963,1159523,1,1,,144213071,4421,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
2964,1159523,1,1,,170465215,4421,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
2965,1159524,1,1,,56422386,4421,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
2966,1159524,1,1,,124883418,4421,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
2967,1159525,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
2968,1159525,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
2969,1159525,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
2970,1159526,1,1,,144208675,4421,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
2971,1159526,1,1,,144213071,4421,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
2972,1159526,1,1,,170465215,4421,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
2973,1159527,1,1,,144208675,4421,Inconclusive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
2974,1159527,1,1,,144213071,4421,Inconclusive,325495497.0,6256.0,8.7076,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
2975,1159527,1,1,,170465215,4421,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
2976,1159528,1,1,,144208675,4421,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
2977,1159528,1,1,,144213071,4421,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
2978,1159528,1,1,,170465215,4421,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
2979,1159529,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
2980,1159529,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
2981,1159529,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
2982,1159531,1,1,,144208675,4421,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
2983,1159531,1,1,,144213071,4421,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
2984,1159531,1,1,,170465215,4421,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
2985,1159550,3,1,,252401137,4421,Inactive,12653201.0,5226.0,,,Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening,Screening,26479318.0,
2986,1159551,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
2987,1159551,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
2988,1159551,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
2989,1159552,1,1,,144208675,4421,Inactive,325495463.0,5914.0,76.8806,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2990,1159552,1,1,,144213071,4421,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2991,1159552,1,1,,170465215,4421,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2992,1159553,2,1,,144208675,4421,Inconclusive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2993,1159553,2,1,,144213071,4421,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2994,1159553,2,1,,170465215,4421,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
2995,1159555,1,1,,144208675,4421,Inconclusive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
2996,1159555,1,1,,144213071,4421,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
2997,1159555,1,1,,170465215,4421,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
2998,1159580,2,1,,268734775,4421,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
2999,1159583,2,1,,178127345,4421,Inactive,,,,,High throughput screen for small molecule inhibitors of a hypoxia-regulated fluorescent biosensor in Mycobacterium tuberculosis,Other,,
3000,1159606,1,1,,56422386,4421,Inactive,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
3001,1159607,2,1,,312309653,4421,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
3002,1159614,1,2,,170465215,4421,Inactive,22328079.0,2581.0,,Potency,A Novel Cell-Based Assay to Identify Small Molecules for B -Galactocerebrosidase,Confirmatory,,
3003,1164958,1,2,,103163814,4421,Unspecified,84028817.0,,100.0,IC50,Inhibition of Escherichia coli DNA gyrase assessed as supercoiled plasmid DNA formation after 30 mins by electrophoretic analysis,Confirmatory,25238443.0,
3004,1164958,1,2,,103163814,4421,Unspecified,84028820.0,,100.0,IC50,Inhibition of Escherichia coli DNA gyrase assessed as supercoiled plasmid DNA formation after 30 mins by electrophoretic analysis,Confirmatory,25238443.0,
3005,1164959,1,1,,103163814,4421,Unspecified,,,806.0,IC50,Inhibition of Escherichia coli topoisomerase 4 assessed as inhibition of decatenation of catenated kinetoplast DNA after 30 mins by electrophoretic analysis,Confirmatory,25238443.0,
3006,1222793,1,1,,103163814,4421,Unspecified,,,,,"Dissociation constant, pKa of the compound",Other,23454828.0,
3007,1224824,1,1,,174006246,4421,Inactive,,,0.2957,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
3008,1224825,1,1,,174006246,4421,Inactive,,,0.4176,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
3009,1224834,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
3010,1224834,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
3011,1224834,3,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
3012,1224835,1,1,,144208675,4421,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
3013,1224835,1,1,,144213071,4421,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
3014,1224835,1,1,,170465215,4421,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
3015,1224836,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
3016,1224836,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
3017,1224836,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
3018,1224837,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
3019,1224837,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
3020,1224837,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
3021,1224838,1,1,,144208675,4421,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
3022,1224838,1,1,,144213071,4421,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
3023,1224838,1,1,,170465215,4421,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
3024,1224839,1,1,,144208675,4421,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
3025,1224839,1,1,,144213071,4421,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
3026,1224839,1,1,,170465215,4421,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
3027,1224840,3,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
3028,1224840,3,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
3029,1224840,3,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
3030,1224841,3,1,,144208675,4421,Inconclusive,325495545.0,2101.0,2.7278,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
3031,1224841,3,1,,144213071,4421,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
3032,1224841,3,1,,170465215,4421,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
3033,1224842,3,1,,144208675,4421,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
3034,1224842,3,1,,144213071,4421,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
3035,1224842,3,1,,170465215,4421,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
3036,1224843,1,1,,144208675,4421,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
3037,1224843,1,1,,144213071,4421,Inconclusive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
3038,1224843,1,1,,170465215,4421,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
3039,1224844,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
3040,1224844,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
3041,1224844,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
3042,1224845,1,1,,144208675,4421,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
3043,1224845,1,1,,144213071,4421,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
3044,1224845,1,1,,170465215,4421,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
3045,1224846,1,1,,144208675,4421,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
3046,1224846,1,1,,144213071,4421,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
3047,1224846,1,1,,170465215,4421,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
3048,1224847,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
3049,1224847,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
3050,1224847,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
3051,1224848,3,1,,144208675,4421,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
3052,1224848,3,1,,144213071,4421,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
3053,1224848,3,1,,170465215,4421,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
3054,1224849,3,1,,144208675,4421,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
3055,1224849,3,1,,144213071,4421,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
3056,1224849,3,1,,170465215,4421,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
3057,1224857,2,1,,170465215,4421,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
3058,1224857,2,1,,174006246,4421,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
3059,1224859,2,1,,170465215,4421,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
3060,1224859,2,1,,174006246,4421,Inactive,,,,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
3061,1224863,1,1,,316920488,4421,Inactive,90421313.0,1080.0,,IC50,Phenotypic Assay to Identify Small Molecules that Upregulate Production of hCFTR in HeLa Cells,Confirmatory,,
3062,1224864,1,2,,316934607,4421,Inactive,,,,,HCS microscopy assay (F508del-CFTR),Screening,27732613.0,
3063,1224865,1,2,,56422386,4421,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
3064,1224867,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
3065,1224867,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
3066,1224867,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
3067,1224868,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
3068,1224868,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
3069,1224868,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
3070,1224869,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
3071,1224869,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
3072,1224869,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
3073,1224870,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
3074,1224870,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
3075,1224870,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
3076,1224871,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
3077,1224871,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
3078,1224871,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
3079,1224872,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
3080,1224872,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
3081,1224872,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
3082,1224873,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
3083,1224873,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
3084,1224873,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
3085,1224874,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
3086,1224874,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
3087,1224874,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
3088,1224875,1,1,,144208675,4421,Inconclusive,,,0.616,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
3089,1224875,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
3090,1224875,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
3091,1224876,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
3092,1224876,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
3093,1224876,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
3094,1224877,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
3095,1224877,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
3096,1224877,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
3097,1224878,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
3098,1224878,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
3099,1224878,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
3100,1224879,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
3101,1224879,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
3102,1224879,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
3103,1224880,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
3104,1224880,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
3105,1224880,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
3106,1224881,1,1,,144208675,4421,Inconclusive,,,0.6912,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
3107,1224881,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
3108,1224881,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
3109,1224882,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
3110,1224882,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
3111,1224882,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
3112,1224883,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
3113,1224883,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
3114,1224883,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
3115,1224884,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
3116,1224884,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
3117,1224884,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
3118,1224885,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
3119,1224885,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
3120,1224885,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
3121,1224886,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
3122,1224886,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
3123,1224886,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
3124,1224887,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
3125,1224887,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
3126,1224887,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
3127,1224888,1,1,,144208675,4421,Inconclusive,,,0.5489999999999999,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
3128,1224888,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
3129,1224888,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
3130,1224889,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
3131,1224889,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
3132,1224889,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
3133,1224890,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
3134,1224890,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
3135,1224890,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
3136,1224892,1,1,,144208675,4421,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
3137,1224892,1,1,,144213071,4421,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
3138,1224892,1,1,,170465215,4421,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
3139,1224893,1,1,,144208675,4421,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
3140,1224893,1,1,,144213071,4421,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
3141,1224893,1,1,,170465215,4421,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
3142,1224894,1,1,,144208675,4421,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
3143,1224894,1,1,,144213071,4421,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
3144,1224894,1,1,,170465215,4421,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
3145,1224895,1,1,,144208675,4421,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
3146,1224895,1,1,,144213071,4421,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
3147,1224895,1,1,,170465215,4421,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
3148,1224896,1,1,,144208675,4421,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
3149,1224896,1,1,,144213071,4421,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
3150,1224896,1,1,,170465215,4421,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
3151,1225592,1,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli NIHJ,Other,25738967.0,
3152,1225593,1,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Escherichia coli NIHJ JC2,Other,25738967.0,
3153,1225594,1,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae 602,Other,25738967.0,
3154,1225595,1,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Klebsiella pneumoniae PCI602,Other,25738967.0,
3155,1225596,1,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Proteus mirabilis GN2425,Other,25738967.0,
3156,1225597,1,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Proteus vulgaris HX19,Other,25738967.0,
3157,1225598,1,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Salmonella typhi T58,Other,25738967.0,
3158,1225599,1,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus 209P,Other,25738967.0,
3159,1225600,1,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus 209p JC1,Other,25738967.0,
3160,1225601,1,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Pseudomonas aeruginosa 104,Other,25738967.0,
3161,1225602,1,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Pseudomonas aeruginosa TU408,Other,25738967.0,
3162,1243364,1,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Staphylococcus aureus ATCC 25923 incubated for 18 hrs by agar dilution method,Other,26253630.0,
3163,1243365,1,1,,103163814,4421,Unspecified,,,,,Antimicrobial activity against Streptococcus pyogenes ATCC 19615 incubated for 18 hrs by agar dilution method,Other,26253630.0,
3164,1243366,1,1,,103163814,4421,Active,,,,,Antimicrobial activity against Salmonella typhimurium ATCC 19430 incubated for 18 hrs by agar dilution method,Other,26253630.0,
3165,1243367,1,1,,103163814,4421,Active,,,,,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 18 hrs by agar dilution method,Other,26253630.0,
3166,1246781,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus at 10 ug/disk after 24 hrs by agar plate disk diffusion method,Other,26277407.0,
3167,1246782,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli at 10 ug/disk after 24 hrs by agar plate disk diffusion method,Other,26277407.0,
3168,1246783,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus vulgaris at 10 ug/disk after 24 hrs by agar plate disk diffusion method,Other,26277407.0,
3169,1246784,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa at 10 ug/disk after 24 hrs by agar plate disk diffusion method,Other,26277407.0,
3170,1246785,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella typhi at 10 ug/disk after 24 hrs by agar plate disk diffusion method,Other,26277407.0,
3171,1246786,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella paratyphi at 10 ug/disk after 24 hrs by agar plate disk diffusion method,Other,26277407.0,
3172,1246787,1,1,,103163814,4421,Unspecified,,,,,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 5 days by micro alamar blue assay,Other,26277407.0,
3173,1246788,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus after 24 hrs by agar dilution method,Other,26277407.0,
3174,1246789,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Staphylococcus aureus after 5 days by microdilution method,Other,26277407.0,
3175,1246790,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli after 24 hrs by agar dilution method,Other,26277407.0,
3176,1246791,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Escherichia coli after 5 days by microdilution method,Other,26277407.0,
3177,1246792,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus vulgaris after 24 hrs by agar dilution method,Other,26277407.0,
3178,1246793,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Proteus vulgaris after 5 days by microdilution method,Other,26277407.0,
3179,1246794,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa after 24 hrs by agar dilution method,Other,26277407.0,
3180,1246795,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Pseudomonas aeruginosa after 5 days by microdilution method,Other,26277407.0,
3181,1246796,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella typhi after 24 hrs by agar dilution method,Other,26277407.0,
3182,1246797,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella typhi after 5 days by microdilution method,Other,26277407.0,
3183,1246798,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella paratyphi after 24 hrs by agar dilution method,Other,26277407.0,
3184,1246799,1,1,,103163814,4421,Unspecified,,,,,Antibacterial activity against Salmonella paratyphi after 5 days by microdilution method,Other,26277407.0,
3185,1259241,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
3186,1259241,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
3187,1259241,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
3188,1259242,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
3189,1259242,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
3190,1259242,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
3191,1259243,1,1,,144208675,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
3192,1259243,1,1,,144213071,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
3193,1259243,1,1,,170465215,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
3194,1259244,1,1,,144208675,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
3195,1259244,1,1,,144213071,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
3196,1259244,1,1,,170465215,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
3197,1259247,1,1,,144208675,4421,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
3198,1259247,1,1,,144213071,4421,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
3199,1259247,1,1,,170465215,4421,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
3200,1259248,1,1,,144208675,4421,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
3201,1259248,1,1,,144213071,4421,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
3202,1259248,1,1,,170465215,4421,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
3203,1259252,1,1,,174006246,4421,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
3204,1259253,1,1,,174006246,4421,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
3205,1259255,1,1,,174006246,4421,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
3206,1259256,1,1,,174006246,4421,Inactive,169655958.0,,,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
3207,1259309,1,1,,178127345,4421,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220 with the processive glycosyltransferase UgtP deleted,Other,,
3208,1259310,1,1,,104169992,4421,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
3209,1259310,1,1,,332877401,4421,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
3210,1259310,1,1,,332877430,4421,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
3211,1259311,1,1,,178127345,4421,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220,Other,,
3212,1259313,1,1,,56422386,4421,Inactive,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
3213,1259318,1,1,,855620,4421,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
3214,1259325,1,2,,336954238,4421,Inactive,4504843.0,3763.0,,,Discovering small molecule activators of G protein-gated inwardly-rectifying potassium subunit 2 (GIRK2) containing channels utilizing methyl-2 4-pentanediol (MPD) for partial channel activation during screening,Screening,,
3215,1259344,1,1,,144204386,4421,Inactive,,,,Potency,qHTS assay to identify small molecule phospholipidosis (PLD) inducers,Confirmatory,,
3216,1259355,1,1,,26751460,4421,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-1,Confirmatory,,
3217,1259356,1,1,,144204386,4421,Inactive,,,,Potency,qHTS assay to identify small molecule inhibitors of chordoma cells - UCH-2,Confirmatory,,
3218,1259364,1,1,,144208675,4421,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
3219,1259364,1,1,,144213071,4421,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
3220,1259364,1,1,,170465215,4421,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
3221,1259365,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
3222,1259365,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
3223,1259365,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
3224,1259366,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
3225,1259366,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
3226,1259366,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
3227,1259367,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
3228,1259367,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
3229,1259367,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
3230,1259368,1,1,,144208675,4421,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
3231,1259368,1,1,,144213071,4421,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
3232,1259368,1,1,,170465215,4421,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
3233,1259369,1,1,,144208675,4421,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
3234,1259369,1,1,,144213071,4421,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
3235,1259369,1,1,,170465215,4421,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
3236,1259370,2,2,,124637139,4421,Inactive,312803.0,1017.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
3237,1259370,2,2,,124637139,4421,Inactive,510604.0,890.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
3238,1259370,2,2,,124637139,4421,Inactive,14602917.0,994.0,,,Inhibitors of CDC25B-CDK2/CyclinA interaction,Other,,
3239,1259377,1,1,,144208675,4421,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
3240,1259377,1,1,,144213071,4421,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
3241,1259377,1,1,,170465215,4421,Inconclusive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
3242,1259378,1,1,,144208675,4421,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
3243,1259378,1,1,,144213071,4421,Inconclusive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
3244,1259378,1,1,,170465215,4421,Inconclusive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
3245,1259379,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
3246,1259379,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
3247,1259379,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
3248,1259380,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
3249,1259380,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
3250,1259380,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
3251,1259381,1,1,,144208675,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
3252,1259381,1,1,,144213071,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
3253,1259381,1,1,,170465215,4421,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
3254,1259382,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
3255,1259382,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
3256,1259382,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
3257,1259383,1,1,,144208675,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
3258,1259383,1,1,,144213071,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
3259,1259383,1,1,,170465215,4421,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
3260,1259384,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
3261,1259384,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
3262,1259384,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
3263,1259385,1,1,,144208675,4421,Inconclusive,119601739.0,7253.0,68.5199,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
3264,1259385,1,1,,144213071,4421,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
3265,1259385,1,1,,170465215,4421,Inconclusive,119601739.0,7253.0,33.4915,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
3266,1259386,1,1,,144208675,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
3267,1259386,1,1,,144213071,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
3268,1259386,1,1,,170465215,4421,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
3269,1259387,1,1,,144208675,4421,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
3270,1259387,1,1,,144213071,4421,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
3271,1259387,1,1,,170465215,4421,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
3272,1259388,1,1,,144208675,4421,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
3273,1259388,1,1,,144213071,4421,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
3274,1259388,1,1,,170465215,4421,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
3275,1259389,1,1,,124637139,4421,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
3276,1259390,1,1,,144208675,4421,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
3277,1259390,1,1,,144213071,4421,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
3278,1259390,1,1,,170465215,4421,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
3279,1259391,1,1,,144208675,4421,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
3280,1259391,1,1,,144213071,4421,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
3281,1259391,1,1,,170465215,4421,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
3282,1259392,1,1,,144208675,4421,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
3283,1259392,1,1,,144213071,4421,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
3284,1259392,1,1,,170465215,4421,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
3285,1259393,1,1,,144208675,4421,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
3286,1259393,1,1,,144213071,4421,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
3287,1259393,1,1,,170465215,4421,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
3288,1259394,1,1,,144208675,4421,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
3289,1259394,1,1,,144213071,4421,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
3290,1259394,1,1,,170465215,4421,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
3291,1259395,1,1,,144208675,4421,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
3292,1259395,1,1,,144213071,4421,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
3293,1259395,1,1,,170465215,4421,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
3294,1259396,1,1,,144208675,4421,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
3295,1259396,1,1,,144213071,4421,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
3296,1259396,1,1,,170465215,4421,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
3297,1259400,1,1,,170465215,4421,Inactive,166209887.0,59350.0,,,qHTS Assay for Antagonists of the Relaxin Receptor RXFP1,Screening,,
3298,1259401,1,1,,144208675,4421,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
3299,1259401,1,1,,144213071,4421,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
3300,1259401,1,1,,170465215,4421,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
3301,1259402,1,1,,144208675,4421,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
3302,1259402,1,1,,144213071,4421,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
3303,1259402,1,1,,170465215,4421,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
3304,1259403,1,1,,144208675,4421,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
3305,1259403,1,1,,144213071,4421,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
3306,1259403,1,1,,170465215,4421,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
3307,1259404,1,1,,144208675,4421,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
3308,1259404,1,1,,144213071,4421,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
3309,1259404,1,1,,170465215,4421,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
3310,1259406,1,1,,363920474,4421,Unspecified,,,,,BK Channel Variant Modulator Selectivity Assay,Screening,,
3311,1259406,1,1,1.0,363920474,4421,Inactive,26638650.0,3778.0,0.0464093,LogChange(F380Y),BK Channel Variant Modulator Selectivity Assay,Screening,,
3312,1259406,1,1,2.0,363920474,4421,Inactive,4758626.0,3779.0,0.00257639,LogChange(F380Y/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
3313,1259406,1,1,3.0,363920474,4421,Inactive,5031823.0,10242.0,0.015187799999999998,LogChange(F380Y/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
3314,1259406,1,1,4.0,363920474,4421,Inactive,26051275.0,27345.0,0.025170599999999998,LogChange(F380Y/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
3315,1259406,1,1,5.0,363920474,4421,Inactive,160410009.0,389816.0,0.025854500000000002,LogChange(F380Y/Slo1WT/gamma1),BK Channel Variant Modulator Selectivity Assay,Screening,,
3316,1259406,1,1,6.0,363920474,4421,Inactive,26638650.0,3778.0,-0.0164829,LogChange(R275C),BK Channel Variant Modulator Selectivity Assay,Screening,,
3317,1259406,1,1,7.0,363920474,4421,Inactive,4758626.0,3779.0,0.036597000000000005,LogChange(R275C/beta1),BK Channel Variant Modulator Selectivity Assay,Screening,,
3318,1259406,1,1,8.0,363920474,4421,Inactive,5031823.0,10242.0,0.00075068,LogChange(R275C/beta2Delta),BK Channel Variant Modulator Selectivity Assay,Screening,,
3319,1259406,1,1,9.0,363920474,4421,Inactive,26051275.0,27345.0,0.0726138,LogChange(R275C/beta4),BK Channel Variant Modulator Selectivity Assay,Screening,,
3320,1259406,1,1,10.0,363920474,4421,Inactive,5031823.0,10242.0,-0.00423059,LogChange(R275C/Slo1WT/beta2),BK Channel Variant Modulator Selectivity Assay,Screening,,
3321,1259407,1,1,,363900315,4421,Inactive,,,,,CCRIS mutagenicity studies,Other,,
3322,1259408,1,1,,363895602,4421,Active,,,,,GENE-TOX mutagenicity studies,Other,,
3323,1259411,1,1,,363900315,4421,Unspecified,,,,,CCRIS carcinogenicity studies,Other,,
3324,1259413,1,2,,104169992,4421,Inactive,47605623.0,173990.0,,,Modulators of fzo-1,Other,,
3325,1259415,1,1,,855620,4421,Inactive,,,,,qHTS Assay for inhibitors of the human cytomegalovirus (HCMV),Screening,,
3326,1259416,1,2,,855620,4421,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
3327,1259416,1,2,,340080289,4421,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
3328,1259421,1,1,,340080289,4421,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
3329,1259423,1,2,,354791558,4421,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
3330,1259423,1,2,,354937107,4421,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
3331,1259423,1,2,,354969305,4421,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
3332,1259423,1,2,,354981257,4421,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
